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We are all aware of the problems facing individuals,
families and communities as a result of drug misuse.
However, solutions are not clear or easy and
addressing this complex problem requires a
multidisciplinary response by a range of Government
Departments, Agencies and communities. 
It was for this reason that the Government agreed the
National Drugs Strategy 2001-2008. The Strategy
brings together for the first time all the key agencies
involved in the drugs field in a co-ordinated manner
in order to tackle the problem of drug misuse. It sets
out a series of objectives, performance indicators and
actions. The publication of this report covering the
period 2001 to mid 2004 provides us with an
opportunity to assess progress to date, to look at the
challenges ahead and to ensure to that we continue
to deliver on the commitments in the Strategy.
Although many challenges remain, it is important to
note the progress that has been made. 
In relation to supply, while there are annual
fluctuations, there has been an increase in the
volume of drugs seized in almost all drug categories
over the period. Of particular note has been the big
increase in cannabis resin, amphetamines, cocaine
and ecstasy seizures in 2003.
Under the prevention pillar, the Department of Education
and Science has put substance misuse programmes on
all school curricula since September 2003. In addition,
under this pillar the National Awareness Campaign on
Drugs was launched in May 2003 to promote greater
awareness and communication about the drugs issue. 
It is being rolled out over three years. The campaign 
has featured a number of television, radio and press
advertisements which are supported by information
brochures and a website. 
Regarding treatment, considerable progress has 
been made in increasing the number of methadone
treatment places. As of July 2004, the number in
treatment was over 7,000, exceeding the target of
6,500 set in the Strategy and is an increase of 40%
since December 2000. In addition, although more
work remains to be done to reach the targets set 
in the Strategy, waiting lists for treatment have also
been reduced. 
In relation to research, the National Advisory
Committee on Drugs (NACD) have produced a
number of important reports which are outlined in
Chapter 2, including the All-Ireland Drug Prevalence
Survey and an estimate of opiate users which provide
sound and reliable base-line data essential for tracking
progress in the years ahead.
I am also very glad to say that all ten of the Regional
Drugs Task Forces (RDTFs) are up and running since
the end of 2003. Although this has taken longer than
expected, I believe that it has been time well spent.
The Task Forces are currently mapping out the
patterns of drug misuse in their areas – as well as 
the range and level of existing services – with a view
to better co-ordination and addressing gaps in the
overall provision. The work being undertaken by the
RDTFs will feed into the drafting of regional action
plans and I am confident that these will be rolled 
out in 2005. 
In addition, the valuable work being done through 
the Local Drugs Task Forces and the Young People’s
Facilities and Services Fund is ongoing. Since the
Strategy was launched in 2001, the second round 
of LDTF plans have got underway and I also launched
a second round of the YPFSF in early 2004. 
In this regard, it is worth pointing out that since 1997,
over €80m has been allocated to the Task Forces 
to implement their two rounds of local action plans. 
A further €12.8m has been allocated to capital
projects under the Premises Initiative for Community
Drugs Projects and approx. €80m has been allocated
to support the work of the YPFSF. 
I am also aware that trends in drug misuse continue
to change and, in particular, cocaine use now poses
serious challenges for all those involved in delivering
drugs services. In this regard, I have recently approved
various pilot projects in the areas of training,
education and treatment aimed at tackling the
Minister’s Foreword
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problem of cocaine use. I am confident that the
results of these pilots will help us improve our
knowledge in this area. These projects will be rolled
out during 2005.
In addition to this report, my Department is working
on the mid-term review of the Strategy. The review
will allow us to assess the current state of the
Strategy and re-focus it, if necessary, in the remaining
years up to 2008. A widespread public consultation
process has been carried out and the outcome of the
process will no doubt highlight many new challenges
for the remainder of the Strategy.
A number of Departments and Agencies have helped
provide the information in this report and I thank
them for their input. I would also like thank the
individual projects mentioned in Chapter 4 for
providing information on the important work which
they carry out in Local Drug Task Force areas.
In conclusion, I think it is important to say that the
Strategy set many challenging and ambitious targets
and in the three years or so since it was launched, 
I believe that significant progress has been made
across the four pillars. However, I am also aware that
we are just at the halfway stage and that many key
challenges remain to be tackled. Accordingly, we must
continue to vigorously pursue the implementation of
the Strategy in order to meet our overall objective of
significantly reducing the harm caused by drugs to
individuals, families and communities. This must
continue to be a priority for all of us who are involved
in this area in the coming years.
Noel Ahern T.D.
Minister of State for the National Drugs Strategy
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Background to the Strategy and
structures involved in its delivery
1.1 Background
1.1.1 The National Drugs Strategy 2001-2008 was
launched in May 2001 and brings together, 
for the first time, all of the elements of 
drugs policy in Ireland into a single policy
framework. The overall strategic objective 
of the National Drugs Strategy is: 
“..to significantly reduce the harm caused 
to individuals and society by the misuse 
of drugs through a concerted focus on 
supply reduction, prevention, treatment 
and research.” 
The Strategy assigns responsibility to – and
sets targets for – the different Government
Departments and Agencies involved in
delivering drugs policy across the four pillars
of supply reduction, prevention (including
education and awareness), treatment
(including rehabilitation and risk reduction)
and research. Under each of the pillars, a
series of objectives and key performance
indicators have been set. The Strategy also
sets out 100 actions for implementation 
by individual Departments and Agencies.
These actions are designed to drive the
Strategy forward. 
1.2 Structures of the National 
Drugs Strategy
1.2.1 Aside from the individual Departments and
Agencies which are outlined in Table 1.1,
there are a number of other structures
involved in implementing the Drugs Strategy:
• Cabinet Committee on Social Inclusion 
(CCSI)
• Inter-Departmental Group on Drugs (IDG)
• Department of Community, Rural and 
Gaeltacht Affairs – Drugs Strategy Unit
• National Drugs Strategy Team (NDST)
• National Advisory Committee on Drugs 
(NACD)
• Local Drugs Task Forces (LDTFs)
• Regional Drugs Task Forces (RDTFs)
• National Assessment Committee (NAC) for 
the Young People’s Facilities and Services 
Fund (YPFSF)
• Young People’s Facilities and Services Fund 
Development Groups 
Cabinet Committee on Social Inclusion (CCSI)
1.2.2 The Cabinet Committee on Social Inclusion 
is chaired by the Taoiseach and comprises 
the Tánaiste and relevant Ministers. The 
CCSI gives overall political direction to the
Government’s social inclusion policies,
including the National Drugs Strategy. It has,
inter alia, responsibility for reviewing trends 
in the area of drug misuse, assessing progress
in implementing the Drugs Strategy and
resolving policy or organisational difficulties
which may inhibit effective responses to the
problem.
Inter-Departmental Group on Drugs (IDG)
1.2.3 The IDG is an inter-departmental committee
which has representatives from relevant
Departments at senior official level. It’s role 
is to oversee progress on the implementation
of the Strategy and endeavour to overcome
obstacles that may arise. It is chaired by
Minister of State Noel Ahern T.D. who has
responsibility for the National Drugs Strategy
at the Department of Community, Rural and
Gaeltacht Affairs. The Department also
provides the secretariat to the Group. The
current membership of the IDG is set out 
in Appendix 1.
1.2.4 In general, the IDG monitors progress made
and addresses problems encountered under
the four pillars of the Strategy. In addition,
developments in the LDTFs and RDTFs, the
YPFSF and the NACD are regularly monitored
Chapter One
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by the IDG. Problems and obstacles are
discussed and consensus sought on possible
solutions. The IDG also approves submissions
to the CCSI. 
Department of Community, Rural and Gaeltacht
Affairs (D/CRGA)
1.2.5 The Department is responsible for the overall
co-ordination of the implementation of the
National Drugs Strategy and for funding the
work of the LDTFs, the YPFSF and the NACD.
The Drugs Strategy Unit of the Department
carries out these functions. The Unit services
and provides the secretariat for the IDG, which
is chaired by the Minister of State and, in
addition, provides the chair and secretariat for
the National Assessment Committee of the
YPFSF. The Unit is also represented on the
NDST and the NACD. It also chairs the British-
Irish Council Sectoral Group on the Misuse of
Drugs1 and represents Ireland at the meetings
of the EU National Drugs Co-ordinators.
Membership of the Unit is attached as
Appendix 2.
National Drugs Strategy Team (NDST)
1.2.6 The NDST is a cross-departmental team
comprising personnel from a number of
Departments and Agencies. In addition, the
community and voluntary sectors each have 
a representative on the Team. The NDST
currently has an independent chairperson 
and 4.5 support staff, including a Director, 
a Development Worker and a Finance Officer.
The NDST’s role is to ensure that there is
effective co-ordination between Departments
and Agencies in the delivery of the LDTF and
RDTF plans. The Team also oversee the work
of the LDTFs and the RDTFs and identify and
consider policy issues arising out of the work
of the LDTFs and RDTFs. 
1.2.7 Each member of the NDST acts as a liaison
person for an LDTF and RDTF. The NDST also
meets on a regular basis with the chairpersons
and co-ordinators of the Task Forces and with
the Voluntary Drug Treatment Network2 and
Citywide3 to review progress and identify
issues to be addressed. In addition, under the
Strategy, the NDST is charged with meeting
the co-ordinator of the National Alcohol Policy
on a regular basis. In this way, issues of
mutual concern can be discussed and future
co-operation considered.
Membership of the Team is attached as
Appendix 3.
Local Drugs Task Forces (LDTFs) 
1.2.8 The 14 LDTFs4 were established in areas
experiencing the highest levels of drug
misuse, particularly heroin. Thirteen of the
fourteen were established in 1997 with Bray
being set up in 2000. The overall role of the
LDTFs is to prepare and implement local
action plans which identify existing and
emerging gaps in services in relation to
education/prevention, treatment, rehabilitation
Chapter One
1 The British Irish Council (BIC) was created under Strand Three of the Good Friday Agreement in 1998 to promote positive, practical
relationships among its Members who are the British and Irish Governments, the devolved administrations of N. Ireland, Wales and
Scotland and Jersey, Guernsey and the Isle of Man. Since the first BIC Summit meeting in December 1999, the Irish Government 
has taken the lead in advancing work in relation to the issue of drug misuse. In this regard, the Irish Government, in consultation and 
co-operation with all BIC administrations, has successfully carried out two work programmes. Both programmes covered a range of 
issues concerned with drug misuse.
2 The Voluntary Drug Treatment Network was established in the early 1990s as a Dublin based umbrella organisation for a number of
different groups working in the drugs field. Its role and remit in recent times has expanded to a national focus with the establishment of
the RDTFs.
3 Citywide is an organisation which supports and facilitates local communities in developing their own responses to the drug problem and
provides a network for a whole range of community groups and organisations.
4 Twelve of the LDTFs are located in the greater Dublin area – the North Inner City, South Inner City, Ballymun, Ballyfermot, Finglas/Cabra,
Dublin 12 (Crumlin, Drimnagh, Kimmage and Walkinstown), Dublin North East, Canal Communities (Bluebell, Inchicore and Rialto),
Blanchardstown, Clondalkin, Tallaght and Dun Laoghaire-Rathdown. The remaining LDTFs are in Cork City and Bray, Co. Wicklow.
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and curbing local supply. In addition, the
LDTFs provide a mechanism for the co-
ordination of mainstream services in these
areas, while at the same time allowing local
communities and voluntary organisations to
participate in the planning, design and delivery
of those services.
1.2.9 Membership of the LDTFs include
representatives of all the relevant agencies
such as the Health Board, the Gardaí, the
Probation and Welfare Service, the Department
of Education and Science, the Local Authority,
the Youth Service and FÁS. The Task Forces
also include representation from voluntary
agencies, community representatives and
elected public representatives. Each Task Force
has a voluntary chairperson who is nominated
by the local Area Partnership and a full-time
co-ordinator whose post is funded by the
Health Board. All LDTFs, with the exception of
Bray (which, as outlined above, was
established in 2000 and is implementing its
first plan) are currently implementing their
second round of action plans. 
A list of LDTF co-ordinators and chairpersons
is attached as Appendix 4.
Chapter 4 highlights a number of projects
developed through the Task Force plans.
Regional Drugs Task Forces (RDTFs)
1.2.10 By the end of 2003, RDTFs had been
established in the 10 Health Board regions
throughout the country. The RDTFs work in a
partnership manner similar to the LDTFs and
are made up of nominees from state agencies
working in the region, the community and
voluntary sector and elected public
representatives. Each has a voluntary
chairperson and an interim co-ordinator.
1.2.11 At present, the RDTFs are mapping out the
patterns of drug misuse in their areas, as well
as the current levels of services in place to
address drugs misuse in their regions. It is
anticipated that much of this work will be
completed by the end of 2004 and that it will
inform the development of strategic plans to
address gaps in key services going forward.
The RDTFs will then forward these plans to
the NDST for assessment. Recommendations
on funding will then be made to the IDG and
CCSI. It is expected that the RDTFs will begin
implementation of their action plans by mid 
to late 2005. 
National Advisory Committee on Drugs (NACD)
1.2.12 The NACD was established in July 2000 
to advise the Government in relation to 
the prevalence, prevention, treatment and
consequences of problem drug use in Ireland,
based on the Committee’s analysis and
interpretation of research findings and
information available to it. Its membership
reflects statutory, community, voluntary,
academic and research interests as well as
representation from the relevant Government
Departments. The Committee is supported in
its work by a Director, a Research Officer and
two other administrative and support staff. 
The Committee has an annual budget of
€1.27m and operates under the aegis 
of the Department of Community, Rural 
and Gaeltacht Affairs. In July 2004, the
Government extended the mandate of the
NACD up until the end of 2008.
A list of the current membership of the
Committee is set out in Appendix 5. Chapters
2 and 3 give further details on the work of 
the NACD. 
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National Assessment Committee (NAC) – 
Young People’s Facilities and Services Fund (YPFSF)
1.2.13 The YPFSF was established in 1998 to
support the development of youth facilities,
including sport and recreational facilities, 
and services in disadvantaged areas where 
a significant drug problem exists or has 
the potential to develop. The overall aim 
of the fund is to attract young people in
disadvantaged areas into more healthy and
productive pursuits. The Fund is overseen 
by a National Assessment Committee (NAC),
which is chaired by the Drugs Strategy Unit 
in the Department of Community, Rural and
Gaeltacht Affairs.
1.2.14 The NAC reviews plans submitted by
Development Groups and makes
recommendations on funding to the IDG and
the CCSI. The Committee also has an ongoing
role in monitoring progress in implementing
the plans and strategies approved, addressing
any difficulties or issues arising and approving
any major changes to plans.
The current membership of the NAC is set out
in Appendix 6. 
YPFSF – Development Groups
1.2.15 Development Groups for the YPFSF are made
up of representatives of the LDTF, the VEC
and the Local Authority. The Groups prepare
plans for their areas which are assessed by
the NAC and recommendations on funding
are made to the IDG and the CCSI.
Development Groups monitor progress on
implementation of plans and report regularly
to the NAC on that progress.
Further details on the work of the LDTFs and
the YPFSF are set out in Chapter 4. 
Implementing Departments 
1.2.16 As outlined above, the Strategy sets out four
distinct but inter-linked pillars which comprise
the Government response to the drug
problem: 
• supply reduction; 
• prevention (including education 
and awareness)
• treatment (including rehabilitation and risk 
reduction); and 
• research. 
The pillars are underpinned by improved 
inter-agency co-operation and co-ordination.
The principal responsibility for each of these
areas lies with the State agencies as outlined in
Table 1.1. As indicated above, the Department
of Community, Rural and Gaeltacht Affairs is
responsible for the overall co-ordination of 
the implementation of the Strategy. There is, 
of course, a necessary sharing of responsibility.
For example, An Garda Síochána has an
important role in primary prevention in addition
to their more high profile role in supply control.
Similarly, the Prisons Service has a role in
treatment and rehabilitation. In this context, 
the community and voluntary sectors have 
a pivotal role across the four pillars. 
Further details on the work and progress of
the various Departments and Agencies in
implementing the Strategy is set out in
Chapter 3.
Chapter One
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Table 1.1: Departments/Agencies involved in implementing the Strategy
Pillar Lead Department/Agency Other Key Actors
Supply Reduction Department of Justice, Equality 
and Law Reform 
An Garda Síochána
Customs and Excise Service 
in the Office of the Revenue
Commissioners 
Prisons Service
Department of the Environment and
Local Government
Local Authorities
Community and Voluntary Sectors
Prevention Department of Education and Science
Department of Health and Children 
Regional Health Boards
An Garda Síochána 
Community and Voluntary Sectors
Treatment & Rehabilitation Department of Health and Children 
Regional Health Boards
FÁS
Prisons Service
Probation and Welfare Service
Drug Court Programme5
Community and Voluntary Sectors
Research National Advisory Committee on Drugs
Health Research Board
Regional Health Boards
Community and Voluntary Sectors
5 Details on the experience of the Irish Drug Court Project are contained in Appendix 7
Chapter Two
Nature and Extent 
of Drug Misuse in Ireland 
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Nature and Extent of Drug 
Misuse in Ireland 
This chapter sets out the most recent available
information on the nature and extent of drug 
misuse in Ireland in the period covered by this Report
(2001-2004). A number of data sources were used
in compiling this chapter:
• National Advisory Committee on Drugs (NACD) –
publications and research;
• Central (Methadone) Treatment List; 
• Garda Annual Reports – 2000-2003; and 
• National Drug Treatment Reporting System
(NDTRS) data from the Drug Misuse Research
Division in the Health Research Board.6
2.1 All-Ireland Drug Prevalence Survey
National Prevalence
2.1.1 The first Drug Prevalence Survey in Ireland
and Northern Ireland was jointly
commissioned in 2002 by the NACD and the
Drug and Alcohol Information and Research
Unit (DAIRU) within the Department of
Health, Social Services and Public Safety 
in Northern Ireland. The Survey, which was
carried out in accordance with European
Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) guidelines, used a 
pre-prepared questionnaire and face-to-face
interviews among the 15-64 year age group7.
Information on the following was collected:
• lifetime use (has the respondent used the 
drug at least once in their lifetime);
• recent use (has the respondent used the 
drug at least once in the last year); and 
• current use (has the respondent used the 
drug at least once in the last month).
Fieldwork for the survey was carried out
between October 2002 and April 2003 and
8,442 people were interviewed (4,925 in
Ireland and 3,517 in Northern Ireland). 
2.1.2 The key findings from the first bulletin of the
survey were published in October 2003. In
particular, the survey found that just under
one in five people (19%) (see Figure 2.1)
surveyed reported ever using an illegal drug,
one in eighteen (5.6%) reported use within
the previous year, while one in thirty-three
(3%) reported use in the previous month.
Cannabis is reported as the most widely used
illegal drug, with just under 18% reporting
having used the drug at least once in their
lifetime. The corresponding figures for recent
and current use were 5.1% and 2.6%. 
Figure 2.1
Prevalence of Illegal Drug use
2.1.3 Prevalence of other illegal drugs were
substantially lower (Figure 2.2) and largely
confined to the younger age groups. Lifetime
prevalence rates for other drugs were
substantially lower – magic mushrooms (4%),
Chapter Two
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6 The Drug Misuse Research Division (DMRD) of the HRB is involved in national and international research, information gathering and
dissemination on drugs and their misuse in Ireland. Through its activities the DMRD aims to inform policy and contribute to the academic
understanding of drug misuse. The DMRD is funded by national and EU sources and by contract research.
7 According to the 2002 Census, there are approximately 2.65 million people in Ireland in this age bracket. 
ecstasy (3.8%), cocaine (3.1%), LSD and
amphetamines (each 3%), poppers (2.6%)
and solvents (1.8%). Less than one per cent
of respondents reported ever using heroin
(0.5%) or crack (0.4%) although this type of
survey is not necessarily a good measure of
hidden populations such as these.8
Figure 2.2
Lifetime Prevalence by Drug
2.1.4 Lifetime prevalence rates for different drugs
varied between age groups with the highest
lifetime prevalence amongst the 25-34-year-
old age group, except for certain drugs such
as ecstasy, cocaine, poppers and solvents
which were highest amongst 15-24-year-olds.
In contrast, the use of sedatives, tranquillisers
and anti-depressants increased with age, with
those aged 55-64 reporting the highest level
of lifetime use. In relation to recent and
current use, those aged 15-24 had the
highest prevalence rate for illegal drugs and
those aged 35 and over reported minimal
levels of use of such drugs. Almost twice as
many men as women reported using illegal
drugs in all prevalence brackets. As this is the
first study of its kind, it is not possible to
compare these figures with earlier studies and
discern trends. However, these figures provide
a very good baseline and it is planned to
repeat the study in 2006. The findings are
outlined in Tables 2.1-2.3. 
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Chapter Two
8 This research method is not intended to capture clusters of problematic drug use in areas. Consequently, when no respondents report the
use of a particular drug this does not mean that there is no use of that drug in the area, although it may be indicative of low levels of use.
For that reason it is not particularly suitable method for measuring prevalence of drugs such as heroin.
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Table 2.1: Ireland – Lifetime prevalence (%)
- no respondents in this category
* less than a half of 0.1 percent (< 0.05) 
NOTE: all figures less than 0.1 are rounded to the nearest decimal place.
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All
adults
15-64
19.0
17.6
0.5
0.4
3.1
3.1
0.4
3.0
3.0
3.8
3.0
4.0
1.8
2.6
12.2
Males
24.4
22.5
0.7
0.4
2.1
4.5
0.6
4.3
4.1
4.9
4.6
5.9
2.3
3.9
9.3
Females
13.5
12.5
0.3
0.4
4.0
1.7
0.1
1.7
1.9
2.6
1.5
2.1
1.2
1.3
15.1
Young
adults
15-34
26.4
24.4
0.7
0.7
3.0
4.8
0.5
4.7
4.9
7.1
4.6
6.2
3.4
4.7
8.3
15-24
25.2
23.3
0.4
0.3
1.6
5.3
0.5
5.1
4.6
7.8
3.9
5.8
3.6
4.8
6.5
25-34
27.7
25.5
1.0
1.2
4.5
4.2
0.5
4.2
5.3
6.4
5.3
6.6
3.3
4.6
10.1
35-44
18.1
17.4
0.5
0.4
3.9
2.9
0.4
2.7
1.9
1.6
2.4
4.4
0.4
1.3
12.6
45-54
11.1
10.3
0.3
-
3.0
1.1
0.2
0.9
0.9
0.1
1.6
0.8
-
0.4
15.0
55-64
4.6
3.5
-
-
1.9
0.3
0.1
0.1
0.4
0.2
0.3
0.3
0.5
0.1
21.8
Drug
Any illegal drugs9
Cannabis
Heroin
Methadone
Other Opiates10
Cocaine (total,
including crack) 
Crack
Cocaine Powder
Amphetamines
Ecstasy
LSD
Magic Mushrooms
Solvents
Poppers11
Sedatives,
Tranquillisers,
Anti-depressants
9 For the purposes of this study, illegal drug use refers to the use of amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD,
magic mushrooms, poppers and solvents.
10 Other opiates i.e. opiates, opium, Temgesic®, buprenorphine, Diconal®, napps, MSTs, pethidine, DF118® (dihydrocodeine), 
and morphine. 
11 Poppers i.e. amyl or butyl nitrite.
11National Drugs Strategy Progress Report 
Table 2.2: Ireland – Last year prevalence (%)
- no respondents in this category
* less than a half of 0.1 percent (< 0.05)
NOTE: all figures less than 0.1 are rounded to the nearest decimal place.
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All
adults
15-64
5.6
5.1
0.1
0.2
0.5
1.1
0.1
1.1
0.4
1.1
0.1
0.3
0.1
0.4
5.7
Males
7.7
7.1
0.1
0.2
0.5
1.7
0.1
1.7
0.7
1.5
0.2
0.6
*
0.4
4.0
Females
3.4
3.0
0.2
0.2
0.5
0.5
0.1
0.5
0.2
0.6
-
0.1
0.1
0.4
7.3
Young
adults
15-34
9.7
8.7
0.2
0.4
0.5
2.0
0.2
2.0
0.8
2.2
0.2
0.6
0.1
0.7
3.7
15-24
12.8
11.1
0.3
0.3
0.6
2.7
0.1
2.7
1.2
2.9
0.2
1.1
0.2
1.0
3.5
25-34
6.5
6.1
0.2
0.5
0.4
1.3
0.2
1.3
0.3
1.6
0.2
0.2
0.1
0.5
3.9
35-44
3.4
3.3
-
0.2
0.3
0.5
-
0.5
0.2
-
-
0.2
-
0.1
4.5
45-54
1.1
1.1
-
-
0.5
0.2
-
0.2
-
-
-
-
-
-
7.6
55-64
0.5
0.5
-
-
0.4
-
-
-
-
-
-
0.1
-
-
12.0
Drug
Any illegal drugs 
Cannabis
Heroin
Methadone
Other Opiates 
Cocaine (total,
including crack) 
Crack
Cocaine Powder
Amphetamines
Ecstasy
LSD
Magic Mushrooms
Solvents
Poppers
Sedatives,
Tranquillisers,
Anti-depressants
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Table 2.3: Ireland – Last month prevalence (%)
- no respondents in this category
* less than a half of 0.1 percent (< 0.05) 
NOTE: all figures less than 0.1 are rounded to the nearest decimal place.
Chapter Two
All
adults
15-64
3.0
2.6
0.1
0.1
0.2
0.3
-
0.3
0.2
0.3
*
0.1
*
0.1
3.9
Males
4.1
3.4
0.1
0.1
0.2
0.7
-
0.7
0.2
0.6
*
0.1
*
0.1
2.9
Females
1.8
1.7
0.1
0.2
0.1
-
-
-
0.1
*
-
-
-
*
5.0
Young
adults
15-34
5.2
4.4
0.1
0.2
0.1
0.7
-
0.7
0.3
0.6
*
0.1
0.1
0.2
2.1
15-24
6.9
5.7
0.3
0.1
0.1
0.9
-
0.9
0.6
0.8
-
0.1
0.1
0.3
1.9
25-34
3.3
3.0
-
0.3
0.2
0.4
-
0.4
-
0.5
0.1
-
-
-
2.2
35-44
1.6
1.6
-
0.2
0.1
0.1
-
0.1
0.1
-
-
-
-
-
2.6
45-54
0.6
0.6
-
-
0.3
-
-
-
-
-
-
-
-
-
6.1
55-64
0.4
0.4
-
-
0.1
-
-
-
-
-
-
0.1
-
-
9.6
Drug
Any illegal drugs
Cannabis
Heroin
Methadone
Other Opiates
Cocaine (total,
including crack) 
Crack
Cocaine Powder
Amphetamines
Ecstasy
LSD
Magic Mushrooms
Solvents
Poppers
Sedatives,
Tranquillisers,
Anti-depressants
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Regional Prevalence
2.1.5 The second bulletin of the Population Survey
was published in April 2004 and gives a
breakdown of drug prevalence by Health
Board Region. The key finding from the
second bulletin was that the proportion of
those surveyed who reported ever having
taken an illegal drug (lifetime prevalence)
varied between 11.3% (North Western Health
Board) and 29.5% (Northern Area Health
Board) across the health board areas. These
boards also had the lowest and highest rates
of recent (2.6% and 8.5% respectively) and
current use (0.5% and 5.4% respectively). 
In general, the survey showed that prevalence
rates across all measures (lifetime, recent and
current) tended to be higher in the Eastern
part of the country. Cannabis was the main
illegal drug used on a lifetime, recent or
current basis in all health board areas and
prevalence rates for cannabis were at least
twice as high for other illegal drugs. 
2.1.6 Prevalence rates for other illegal drugs were
considerably lower than for cannabis across 
all areas and periods of time. For example, 
the highest prevalence rate for recent use of
ecstasy was 3% and cocaine (powder) 2%
compared to 8% for cannabis. The profile of
illegal drug users showed a great deal of
consistency across Health Boards. In almost all
areas, prevalence rates for lifetime, recent and
current use were higher amongst men than
women and higher amongst young people
than older people. Details are outlined below
in Table 2.4.
Chapter Two
Lifetime 
All adults 
15-64 
19.0%
25.8%
11.2%
12.5%
19.1%
11.3%
29.5%
18.9%
24.1%
12.3%
15.1%
Lifetime
Young
adults
15-34
26.4%
35.8%
15.8%
17.8%
32.9%
13.9%
38.6%
27.5%
29.6%
18.6%
19%
Lifetime
Older
adults
35-64
12.3%
17.7%
7.3%
7.8%
7.1%
9.2%
20.7%
11.8%
17.1%
7.1%
11.8%
Recent
All adults
15-64 
5.6%
6.4%
2.8%
3.2%
6.4%
2.6%
8.5%
6.8%
7.5%
4.7%
2.8%
Recent
Young
adults
15-34 
9.7%
11.4%
5.1%
6.0%
13.3%
4.8%
14.3%
13.6%
10.1%
8.6%
3.4%
Recent
Older
adults
35-64 
1.9%
2.3%
0.8%
0.8%
0.4%
0.8%
2.9%
1.3%
4.1%
1.4%
2.3%
Current
All adults
15-64 
3.0%
4.1%
1.0%
1.6%
2.5%
0.5%
5.4%
3.1%
4.3%
2.1%
1.9%
Current
Young
adults
15-34 
5.2%
8.1%
1.3%
2.6%
4.8%
0.7%
9.2%
6.9%
6.1%
4.1%
2.0%
Current
Older
adults
35-64
1.0%
1.0%
0.8%
0.8%
0.4%
0.4%
1.7%
_
1.9%
0.4%
1.8%
3.0
IRELAND
ECAHB
MHB
MWHB
NEHB
NWHB
NAHB
SEHB
SWAHB
SHB
WHB
Table 2.4: Ireland – Illegal Drugs – Regional Breakdown (%)12 
- no respondents in this category 
12 Midland Health Board, Mid-Western Health Board, North Eastern Health Board, North Western Health Board, Southern Health Board, South
Eastern Health Board and Western Health Board, East Coast Area Health Board, Northern Area Health Board and South Western Area
Health Board. 
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2.2 Opiate Use in Ireland 
2.2.1 In May 2003, the NACD launched “A 3-Source
Capture-Recapture Study of the Prevalence of
Opiate Use in Ireland 2000-2001” which was
the first national estimate of opiate use carried
out. A previous estimate, produced in 1998
and based on 1996 figures, estimated
prevalence in the 15-54-year-old age bracket
for Dublin City and County only. The research
for the more recent report began in mid-2002
and was based on 2000 and 2001 statistics
from the following three data sources:
• Central (Methadone) Treatment List;
• National Garda Study on Drugs, Crime and 
Related Criminal Activity; and 
• Hospital In-Patient Enquiry (HIPE) 
Database.
2.2.2 The study estimated that there were 14,452
opiate users in Ireland in 2001. Of this figure,
12,456 relate to Dublin and 2,225 relate to
outside of Dublin. This was the first estimate
of opiate use outside of Dublin. When
compared to the figure for Dublin from the
previous study, the study also showed a slight
decrease on the 1996 figure of 13,461 to
12,456. These figures translate into
prevalence estimates of 5.6 per thousand
nationally and 16 per thousand in Dublin.
The main estimates from the study are
outlined below13:
• National 2001 14,452
• Non-Dublin 2,225
• Dublin 2001 12,456
• Dublin 1996 13,461
National Prevalence Rate – 5.6 per thousand
of 15-64-year-old age group
Dublin Prevalence Rate – 16 per thousand of
15-64-year-old age group
2.2.3 In terms of the prevalence rate in Dublin, 
as opposed to actual numbers, there has
been a significant change, much of which 
is due to the increase in the population in
Dublin in the period. In order to facilitate
comparison between both estimates,
prevalence rates are presented below on 
the same basis i.e. for the 15-54 age bracket. 
Dublin (15-54-year-olds)
Dublin 2001 Prevalence Rate – 18.2 per
thousand of 15-54-year-old age group
Dublin 1996 Prevalence Rate – 21 per
thousand of 15-54-year-old age group
2.2.4 The study also pointed out a possibly
significant trend in relation to the age profile
of users. In 1996, 53% of users were in the
15-24-year-old age bracket in Dublin, whereas
the equivalent national (including Dublin)
figure is 36%. This has had a complementary
impact on those in the 25-34-year-old age
bracket. In 1996, the proportion in this age
group in Dublin was just under 34%, whereas
in 2001, the national figure was approximately
44%. With regard to the 35-54-year-old age
group, in 1996, they accounted for 12% 
of the user population in Dublin compared 
to the percentage nationally of 20% in 
2001. The different bases of the studies
notwithstanding, this points to an aging of 
the opiate using population and to a possibly
lower rate of initiation into opiate use. 
Chapter Two
13 Figures do not add to national total as they are the result of separate statistical calculations performed independently of each other.
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2.3 Treatment Statistics
Central (Methadone) Treatment list
2.3.1 The Central (Methadone) Treatment List is 
a register of patients receiving methadone
maintenance in Ireland and it is compiled by
the ERHA.14 At the end of July 2004, there
were 7,052 patients availing of methadone
maintenance, up over 40% since the end 
of 2000. A breakdown is provided below 
in Figure 2.3 and Table 2.5. 
2.3.2 As the table also shows, the numbers
receiving methadone treatment outside the
ERHA region has increased as well, up from
96 or just 2% in December 2000 to 336 or
just under 5% in July 2004. This reflects a
number of trends including the increased
availability of methadone treatment outside
the ERHA region, which can result in users
staying in their own Health Board area and
not having to travel for treatment to the ERHA
region. An increase in the numbers of users
residing outside the ERHA region, including
migration of existing users from the ERHA, 
is also likely to be another factor. These
figures are consistent with the findings of 
the NACD capture-recapture study and the
trend demonstrated in the ERHA region that
increased availability leads to more users
coming forward for treatment. While in
percentage terms, the increase in the non-
ERHA regions is very significant, the vast bulk
of methadone treatment continues to take
place in the ERHA area. Another development
of note since 2001 is the significant increase
in the availability of the provision of
methadone through the Prison Service.
Chapter Two
Table 2.5 – Numbers on Methadone Treatment
Breakdown of Patients Dec 2000 Dec 2001 Dec 2002 Dec 2003 Jul 2004
Total 5,032 5,865 6,449 6,883 7,052
ERHA Clinics 2,849 3,174 3,346 3,543 3,677 
National Clinics 41 66 91 123 149 
Trinity Court 513 510 506 501 499 
Prisons within the ERHA 229 425 402 286 
Prisons outside of the ERHA 4 
General Practitioners within the ERHA area 1,574 1,782 1,961 2,160 2,250 
General Practitioners outside the ERHA area 55 104 120 154 187
14 Counties Dublin, Kildare and Wicklow. The Eastern Health Board was dissolved under the Health (Eastern Regional Health Authority) 
Act 1999 and replaced by the ERHA and three new Health Boards i.e. the Northern, East Coast and South Western Health Boards 
which are delegated functions by the ERHA. The ERHA took formal responsibility for health services in Dublin, Kildare and Wicklow from 
1 March 2002. 
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Figure 2.3
Breakdown of Patients on Methadone 
Treatment July 2004
2.3.3 Table 2.6 below shows the numbers of
Pharmacies and General Practitioners
participating in the Methadone Protocol.
Overall the numbers of pharmacies have
increased by just under 45% and the number
of GPs by 39% since December 2000. 
The figures also show an expansion in the
numbers of clinics involved in delivering 
the service, with an 18% increase since
December 2000 from 56 to 66, of which 
7 are located outside the ERHA. 
2.3.4 Table 2.7 shows the breakdown of the
methadone waiting list for the ERHA region 
for December 2000 to July 2004. There has
been a significant cut in the numbers on the
waiting list of 249 people or just over 48%
since July 2001. However, this is much
smaller than the increase in the number of
treatment places available, indicating that
more users are coming forward for treatment
as services become more available. 
2.3.5 In relation to the age and gender of the
clients, the bulk (74%) are aged between 
20 and 34 years of age, most of the
remainder are in the 35-44 age bracket and
with very small numbers below 20 years of
age. This could be partly due to the aging 
of the population as outlined in the capture-
recapture study or the delay between
commencing opiate use and seeking
treatment that has been noted in other
studies, particularly through the NDTRS.15
In relation to gender, the majority of the
population (68%), particularly in the older 
age groups, is male. 
Chapter Two
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499
1874
Prisons outside ERHA area
General Practitioners within ERHA area
General Practitioners outside ERHA area
Table 2.6 Area Breakdown of Participating Pharmacies and GPs 
Area Breakdown of Participating Pharmacies Dec 2000 July 2004
Pharmacies with ERHA area 158 190
Pharmacies outside ERHA area 58 123
Total: 216 313
Area Breakdown of Participating General Practitioners Dec 2000 July 2004
The No. of GP’s participating within the ERHA area 130 178
The No. of GP’s participating outside the ERHA area 27 40
Total 157 218
15 HRB Occasional Paper 13:‘Trends in treated problem opiate use in the seven health board areas outside the Eastern Regional Health
Authority from 1998–2002’. This paper noted a time lag of almost four years was recorded between commencing opiate use and users
seeking treatment in the study area. 
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NDTRS (National Drug Treatment Reporting System)
2.3.6 The National Drug Treatment Reporting System
(NDTRS) is an epidemiological database on treated
problem drug use in Ireland co-ordinated by the Drug
Misuse Research Division (DMRD) of the Health
Research Board (HRB).16 Figures produced up to
2002 show that there has been a substantial increase
in the numbers of drug users in treatment in most
Health Boards. It covers a range of treatments being
administered for a number of drugs as reflected in
Table 2.8 below, but the figures are only available up
to 2002. The numbers in treatment for all drugs and
reported to the NDTRS has increased steadily, from
6,919 in 2000 to 8,596 in 2002 (Table 2.8). This
increase is probably due to a number of factors
including an increase in the availability of treatment
services and users new to treatment consequentially
coming forward, an increase in the number of centres
reporting cases to the NDTRS as well as the possibility
of an increase in the prevalence of drug use. 
Chapter Two
Table 2.7 Waiting List Breakdown
Dec 2000 July 2001 Jul 2002 Jul 2003 Jul 2004
NAHB 63 82 51 20 47
SWAHB 197 230 133 133 126
ECAHB 6 11 7 8 2
Trinity Court 162 189 122 136 98
Total 428 512 313 297 273
Table 2.8 Main problem drug reported by cases treated for problem drug use by health board of
residence 2000-2002
Main problem drug 2000 2001 2002
ERHA 5,323 (%) 5,868 (%) 6,248 (%)
Opiates 5,031 (94.5) 5,631 (96.0) 5,921 (94.8)
Ecstasy 32 (0.6) 30 (0.5) 18 (0.3)
Cocaine 47 (0.9) 43 (0.7) 73 (1.2)
Amphetamines 2 (0.0) 4 (0.1) 1 (0.0)
Benzodiazepines 56 (1.1) 57 (1.0) 42 (0.7)
Volatile inhalants 11 (0.2) 3 (0.1) 3 (0.0)
Cannabis 137 (2.6) 95 (1.6) 177 (2.8)
Other substances 7 (0.1) 5 (0.1) 13 (0.2)
Outside ERHA 1,596 (%) 2,024 (%) 2,328 (%)
Opiates 241 (15.1) 397 (19.6) 490 (21.0)
Ecstasy 257 (16.1) 271 (13.4) 245 (10.5)
Cocaine 31 (1.9) 52 (2.6) 79 (3.4)
Amphetamines 28 (1.8) 17 (0.8) 29 (1.2)
Benzodiazepines 42 (2.6) 52 (2.6) 64 (2.7)
Volatile inhalants 30 (1.9) 37 (1.8) 43 (1.8)
Cannabis 933 (58.5) 1,146 (56.6) 1,334 (57.3)
Other substances 34 (2.1) 52 (2.6) 44 (1.9)
Total 6,919 7,892 8,576
Source: unpublished analysis from the NDTRS
16 For the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to ameliorate the psychological, medical or social
state of individuals who seek help for their drug problems.’
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2.3.7 The numbers treated for problem drug use
and residing in the ERHA area increased by
17% between 2000 and 2002 while the
numbers treated for problem drug use and
residing in the seven Health Board areas
outside the ERHA increased by 46% during
the same period (Table 2.8) which is
consistent with expansion in treatment
services. However, the numbers treated for
problem drug use and residing in the ERHA
area are still substantially higher than the total
of those residing in the other seven Health
Board areas.17
2.3.8 The table also shows some significant
differences between the ERHA and the rest 
of the country. Almost 94% of treated cases
residing in the ERHA area reported opiates as
their main problem drug compared to almost
19% of treated cases residing outside the
ERHA area. In total, according to 2002 figures
for all forms of treatment, the ERHA
accounted for 92.5% of people who had
treatment for opiate use. However, as noted
previously, there has been a substantial
increase in the absolute numbers in treatment
outside the ERHA region. 
2.3.9 In relation to cannabis, just under 3% of those
in treatment in the ERHA area reported
cannabis as their main problem drug while
just under 56% of those residing outside 
the ERHA area reported this as their main
problem drug. In both areas, the numbers 
of cases in treatment for cocaine use has
increased which mirrors trends noted
elsewhere, although absolute numbers remain
small. However, it should be noted that
cocaine is often used within a polydrug use18
environment and the numbers increase when
those who reported using cocaine as a
secondary or other drug are included. 
2.3.10 Table 2.9 presents demographic and socio-
economic information by health board area 
of residence. The numbers living in the ERHA
Chapter Two
Table 2.9 Demographic and socio-economic characteristics of cases treated for problem drug use by
health board of residence 1998-2002*
2000 2001 2002
ERHA* 5,323 (%) 5,868 (%) 6,248 (%)
Number (%) under 18 years 180 (3.4) 161 (2.8) 169 (2.7)
Number (%) males 3,601 (67.8) 3949 (68.0) 3,972 (67.0)
Number (%) of early school leavers† 1,433 (30.9) 1,527 (29.5) 1,585 (28.5)
Number (%) aged 16 to 64 years employed 1,358 (26.8) 1,347 (24.4) 1,337 (22.8)
Outside ERHA* 1,596 (%) 2,024 (%) 2,328 (%)
Number (%) under 18 years 279 (17.5) 346 (17.1) 422 (18.3)
Number (%) males 1,264 (79.6) 1,571 (78.2) 1,811 (80.4)
Number (%) of early school leavers† 241 (19.7) 320 (21.0) 302 (17.7)
Number (%) aged 16 to 64 years employed 507 (34.5) 645 (34.9) 659 (31.3)
Total 6,919 7,892 8,576
* It should be noted that not all forms returned had complete data. 
† Left school before the age of 15 years.
Source: unpublished analysis from the NDTRS
17 The seven Health Board areas are the: Midland Health Board, Mid-Western Health Board, North Eastern Health Board, North Western
Health Board, Southern Health Board, South Eastern Health Board and Western Health Board.
18 Polydrug use is the use of more than one drug often with the intention of enhancing or countering the effects of another drug. Polydrug
use may however simply occur because the user’s preferred drug is unavailable or too expensive at the time.
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area in treatment that were under 18 years
old decreased between 2000 and 2002,
while the number living in the seven Health
Board areas under 18 years old in treatment
increased. A higher proportion of those in
treatment living in the ERHA area were female
than the proportion living outside the ERHA.
Also of note, a higher proportion of treated
drug users living in the ERHA area left school
before their fifteenth birthday than their
counterparts living outside the ERHA. Overall,
there are very low rates of employment
among treated drug users. 
2.4 Garda Síochána Statistics
2.4.1 The figures below contained in Tables 2.10 -
15 relating to possession and seizure data
from 2000-2003 are taken primarily from 
An Garda Síochána Annual Crime Reports. 
The offence data details all drug offences
recorded where proceedings have been
instituted within the year in question. The
seizure data relates to the overall quantities 
of drugs seized in a given year. 
2.4.2 Overall, the data in this period shows that
cannabis constitutes the majority of all offences,
followed by ecstasy, heroin, cocaine and
amphetamines (Table 2.10). Possession
offences show a reduction for 2003, although
the reasons for this are not clear. Care should
be taken in interpreting fluctuations in both
possession and seizure data as substantial
individual seizures and operations can distort
overall patterns. In terms of regional
breakdown, Dublin continues to have the
highest concentration of drug possession
offences in the country followed by the South
Eastern, Southern and Eastern regions. The
Northern and Western regions continue to have
the lowest recorded number of offences.19
2.4.3 Tables 2.10 -14 set out the possession
offences by region and drug for the years
2000-2003. They show that heroin offences
have remained relatively stable over the
period while ecstasy offences have fallen 
and cocaine offences have risen year on 
year. Table 2.14 sets out the figures for drugs
offences in 2003. It shows that cannabis, resin
and plants, still account for the bulk of drugs
offences, approximately 58%. The highest
number of these offences were committed 
in Dublin, although there are a high number
of cases in other regions particularly the
Southern and South Eastern regions. In
relation to heroin, Dublin is still the
predominant region in relation to these
offences with 83% of all possession 
offences committed in that region. Taken 
in combination with the Eastern region, the
total of the two regions is 93%. However, 
this is lower than the figures from 2000,
when the Dublin region alone accounted 
for 94% of all offences. 
2.4.4 Dublin is also the dominant region in terms of
cocaine possession offences with almost 60%
of all offences in 2003. The Southern and
Eastern regions were the next highest, they
respectively recorded 17% and 12% of these
offences. In relation to ecstasy, the Eastern
region has the highest number of recorded
offences followed by Dublin, the South
Eastern and the Southern regions. The
Western and Northern regions have the
lowest levels of offences in nearly all
categories.
Chapter Two
19 The Dublin Metropolitan Region (DMR) comprising of the North Central, South Central, Northern, Southern, Eastern and Western Divisions.
The Eastern Region comprising of Carlow/Kildare, Laois/Offaly, Louth/Meath and Longford/Westmeath Divisions.  The Southern Region
comprising of the Cork City, Cork North, Cork West, Kerry and Limerick Divisions.  The Northern Region comprising of the Donegal,
Sligo/Leitrim and Cavan/Monaghan Divisions.  The South Eastern Region comprising of the Waterford/Kilkenny, Wexford and Tipperary
Divisions.  The Western Region comprising of the Mayo, Galway West, Roscommon/Galway East and Clare Divisions.
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Table 2.10 An Garda Síochána National Breakdown of Drug Offences By Drug Type 2000-2003.
2000 2001 2002 2003
No. % No. % No. % No. %
Cannabis 796 9.5 1,066 12.0 872 10.2 852 12.6
Cannabis Resin 4,031 48.0 4,053 48.0 4,595 54.0 3,003 44.5
Cannabis Plant 53 0.6 24 0.5 33 0.4 36 0.5
Heroin 730 8.7 908 11.0 796 9.4 719 10.6
Ecstasy 2,086 24.8 1,845 22.0 1,351 15.9 960 14.2
Cocaine 180 2.1 297 3.0 478 5.6 607 9.0
Amphetamine 391 4.7 207 2.0 300 3.5 180 2.7
Other 128 1.6 129 1.5 92 1.0 401 5.9
Total 8,395 100.0 8,529 100.0 8,517 100.0 6,758 100.0
Table 2.11 An Garda Síochána Breakdown of Offences by Drug Type Per Region 2000. 
DMR Eastern Southern South East Northern Western Total
No. % No. % No. % No. % No. % No. %
Cannabis 200 25.1 158 19.8 100 12.6 209 26.3 54 6.8 74 9.3 796
Cannabis Resin 1,070 26.5 633 15.7 1,100 27.3 424 10.5 320 7.9 484 12.0 4,031
Cannabis Plant 18 34.0 7 13.2 19 35.8 1 1.9 1 1.9 7 13.2 53
Heroin 692 94.8 24 3.3 5 0.7 3 0.4 4 0.5 2 0.3 730
Ecstasy 277 13.3 626 30.0 529 25.4 260 12.5 232 11.1 162 7.8 2,086
Cocaine 120 66.7 19 10.6 21 11.7 11 6.1 2 1.1 7 3.9 180
Amphet 116 29.7 81 20.7 90 23.0 66 16.9 5 1.3 33 8.4 391
Other 83 64.8 8 6.3 11 8.6 1 0.8 14 10.9 11 8.6 128
Total 2,576 30.7 1,556 18.5 1,876 22.3 975 11.6 632 7.5 780 9.3 8,395
Chapter Two
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Table 2.12 An Garda Síochána Breakdown of Offences by Drug Type Per Region 2001. 
DMR Eastern Southern South East Northern Western Total
No. % No. % No. % No. % No. % No. %
Cannabis 419 39.3 237 22.2 72 6.8 134 12.6 97 9.1 107 10.0 1,066
Cannabis Resin 1,289 31.8 345 8.5 1,307 32.2 470 11.6 288 7.1 354 8.7 4,053
Cannabis Plant 2 8.3 3 12.5 5 20.8 6 25.0 0 0.0 5 20.8 24
Heroin 806 88.8 45 5.0 9 1.0 16 1.8 26 2.9 9 1.0 908
Ecstasy 478 25.9 215 11.7 482 26.1 272 14.7 233 12.6 175 9.5 1,845
Cocaine 184 62.0 14 4.7 51 17.2 18 6.1 13 4.4 17 5.7 297
Amphet 28 13.5 47 22.7 45 21.7 45 21.7 7 3.4 35 16.9 207
Other 59 45.7 15 11.6 17 13.2 24 18.6 5 3.9 9 7.0 129
Total 3,265 38.3 921 10.8 1,988 23.3 985 11.5 659 7.7 711 8.3 8,529
Table 2.13 An Garda Síochána Breakdown of Offences by Drug Type Per Region 2002.
DMR Eastern Southern South East Northern Western Total
No. % No. % No. % No. % No. % No. %
Cannabis 194 22.2 332 38.1 147 16.9 61 7.0 32 3.7 105 12.0 872
Cannabis Resin 1,287 28.0 336 7.3 1,473 32.1 730 15.9 339 7.4 430 9.4 4,595
Cannabis Plant 7 21.2 7 21.2 8 24.2 3 9.1 4 12.1 4 12.1 33
Heroin 681 85.6 44 5.5 36 4.5 7 0.9 8 1.0 20 2.5 796
Ecstasy 219 16.2 286 21.2 352 26.1 200 14.8 151 11.2 143 10.6 1,351
Cocaine 278 58.2 27 5.6 136 28.5 20 4.2 5 1.0 12 2.5 478
Amphet 52 17.3 54 18.0 70 23.3 101 33.7 10 3.3 13 4.3 300
Other 38 41.3 4 4.3 14 15.2 19 20.7 14 15.2 3 3.3 92
Total 2,757 32.4 1,090 12.8 2,236 26.3 1,141 13.4 563 6.6 730 8.6 8,517
Chapter Two
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Table 2.14 An Garda Síochána Breakdown of Offences by Drug Type Per Region 2003. 
DMR Eastern Southern South East Northern Western Total
No. % No. % No. % No. % No. % No. %
Cannabis 413 48.5 138 16.2 109 12.8 84 9.9 25 2.9 83 9.7 852
Cannabis Resin 764 25.4 383 12.8 759 25.3 670 22.3 201 6.7 226 7.5 3,003
Cannabis Plant 11 30.6 2 5.6 13 36.1 2 5.6 4 11.1 4 11.1 36
Heroin 600 83.4 75 10.4 20 2.8 14 1.9 3 0.4 7 1.0 719
Ecstasy 217 22.6 243 25.3 137 14.3 191 19.9 99 10.3 73 7.6 960
Cocaine 362 59.6 72 11.9 106 17.5 35 5.8 17 2.8 15 2.5 607
Amphet 14 7.8 29 16.1 32 17.8 85 47.2 13 7.2 7 3.9 180
Other 154 38.4 20 5.0 100 24.9 64 16.0 21 5.2 42 10.5 401
Total 2,535 37.5 962 14.2 1,276 18.9 1,145 16.9 383 5.7 457 6.8 6,758
Source: All of the above tables are sourced from the relevant Garda Annual Reports.
2.4.5 In relation to seizures, the figures from the period 2000-2003 (Table 2.15) are set out below. It should
be pointed out that seizure figures can be particularly variable from year to year and that drugs seized in 
a particular country may not necessarily be intended for distribution and sale in that country. However,
while there are annual fluctuations, especially in non-resin cannabis, a number of general observations
can be made. In this regard, there has been an increase in volume of drugs seized in almost all drug
categories over the period. Of particular note has been the big increase in cannabis resin,
amphetamines, cocaine and ecstasy seizures in 2003, although ecstasy seizures had been consistently
falling prior to that year. Heroin seizures are relatively stable over the period. 
Table 2.15 Seizures of Selected Drugs by Year*
Drug Type 2000 2001 2002 2003
Cannabis (inc. plants) 208.1kg 9,590.4kg 5,600kg 201.7kg 
(98 plants) (365 plants) (770 plants) (244 plants)
Cannabis resin 379.8kg 567kg 3,332.7kg 5,349kg
Heroin 23.94kg 29.5kg 16.7kg 27.05kg
Ecstasy 551,420 Tabs 469,862 Tabs 129,774 Tabs 1,291,812 Tabs
Amphetamines 5.8kg +149 Tabs 17.9kg 16.4kg 67.7kg
Cocaine 18kg 5.3kg 31.7kg 107.4kg
*An Garda Síochána Annual Reports 2000-03 – Customs seizures are also included in this table.
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2.5 Summary 
The main points in this overview of the nature and
extent of drug misuse can be summarised as follows:
• Just under one in five people (19%) of 15-64-
year-olds have ever used an illegal drug in their
lifetime, with the highest prevalence amongst 
25-34-year-old age group (27.7%) and the lowest
among 55-64-year-olds (4.6%).
• In terms of recent (last year) and current (last
month) use, the rates are 5.6% and 3.0%
respectively with the 15-24-year-old age group
having the highest prevalence and 55-64-year-
olds the lowest.
• Cannabis is the most widely used illegal drug 
in terms of lifetime prevalence followed by 
magic mushrooms, ecstasy, cocaine, LSD and
amphetamines, although the prevalence for all
these drugs is much lower.
• Cannabis is again the most widely used in terms
of recent and current use significantly more than
ecstasy and cocaine, the next most widely used
drugs.
• In relation to regional prevalence, the North
Western Health Board (11.3%) and the Northern
Area Health Board (29.5%) have the lowest and
highest lifetime prevalence across the health
board areas. These boards also had the lowest
and highest rates of recent (2.6% and 8.5%) 
and current use (0.5% and 5.4%). In general,
prevalence rates across all measures (lifetime,
recent and current) tended to be higher in the
Eastern part of the country.
• The first national capture-recapture study of 
opiate use estimated that there are 14,452 opiate
users in Ireland, of which approximately 12,500
are in Dublin. 
• Measured against the earlier estimate for 
Dublin from 1996, there has been a decline 
of approximately 1,000 users in Dublin and
significant shift in terms of the age profile of
opiate users (i.e the population is aging).
• In July 2004, there were over 7,000 people on
the Central (Methadone) Treatment List, 95% of
which are in the ERHA region. 
• The non-ERHA regions have seen an increase 
in numbers on the treatment list from 96 in
December 2000 to 336 in July 2004. 
• There has been a similar expansion in the
numbers of GP’s, pharmacists and clinics as well
as increased provision in the prison system.
• The NDTRS has noted an increase of 24% in the
numbers in treatment for all drugs between 2000
and 2002. This increase is probably due to a
number of factors including an increase in the
availability of treatment services and the users
new to treatment consequentially coming forward,
an increase in the number of centres reporting
cases to the NDTRS as well as the possibility of
an increase in the prevalence of drug use. 
• Almost 94% of treated cases residing in the 
ERHA area reported opiates as their main
problem drug compared to almost 19 % of
treated cases residing outside the ERHA area.
• Just under 3% of those in treatment in the ERHA
area reported cannabis as their main problem
drug, while just under 56% of those residing
outside the ERHA area reported this as their main
problem drug. 
• In most areas, the numbers of cases in treatment
for cocaine use has increased which mirrors
trends noted elsewhere, although absolute
numbers remain small. 
• Those in treatment in ERHA and non-ERHA
regions tended to be male, with a high proportion
of them being early school leavers and
unemployed.
• Garda statistics show that cannabis constitutes the
majority of all possession offences.
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• Dublin has the highest number of possession
offences, followed by the South Eastern, Southern
and Eastern regions. The Northern and Western
regions continue to have the lowest recorded
number of offences.
• In relation to heroin and cocaine, Dublin is still the
predominant region in relation to these offences
with 83% and 60% respectively of all possession
offences for both drugs committed in that region. 
• There has been an increase in the volume of
drugs seized in almost all drug categories over the
period 2000 to 2003. Of particular note has been
the big increase in cannabis resin, amphetamines,
cocaine and ecstasy seizures in 2003, although
ecstasy seizures had been consistently falling prior
to that year. Heroin seizures are relatively stable
over the period. 
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Progress in implementing 
the Strategy
3.1 Introduction
3.1.1 As outlined in chapter 1, the overall strategic
objective of the National Drugs Strategy is to
significantly reduce the harm caused to
individuals and society by the misuse of
drugs through a concerted focus on the
four pillars of supply reduction, prevention,
treatment and research. 
3.1.2 To monitor progress in achieving the overall
strategic objectives, the Strategy sets out 
Key Performance Indicators (KPIs) so 
that Departments and Agencies can measure
their success in implementing the Strategy. 
This chapter examines the progress achieved
by individual Departments and Agencies in
relation to the KPIs. Attached to this chapter 
is a table which sets out the 100 individual
actions, the date set in the Strategy or the
Critical Implementation Path (CIP) for their
completion and a short commentary on
progress. The table reflects the information
contained below in the KPIs.
3.2 Supply Reduction Pillar
3.2.1 The objectives under the supply reduction
pillar are:
• To significantly reduce the volume of illicit
drugs available in Ireland, to arrest the
dynamic of existing markets and to curtail
new markets as they are identified; and
• To significantly reduce access to all drugs,
particularly those drugs that cause most
harm amongst young people, especially in
those areas where misuse is most prevalent.
KPIs – Progress to date
Increase the volume of opiates and all other drugs
seized by 25% by end 2004 and by 50% by end
2008 (using 2000 seizures as a base)
3.2.2 The Garda Síochána and Customs and Excise
are achieving considerable success in relation
to this target to date although heroin seizures
are relatively stable. Seizures of a range of
drugs increased in 2001, 2002 and 2003.
While there are annual fluctuations, especially 
in non-resin cannabis, a number of general
observations can be made. There has been an
increase in volume of drugs seized in almost all
drug categories over the period, in particular
cannabis resin, amphetamines and cocaine.
Ecstasy seizures increased considerably in 2003,
although they had been consistently falling prior
to that year. (Please see Chapter 2 for more
details regarding seizures including tables).
Establish a co-ordinating framework in relation to
drugs policy in each Garda District by end 2001
3.2.3 A co-ordinating framework has been
established under the Assistant Commissioner
and the National Support Services. It assigns
responsibility for co-ordinating the Garda Drugs
Strategy at a regional, divisional and district
level. In addition, the Garda Community
Consultations document was approved by 
the Commissioner in September 2002 and 
a framework to engage the community in
policing issues is part of the Garda Síochána
Bill currently before the Oireachtas. Divisional
policing plans were also posted on the Garda
website during 2004.
Increase the level of Garda resources in Local
Drugs Task Force areas by end 2001, building 
on lessons emanating from the Community
Policing Forum
3.2.4 The concept of Community Policing Fora
involves having a partnership approach in
place between the local community, An Garda
Síochána and the local authorities, which
facilitates the development of a dialogue
between the police and local community on
drugs issues. It also provides a means of
assisting the local authorities to examine
estate management issues within the
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boundary area covered by each forum, such
as poor lighting or actions to tackle the
activities of anti-social tenants.
3.2.5 Two Community Policing Fora have been
developed in the North Inner City and
Finglas/Cabra LDTFs respectively. After the pilot
phase, projects are independently evaluated
and assessed for mainstreaming into the
appropriate State agency. In this regard, the
initial phase of the North Inner City
Community Policing forum has been evaluated
and was extended to further areas in the North
Inner City in June 2003. The Finglas/Cabra
Forum is still in its pilot phase. The Department
of Justice, Equality and Law Reform is currently
putting in place a policy framework and
structures, in the context of the Garda Bill,
which will facilitate the development of formal
and inclusive partnership arrangements on
policing issues between the Garda Síochána
and the communities it serves.
3.2.6 In the context of increasing Garda resources,
the current Garda strength within the LDTF
areas has shown moderate increases. 
A review of overall deployment of Garda
strength is scheduled for mid 2004 in line
with the PULSE (Police Using Leading Systems
Effectively) System and updated Garda
Established Redistribution Model (GERM)20.
The allocation of additional resources in LDTF
areas will be considered in line with an overall
increase in the strength of An Garda Síochána.
Strengthen and consolidate existing coastal watch
and other ports of entry measures designed to
restrict the importation of illicit drugs
3.2.7 Customs and Excise has implemented a
number of measures to enhance drugs
detection capability at points of entry. In
particular, a Customs Drugs Watch programme
was launched in January 2003 and a poster
and public awareness programme is in place
promoting this initiative. The number of
detection dogs available at major entry points
to the State has also increased and the
acquisition of additional technical and other
equipment in order to enhance the ability 
of the Customs Service to detect illegally
imported drugs is reviewed on an ongoing
basis. As part of this review process, a
Customs cutter (RCC Suirbhéir) was
purchased and commissioned in June 2004.
The boat will patrol the coastline for the
purposes of surveillance, monitoring and
intercepting vessels suspected of drug
smuggling. In addition, tenders have been
invited for the acquisition of x-ray scanning
technology for screening containerised freight.
Co-operate and collaborate fully, at every level,
with law enforcement and intelligence agencies,
in Europe and internationally, in reducing the
amount of drugs coming into Ireland
Customs and Excise
3.2.8 Co-operation at international level is on an
ongoing basis. In 2003, Customs and Gardaí
participated in forty international joint
operations (controlled deliveries), up from
seven in 2002, with other European and
international law enforcement agencies. 
As a result of these operations/investigation,
drugs of all categories with a total street value
of €16,000,000 were seized. This included
15kgs. of heroin and 24kgs. of cocaine and 
a total of 51 people were arrested. 
3.2.9 Regarding participation with Europol, in 
excess of 25% of controlled deliveries
undertaken in 2003, were co-ordinated
through Europol, and included the Dutch and
UK authorities. A further 30% were the result
of bilateral operations with the German and
French customs authorities, and the Drug
Enforcement Agency of the USA.
20 GERM is a mechanism for assessing police demand taking into account levels of population, crime and public order in order to determine
resources.
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3.2.10 The Customs Service continues to liaise and
share information and intelligence on an
international basis with other Customs
administrations, the World Customs
Organisation and Europol, utilising Customs
conventions, protocols and agreements. On 
a yearly basis, Irish Customs also participates 
in a number of drugs-focused joint surveillance
exercises carried out under the auspices of the
EU Council’s Customs Co-operation Working
Group. In 2003, the Irish Customs service 
co-ordinated and organised an international
drug focused maritime surveillance exercise
involving 27 administrations which resulted in
the seizure by Customs Services in Europe of
7,270 kgs cannabis resin, 732kgs cocaine and
4.4kgs of amphetamines.
3.2.11 The Customs Service with the assistance of an
Garda Síochána also carried out an evaluation
of the role of Irish Customs in Europol. As a
result it is progressing the assignment of a
Customs Officer as a Europol Liaison Officer
to Europol Headquarters, in The Hague in
accordance with the Europol Act 1997.
An Garda Síochána
3.2.12 An Garda Síochána collaborates fully with
International Law Enforcement Agencies on 
a variety of levels. They are represented on 
a number of EU Working Groups established
to provide greater co-ordination in the fields 
of combating Drug Trafficking and Organised
Crime. These include the Police Co-operation
Working Group and the Multi-disciplinary
Group on Organised Crime.
3.2.13 At an operational level An Garda Síochána has
liaison officers posted in Europol, Interpol, 
The Netherlands, Spain, France and the United
Kingdom. The primary role of these officers 
is to facilitate ongoing co-operation between
An Garda Síochána and Law Enforcement
Officials in other jurisdictions.
3.2.14 In co-operation with a number of EU Member
States, An Garda Síochána has participated in,
and conducted a number of projects under
the EU Agis, Oisin, Falcone and Phare
Programmes. These projects are specifically
designed to increase both the knowledge and
contact between Law Enforcement Officials
across the European Union on policing issues
relative to organised crime, drug trafficking and
money laundering.
3.2.15 In the context of International Investigations
An Garda Síochána received 140 Mutual
Assistance requests in 2003 and 170 in 
2004 to date. In the same period An Garda
Síochána transmitted 29 Mutual Assistance
requests in 2003 and 38 in 2004 to other
Law Enforcement Agencies.
3.2.16 In June 2004 the Criminal Justice (Joint
Investigation Teams) Act 2004 was signed
into law by the President. This legislation
provides for the establishment of Joint
Investigation Teams between EU Member
States in order to carry out criminal
investigations with a cross border dimension.
3.3 Prevention Pillar
3.3.1 The objectives under the prevention pillar are:
• To create greater societal awareness about
the dangers and prevalence of drug
misuse; and
• To equip young people and other
vulnerable groups with the skills and
supports necessary to make informed
choices about their health, personal lives
and social development;
KPIs – Progress to date
Bring drug misuse by school-goers to below the
EU average and, as a first step, reduce the level 
of substance misuse reported to ESPAD by 
school-goers by 15% by 2003 and by 25% 
by 2007 (based on 1999 ESPAD levels as 
reported in 2001)
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3.3.2 The ESPAD – European School Survey Project on
Alcohol and Drugs is a co-ordinated set of school
surveys which is undertaken every four years
among 15-16-year-old school goers. The second
ESPAD study was conducted in 1999 among
approximately 95,000 students in 30
participating countries. The 1999 study reported
that the use of cannabis was twice as common
in Ireland than the average for all ESPAD
countries, while the use of illicit drugs, other than
cannabis, was slightly above average. However
figures reported in 1999 show a decrease in the
use of cannabis since the 1995 survey.21
3.3.3 The latest ESPAD survey was conducted in
2003 and the results will be disseminated in
late 2004. It is also worth noting that, as
outlined in chapter 2, the NACD published an
All Ireland Population Drug Prevalence Survey
in April 2003 and this provides the most up
to date figures in relation to drug misuse in
Ireland. As this is the first such survey, it is not
possible to discern trends, however, the
Survey shows that in Ireland: 
• 25.2% of 15-24-year-olds have used illegal
drugs in their lifetime (Cannabis 23.4%);
• 12.8% have used illegal drugs in the last
year (Cannabis 11.1%); and
• 6.9% have used illegal drugs in the last
month (Cannabis 5.7%).
Develop and launch an ongoing National
Awareness Campaign highlighting the dangers of
drugs, the first stage to commence by end 2001
3.3.4 The National Drugs Awareness Campaign was
launched on 15 May 2003. The launch marked
the beginning of a three-year campaign which
aims to increase awareness amongst the
general population about problem drug use
and its consequences across society through
changing the knowledge and attitude of
targeted groups. The campaign is made up of
different phases with each phase dealing with
different population groups and topics. 
3.3.5 The first phase was aimed at the general
population and centred on a television and
radio advertising campaign with the slogan
“Drugs: there are answers”. Each
advertisement focused on an everyday
situation and how drugs can touch all our
lives. The advert promoted the idea that 
“to make the right choices you need the right
information”. The advertising elements of this
first phase of the campaign were supported
by an information website www.drugsinfo.ie, 
a public relations campaign and a widely
distributed brochure designed to raise
awareness about the causes and
consequences of drug use in Ireland today.
The campaign also includes a drugs
information helpline – 1850 719 819.
3.3.6 In its second phase, the campaign was
specifically aimed at informing parents about
the realities of the drugs issue in order facilitate
more open communication with their children.
This phase of the campaign included parent
oriented television and radio advertisements
with prominent use of the helpline number
and the website address. Additional resources
have also been made available in the form of
a parent’s information booklet and increased
content on the website. The campaign has
also developed a roadshow to which parents
from around the country were invited to an
open question and answer session in their
locality where their questions and issues were
addressed by a panel of experts. 
3.3.7 The next phase of the campaign is concerned
with cocaine use particularly among 18-35-
year-olds, with the tagline “There’s no fairytale
ending with Cocaine”. It is being placed on
posters in recreational settings such as pubs
and nightclubs through beer mats, postcards
as well as targeted press advertising. A
microsite on www.drugsinfo.ie was also
developed to support the campaign.
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3.3.8 In line with best practice, the campaign is
being routinely evaluated. Recent research
shows that the campaign is effective at
communicating a core message that help 
is available with almost one in two parents
recalling some advert for drugs, and one in
four specifically recalling the “Drugs – there
are answers” campaign. There is also evidence
that as the campaign develops, more specific
messages are being identified and recalled by
the target audiences e.g. “Talk to your children
about drugs” and “Where to go for help and
information”.
Figure 3.1 shows examples of TV advertising from
the first two phases of the Awareness Campaign
Figure 3.2 Images from the latest phase of the
awareness campaign which focuses on cocaine
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Develop formal links at local, regional and
national levels with the National Alcohol Policy, by
end 2001 and ensure complementarity between
the different measures being undertaken
3.3.9 The Department of Health and Children,
which has primary responsibility for alcohol
policy, is pursuing a number of initiatives in
the area of alcohol misuse. Increased linkages
have been forged on an ongoing basis
between both alcohol and drugs policies in
terms of cross-representation on the relevant
committees and working groups to ensure
complementarity between the different
measures. The NDST meets with the National
Alcohol Policy Advisor and the NDST and
D/CRGA were represented on the Strategic
Task Force on Alcohol on which the National
Alcohol Policy Advisor is also a member. At
RDTF level, there is cross-membership with
Health Board alcohol policy structures.
Publish and implement a policy statement
specifically relating to education supports for 
Local Drugs Task Force areas, including an audit 
of the level of current supports, by end 2001
3.3.10 A comprehensive review of educational
disadvantage provision is being finalised with 
a view to ensuring that the educational needs
of disadvantaged children and young people
are prioritised and effectively addressed into
the future. In this context, the Department
proposes the following in relation to the 
policy statement/audit of supports: 
• Carry out an exercise to produce a
definitive list, with the assistance of the
LDTFs, of primary and post-primary schools
serving LDTF communities;
• The audit should focus on supplementary
supports being provided in each LDTF 
area and on the extent of involvement in
particular programmes/schemes, rather
than on producing a detailed financial
analysis; and 
• A focused policy statement to be prepared
setting out the current supports for
educational disadvantage and how they 
will evolve.
It is planned that this exercise can be
completed before the end of 2004.
Nominate an official from the Department of
Education and Science to serve as a member of
each of the Local Drugs Task Forces by end 2001
3.3.11 The Cromien Report on the re-organisation 
of the Department of Education and Science
was accepted by Government in late 2000.
One of its findings was that regional offices 
of the Department should be established in
Blanchardstown, Tallaght, Mullingar, Limerick,
Galway, Cork, Sligo, Navan, Waterford and Naas,
as well as a Regional Directorate based in
Dublin. The functions of the regional offices 
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include representing the Department on the
LDTFs and RDTFs, as well as providing for the
Department’s representation on the NDST itself.
Prioritise Local Drugs Task Force areas during the
establishment and expansion of the services of
the National Educational Welfare Board (NEWB)
3.3.12 Under the Education (Welfare) Act, 2000, the
National Educational Welfare Board (NEWB)
was established to ensure that every child
attends school regularly or otherwise receives
an education. To discharge its responsibilities,
the Board is developing a nationwide service
to provide welfare-focused services to children,
families and schools. The NEWB has appointed
a Chief Executive Officer, Directors of
Corporate Services and Educational Welfare
Services and the necessary support and service
delivery staff. To date, fifty-three educational
welfare officers have been appointed and
when the remaining positions are filled, the
total staff complement will be 84. 
3.3.13 At this stage of its development, the aim of
the Board is to provide a service to the most
disadvantaged areas including LDTF areas and
areas designated under the Government’s
RAPID programme and most at-risk groups.
Five regional teams have now been
established in Dublin, Cork, Limerick, Galway
and Waterford and an educational welfare
service is now available, for the first time, in
the cities of Limerick, Galway and Kilkenny.
Twelve towns with significant school going
populations, 11 of which are designated
under the Government’s RAPID programme,
also now have an Educational Welfare Officer
allocated to them. These towns are Dundalk,
Drogheda, Navan, Athlone, Carlow, Wexford,
Bray, Clonmel, Tralee, Ennis, Sligo and
Letterkenny. In addition, the Board will follow
up on urgent cases nationally. For further
information please see www.newb.ie
Have comprehensive substance misuse prevention
programmes in all schools and, as a first step,
implement the “Walk Tall” and “On My Own Two
Feet” Programmes in all schools in the Local
Drugs Task Force areas during the academic year
2001/02
3.3.14 The Department notified all primary and
secondary LDTF schools of the requirement to
implement “Walk Tall” and “On My Own Two
Feet” programmes respectively from September
2001 and information seminars were provided
to facilitate this delivery. The Department
implemented substance misuse prevention
programmes in all schools in the LDTF areas
during the academic year 2001/02. 
Complete the evaluation of the “Walk Tall” and 
“On My Own Two Feet” Programmes by end 2002
3.3.15 Extensive evaluations of the Walk Tall
Programme have been conducted and the
outcomes were positive. The programme has
a widely accepted rationale and has been
accepted by teachers. It was felt by teachers
that the Walk Tall Programme links in well 
with other aspects of Social Personal and
Health Education (SPHE) programme i.e. the
Stay Safe Programme. Teachers held a very
positive view of the programme in terms of 
its potential outcomes for children, including
safety, drug prevention, self-esteem, personal
responsibility and decision-making. The SPHE
post-primary service is undertaking some
preliminary evaluation of the implementation
of the SPHE to junior cycle, including the 
“On My Own Two Feet” programme as a core
element of SPHE, throughout the country. 
A report on this research is expected by end
2004. A more comprehensive evaluation
project is planned for 2005-2006. 
Deliver the SPHE Programme (Social, Personal
and Health Education) in all second level schools
nation-wide by September 2003
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3.3.16 The SPHE Programme has been on the
curriculum of all primary and secondary
schools since September 2003 and LDTF
areas were prioritised in this regard. Ongoing
support to assist second level schools in the
implementation of the SPHE syllabus is being
offered by the Post-Primary SPHE Support
Service. SPHE, as part of the curriculum,
supports the personal development, health
and well-being of young people and helps
them to develop the skills to maintain
supportive relationships. 
3.3.17 An additional Regional Development Officer
has been recruited to the Support Service to
work with second level schools in the LDTF
areas. At primary level, the Primary Curriculum
Support Service has been augmented by 
four SPHE trainers. Two additional National
Support Officers have been recruited and are
dedicated to working with primary schools in
LDTF areas. The Department, in co-operation
with the Health Promotion Unit and the
Health Boards, also drafted guidelines to assist
schools in the formation of a drugs policy in
May 2002, but to date, not all schools have
such policies in place. However, it is expected
that a significant number will put such policies
in place during the course of the school year
2003/04 and the Department will monitor
the situation. The Department is giving
consideration to carrying out an evaluation 
on the implementation of SPHE to date in
both primary and post-primary schools.
3.4 Treatment Pillar
3.4.1 The objectives under the treatment pillar are:
• To encourage and enable those dependent
on drugs to avail of treatment with the aim
of reducing dependency and improving
overall health and social well-being, with
the ultimate aim of leading a drug-free
lifestyle; and
• To minimise the harm to those who
continue to engage in drug-taking activities
that put them at risk.
KPIs – Progress to date
Have immediate access for drug misusers to
professional assessment and counselling by Health
Board services, followed by commencement of
treatment, as deemed appropriate, not later than
one month after assessment
3.4.2 There has been considerable progress on 
this action across the ERHA region including
increased capacity, new centres and increased
involvement of GPs and pharmacies. In
addition, waiting lists have been substantially
reduced. At the end of July 2001, there were
512 on the methadone waiting list compared
to 273 at end July 2004.
3.4.3 However, there is more work to be done
before the target of one month is reached. 
In this regard, Health Boards are working
towards increased involvement of GPs and
pharmacists with regard to the Methadone
Protocol. In July 2001, there were 168 GPs
and 233 pharmacists involved in the scheme
in comparison to 218 GPs and 313
pharmacists involved at the end of July 2004.
The number of clinics involved in delivering
the service has increased since December
2000 from 56 to 66, of which 7 are located
outside the ERHA. Direct access to counselling
and assessment is in place, especially in larger
urban centres. (Chapter 2 contains further
details in relation to treatment).
Have access for under-18s to treatment following
the development of an appropriate protocol for
dealing with this age group
3.4.4 A Working Group, chaired by the Department
of Health and Children, and comprising a
broad range of statutory and non-statutory
service providers and community
representatives was established in October
2001 to develop an appropriate protocol. 
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To fulfil it’s remit, the Group undertook a
number of initiatives, including;
• An examination of the legal issues
surrounding treatment; 
• A literature review; 
• A review of services and service gaps
nationally;
• Focus groups of service misusers within
and outside the ERHA region; and 
• A review of the treatment issues.
3.4.5 The task proved to be more complex than
anticipated and as a result, it was not possible
to meet the mid 2002 deadline. The Group
felt that the complexity of individual needs in
this client group implied that a protocol format
could be overly restrictive, and that it was
preferable to try to establish appropriate broad
guidelines or models for treatment. 
3.4.6 The Group also wished to emphasise the range
of personal, social and economic factors which
contributed to involvement in drug misuse at 
a young age in order to avoid dealing with the
issue of adolescents and children presenting 
to the drug treatment services in too narrow a
fashion. The review was finalised in July 2004
and was presented to the IDG in October. Once
printed, the report will be widely circulated and
its implementation monitored 
by the IDG on an ongoing basis. 
3.4.7 As regards existing services, the three Area
Health Boards within the Eastern Region
provide detoxification and rehabilitation
services on both an in-patient and out-patient
basis. Under-18-year-olds are prioritised for
these services. In order for drug-free treatment
programmes to be successful the individual
must be motivated to commence a
programme of detoxification and engage in
follow-up care. The three Area Health Boards
also utilise in-patient rehabilitation services
outside the Eastern Region. The Matt Talbot
Adolescent Service, a drug-free residential
facility for the treatment of alcohol and drug
misuse in young males between 14 and 18
years in the Southern Health Board, is also in
operation.
Increase the number of treatment places to 6,000
places by end 2001 and to a minimum of 6,500
places by end 2002
3.4.8 Significant progress has been made in relation
to the numbers receiving substitution treatment
and the latest figure for those receiving
methadone at the end of July 2004 is 7,052.
The breakdown of this figure is as follows:
Breakdown of Patients July 2004
ERHA Clinics 3,677
National Clinics 149
Trinity Court 499
Prisons within ERHA area 286
Prisons outside ERHA area 4
General Practitioners within ERHA area 2,250
General Practitioners outside ERHA area 187
Total 7,052
Area Breakdown of Participating Pharmacies
Pharmacies within ERHA area 190
Pharmacies outside ERHA area 123
Total 313
Area Breakdown of Participating General Practitioners
The No. of GP’s participating within the 
ERHA area 178
The No. of GP’s participating outside the 
ERHA area 40
Total 218
Continue to implement the recommendations 
of the Steering Group on Prison-Based Drug
Treatment Services as a priority and implement
proposals designed to end heroin use in prisons
during the period of the Strategy
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3.4.9 The July 2000 report of the Steering Group22
on Prison Based Drug Treatment Services
concluded that the level and extent of the
medical and other supports available to drug
misusers in the wider community should 
be replicated within the prison system. The
Steering Group’s recommendations focused 
on developing a cross-agency, multi-disciplinary
response aimed at delivering effective
treatment and harm reduction measures 
while maintaining – and, where possible,
enhancing the supply reduction measure.
3.4.10 Significant progress has been made in
implementing the recommendations of 
the Steering Group: 
• During 2001, a number of appointments
were made, including (i) a pharmacist to
oversee the development of new systems
and controls in the procurement, storage
and dispensing of medicines; (ii) a co-
ordinator of nursing to provide strategic
leadership for newly appointed professional
nurses; and (iii) a Deputy Governor with
specific responsibility as training officer for
intervention programmes for prison staff on
drug identification and drug use.
• In 2002, a co-ordinator of Drug Treatment
Services (Prisons) was appointed by the
ERHA and is based in Mountjoy Prison and
a three-strong Probation and Welfare
Service was also established which
provides programmes for prisoners to
address their addictions and the necessary
supports during detoxification and
stabilisation.
• In 2004, a consultant psychiatrist in
addiction was appointed by the NAHB to
provide sessions at the Mountjoy Complex.
It is hoped that a similar appointment will
be made shortly by the SWAHB with
sessions at Cloverhill and Wheatfield
Prisons. 
• Eighty-four professional nurses have also
been appointed to work (though not
exclusively) in the areas of detoxification,
managing/supporting prisoners on
methadone and in the treatment of
addiction related conditions. In this regard,
since September, 1999, seven Prison
Officers have been seconded and have
completed nurse training under the PCW
(Pay and Competitiveness at Work)
Agreement. These officers are now
assigned to the Irish Prison Service as
Nurse Officers. 
• The appointment of psychologists and
addiction counsellors for the Mountjoy
Complex, Cloverhill and Wheatfield Prisons
are expected shortly;
• Additional drug free areas are also in
operation in St. Patrick’s Institution,
Cloverhill and Wheatfield prisons; and
• In addition, new inter-agency and multi-
disciplinary structures have evolved to 
co-ordinate and further develop drug
treatment in prisons and throughcare
arrangements with community-based
services – at both policy and operational
levels. 
3.4.11 As a result of these developments, prisoners
now have better access to detoxification
programmes on committal to prison.
Approximately 500 prisoners have completed
Mountjoy Prison’s Drug Treatment Programme
(a six week course involving detoxification,
intensive counselling and psychological
support) and there are structured throughcare
arrangements between prison and drug
treatment centres in the wider community.
The number of prisoners in receipt of
methadone maintenance has also increased –
from 184 in December 2000 to 290 at the
end of July 2004. Methadone maintenance,
combined with throughcare arrangements, 
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has brought stability to the lives of many
prisoners and has helped to overcome
previously chaotic transitions from prison 
to release into the community.
3.4.12 The Irish Prison Service is also continuing 
to take extensive and diverse measures 
to prevent the supply of illicit drugs within
prisons. Traditional means of effecting supply
reduction have been reinforced through 
(i) the use of video surveillance in visiting
rooms, prison yards and other areas where
drugs are likely to change hands; (ii) the
provision of screened visiting rooms and 
(iii) in the case of Mountjoy Prison, new
visiting arrangements which involve prior
nomination and identification of visitors. New
prison rules are currently being drafted and will
provide, inter alia, for mandatory drug testing.
3.4.13 More recently, the Irish Prison Service has
embarked on a programme of installing nets
over prison yards to prevent contraband, such
as drugs, being propelled over perimeter walls.
Future prison designs will seek to locate yards
away from perimeter walls as part of further
efforts to limit the supply of illicit drugs. 
Have in place, in each Health Board area, 
a Service User Charter by end 2002
3.4.14 A Service Users Charter outlines what a
person presenting to the addiction services
can expect and what will be expected of 
them in terms of their rights and also their
responsibilities. Each of the ERHA Health
Boards has developed a charter and other
Health Boards are in the final stages of
developing their charters.
Have in place, in each Health Board area, a range
of treatment and rehabilitation options as part of
a planned programme of progression for each
drug misuser, by end 2002
3.4.15 Health Boards are the primary providers and
drivers of treatment services for problematic
drug misusers. The addiction services seek to
deliver these services in partnership with local
communities and private service providers,
where appropriate. The services designed for
drug misusers provided directly by the Health
Boards include:
• Outreach – making contact with drug users
not currently accessing services, advising 
on services, on safer injecting and sex
practices and providing needle exchange;
• Education – helping to implement the
education component of the National
Drugs Strategy and providing services 
to drug users, schools, families, local
communities and professional groups 
on drug related issues;
• Treatment – a range of interventions
including assessment, stabilisation, harm
reduction measures, care planning,
methadone maintenance, counselling and
detoxification within specialist clinics,
residential settings and within community
settings;
• Rehabilitation – the provision of a range of
options including residential and day
programmes and a planning and brokerage
service designed to equip drug users with
the skills and tools for progression and
reintegration; and
• Community Welfare – a service to assist
clients with accommodation and income
maintenance needs.
3.4.16 Services provided by a range of voluntary and
community sector organisations which are
funded and co-ordinated by the Health Boards
include:
• Drop-in services;
• Peer support services;
• Family Support;
• Education services;
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• Counselling services;
• Rehabilitation and aftercare services;
• HIV/AIDS Support;
• Training services;
• Personal development training.
3.4.17 Health Boards provide residential and day
treatment and rehabilitation both directly,
through Section 65 grants and through
mainstreamed LDTF projects23. The range 
of services being offered is currently under
assessment and based on additional needs
highlighted, services will be developed from
2004 onwards. 
Provide stabilised drug misusers with training 
and employment opportunities and, as a first 
step, increase the number of such opportunities
by 30% by end 2004
3.4.18 There are 54 drugs related Community
Employment Projects up and running with 
a total of approximately 1,120 contracted
places available of which just over 900 are
filled according to the latest figures. In
addition, a drugs awareness training
programme for CE supervisors has been
developed with Merchants Quay. This
programme is currently being piloted and
providing evaluation is successful, will be
available to all CE supervisors during 2004. 
3.5 Research Pillar
3.5.1 The objectives under the research pillar are:
• To have available valid, timely and
comparable data on the extent of drug
misuse amongst the Irish population and
specifically amongst all marginalised groups;
• To gain a greater understanding of the
factors which contribute to Irish people,
particularly young people, misusing drugs.
KPIs – Progress to date
Eliminate all major research gaps in drug research
by end 2003
3.5.2 As outlined in chapter 1, the NACD was
established in 2001 to advise the Government
in relation to prevalence, prevention,
consequences and treatment of problem 
drug use in Ireland based on their analysis 
and interpretation of research findings.
3.5.3 To date, the Committee has either completed
or has work on-going on thirty-eight projects.
Among the more high profile projects are:
• Prevalence Estimate of Opiate Users –
results released in May 2003;
• All-Ireland General Population Survey on
Drug Use:
- 1st bulletin released – October 2003
- 2nd bulletin (Regional Results) released
– April 2004
• Overview of research in relation to the
Prevention of Drug Misuse published in
December 2001 – this helped inform the
development of the National Drugs
Awareness Campaign;
• Study on Cocaine use in Ireland –
published in December 2003;
• Review of Harm Reduction approaches –
published in May 2004;
• Study on Cannabis – published in
September 2004;
• On-going Longitudinal Study on Treatment
Outcomes – will give better information on
the most effective forms of treatment for
drug users;
• Collaborative research projects on drug 
use amongst vulnerable groups such as
Travellers and the Homeless; and 
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• The NACD is also developing a Drug
Trends Monitoring System (DTMS) to
monitor changes in drug misuse
throughout the country. 
Publish an annual report on the nature and extent
of the drug problem in Ireland and on progress
being made in achieving the objectives set out in
the Strategy
3.5.4 This report fulfils this KPI in relation to
progress being made in the Strategy. In
addition, the Critical Implementation Path
(CIP) for the Strategy was published in April
2004. The purpose of the CIP is to map out
how the 100 actions are being delivered and
the timeframes for delivery. Future progress
under the Strategy will be measured against
the steps set out in the CIP. Copies of the
Report are available from the Drugs Strategy
Unit, Department of Community, Rural and
Gaeltacht Affairs, www.pobail.ie or telephone
01 6473000. In addition, in September 2003,
the NACD launched a Progress Report
covering the work of the Committee from July
2000 to July 2003. Copies of the Report are
available from the NACD – www.nacd.ie or
telephone 01 6670760.
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Chapter Three
No. Agency Action Due date Commentary 
1
2
3
Due dates in this table reflect the target dates agreed and published in the Critical Implementation Path 2004.
D/CRGA Continued provision of
accessible, positive alternatives
to drug misuse in areas where
such misuse is most prevalent
through the YPFSF and more
generally, through arts and
culture youth programmes, the
schemes run by the Irish Sports
Council and the facilities
provided through funding under
the Sports Capital Programme.
These should be accessible and
attractive to those most at risk
of drug misuse and those from
socially, educationally and
culturally diverse backgrounds.
In this regard, the LDTF areas
should be prioritised. Specific
efforts should also be made to
ensure that the groups who are
most at risk of drug misuse are
actively engaged in recreational
activities at local level.
Ongoing The YPFSF covers the 14 LDTF areas as well as four
other urban centres. The Sports Capital Programme has
always given extra weighting to areas of disadvantage
and from 2003 is particularly prioritising LDTFs, RAPID 
& CLÁR areas. 
D/CRGA The IDG, in conjunction with the
NDST, to establish an evaluation
framework for the Strategy,
incorporating the performance
indicators against which progress
under the four pillars will be
assessed. Annual reports and
mid-term evaluations would
facilitate progression towards 
key strategic goals. The cost
effectiveness of the various
elements of each pillar of the new
Strategy should be established to
enable priorities to be established
and a re-focusing, if necessary, of
strategic objectives from the mid-
term evaluation stage at 2004.
Ongoing The monthly meetings of the IDG and the Cabinet
Committee on Social Inclusion regularly monitor and
assess the progress of the Strategy with specific
reference to its targets and performance indicators. 
A progress report covering 2001-2004 is being
published in early 2005. The mid-term review will look
at refocusing priorities, if necessary.
D/CRGA The Department, through the
IDG and the NDST to co-ordinate
the implementation of the
National Drug Strategy in
partnership with Government
Departments, State Agencies,
and the community and
voluntary sectors and to bring to
the Cabinet Committee on Social
Inclusion any identified issues
which have a detrimental effect
on the implementation of policy.
Ongoing IDG meetings are held monthly. The Cabinet Committee
on Social Inclusion is given six-monthly reports on
progress in achieving the targets set out in the strategy. 
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4
5
D/JELR
D/JELR
To oversee the establishment of
a framework to monitor
numbers of successful
prosecutions, arrests and the
nature of sentences passed.
To establish, in consultation with
the Gardaí and the community
sector, best practice guidelines
and approaches for community
involvement in supply control
activities with law enforcement
agencies.
2005
Guidelines
2004 
(Late 2005 –
Implement-
ation)
This is a complex and highly technical project as it
requires the development of interfaces between the
databases of the Garda Síochána, the Courts Service and
the Prisons Service, some of which are themselves in a
developmental phase. Work on the development of such
interfaces to facilitate the ready availability of information
on successful prosecutions, arrests and the nature of
sentences passed is ongoing. 
The Minister for Justice, Equality and Law Reform has
recently approved a specific recommendation of the
Expert Group on Crime Statistics that a Central Crime
Statistics Unit be established. It is proposed that one of
the functions of the unit would be to oversee integration
of the various IT systems with a view to the development
of an integrated criminal history repository.
By its nature, this is a mid to long term project and the
Department is anxious to achieve some progress in the
shorter term. Consequently, in conjunction with an Garda
Síochána, they are proceeding with the introduction of a
pilot study to be based in selected Garda Districts aimed 
at tracking pathways of drug offenders through the Criminal
Justice System. The results of this study will inform the
overall comprehensive delivery of this action point.
The Department is currently involved in putting in place 
a policy framework and structures which will facilitate 
the development of formal and inclusive partnership
arrangements on policing issues between An Garda
Síochána and the communities it serves. Included in 
its draft provisions are mechanisms for enhanced 
co-operation between the Gardaí and Local Authorities
through the establishment of Policing Committees. 
It is intended that such committees will act as fora 
where matters relating to all aspects of policing can be
discussed and where strategies and recommendations 
for dealing with issues arising locally can be decided. It is
intended that these Policing Committees will facilitate the
establishment of local policing fora to address specific
matters, including drug supply issues, in local areas. 
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No. Agency Action Due date Commentary 
6
7
8
9
D/JELR
Garda
Síochána
Garda
Síochána
Garda
Síochána
To review the ongoing
effectiveness of crime
legislation, in tackling drug-
related activity.
To increase the level of Garda
resources in LDTF areas by end
2001 and build on lessons
emanating from the Community
Policing Forum (CPF) model.
To establish a co-ordinating
framework for drugs policy in
each Garda District, to liaise with
the community on drug-related
matters and act as a source of
information for parents and
members of the public. Each
Garda District and Sub-District
be required to produce a Drug
Policing Plan to include multi-
agency participation in targeting
drug dealers.
To target the assets of middle-
ranking criminals involved in
drug dealing. 
Late 2004
Late 2004
Early 2004
2004
The EU carried out a mutual evaluation report on
Ireland’s law enforcement response in the fight against
drug trafficking (2002). It concluded that most of the
core legislation relating to drug trafficking and financial
investigations is relatively recent and the provisions are
comprehensive and support strong and effective law
enforcement. Furthermore, sections of the Criminal
Justice (Drug Trafficking) Act 1996 which relate to Garda
powers of detention in drug trafficking cases were
reviewed during 2002 by the D/JELR in conjunction with
Garda Authorities. Arising from this review an extension
to the applicability of sections 2,3,4,5, and 6 (Garda
powers of detention) until Dec 2004 was approved 
by the Oireachtas in December 2002. In addition a
research study has been commissioned on the utilisation
of the provisions in respect of drug trafficking offences
which were introduced under Part 2 of the Criminal
Justice Act 1999. The results of this study are expected
to be available in late 2004. The Department will
continue to assess the need to review particular
elements of drug related legislation. 
The current strength within the LDTF areas has shown
moderate increases. A review of overall deployment of
Garda strength is scheduled for 2004 in line with the
Pulse System and up-dated General Established
Redistribution Model (GERM). The allocation of additional
resources in LDTF areas will be considered in line with an
overall increase in the strength of An Garda Síochána.
The Garda Community Consultations document was
approved by the Commissioner in September 2002. 
A framework to engage the community in policing issues
is part of the Garda Síochána Bill currently before the
Oireachtas. Divisional policing plans were also posted 
on the Garda website during 2004.
Working Group submitted proposals to the Garda
authorities in June 2003. Regional managerial briefings
on asset forfeiture were held between May and
September 2003. Training courses for divisional
personnel in asset forfeiture and confiscation is ongoing
with the aim of asset profilers in each region to be in
place by Mid 2005.
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10
11
12
13
14
15
16
Garda
Síochána
Garda
Síochána
Garda
Síochána
Garda
Síochána/
Customs 
& Excise
Garda
Síochána/
Customs 
& Excise
Garda
Síochána/
Customs 
& Excise
To extend the Community
Policing Fora (CPF) initiative to all
LDTF areas, if the evaluation of
the pilot proves positive. The
proposed RDTFs should be
consulted in assessing whether
CPFs should be in regional areas
of particular need. Where CPFs
do not exist, CPF methods should
be adopted for best practice for
mainstream policing policy.
To ensure that operations similar
to Dochas, Nightcap and
Cleanstreet are implemented in
urban centres throughout
Ireland, where drug dealing is
ongoing.
To monitor the efficacy of the
existing arrest referral schemes
and expand them, as
appropriate.
To continue to work more
closely together in accordance
with the principles of their
Memorandum of Understanding
(MOU). They should also co-
operate and collaborate fully
with law enforcement and
intelligence agencies in Europe
and internationally in reducing
the amount of drugs coming
into Ireland.
To strengthen and consolidate
existing coastal watch and other
ports of entry measures
designed to restrict the
importation of illicit drugs by
end 2002.
To develop benchmarks against
which seizures of heroin and
other drugs can be evaluated
under the EU Action Plan in
order to establish progress on 
a yearly basis.
Ongoing 
from 
Late 2003
Mid 2004
onwards
Mid 2004
onwards
Ongoing
Early 2003
Ongoing
There are currently three Community Police Fora in the
North Inner City, Finglas/Cabra area and the South Inner
City. Further development of fora as per Garda Síochána
Bill in Action 7. 
Clean Street VII and VIII were conducted during 2003. 
A number of Nightcap operations were also conducted
during the year in locations throughout the country. 
A draft document on the future conduct of such
operations has been submitted to the Commissioner.
This document recommends regional training which is
anticipated to commence during 2004.
Pilot surveys in Dun Laoghaire, Ballymun and Cork
commenced in June 2003. Research is currently
underway in the North Inner City LDTF funded by 
the D/JELR.
Co-operation is ongoing in accordance with the MOU
and Operational Protocol. Local liaison structures have
been enhanced following a series of regional
Garda/Customs liaison meetings in Sept/Oct 2003. 
Co-operation at international level has also been
enhanced.
Customs & Excise, who have primary responsibility in 
this area, have implemented a number of measures to
enhance drugs detection capability at points of entry. The
Customs Drugs Watch programme was re-launched in
January 2003. A poster and public awareness programme
is in place. A Customs cutter (RCC Suirbhéir) has been
purchased and was commissioned in June 2004.
Benchmarks established. Progress being monitored
against targets set.
Garda
Síochána
To continue to target dealers at
local level by making additional
resources available to existing
drugs units and for the
establishment of similar units in
areas where they do not
currently exist.
Late 2004 A number of Divisional and District Drug Units have
been established in areas of identified need. A working
group is currently examining the resources of dedicated
drug units. This work will incorporate a review of the
GERM model scheduled to commence in 2004.
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17
18
19
20
Garda
Síochána/
Customs 
& Excise
Garda
Síochána/
Customs 
& Excise 
Garda
Síochána
and Health
Boards
Courts
Services
To ensure greater integration of
Customs and Excise within a
European context, an Officer of
the Customs and Excise Division
should be appointed to the
Europol National Unit.
To have available to the
enforcement agencies detection
dogs and other resources to
restrict the importation of illicit
drugs.
Incidences of early use of
alcohol or drugs by young
people coming to Garda
attention to be followed up by
the Community Police and/or
the health and social services, in
order that problem drug misuse
may be diagnosed/halted early
on through appropriate early
intervention.
To have in all LDTF areas an
early intervention system, based
on the Drug Court model, if the
evaluation in the North Inner
City of Dublin is positive. This
should be accompanied by
appropriate familiarisation for
the judiciary on the role of the
Drug Court.
Mid 2001
Ongoing
Mid 2005
Late 2005
Customs Officer appointed to Europol National Office in
July 2001.
Customs and Excise have detector dogs currently 
in place at all major entry points to the state and 
An Garda Síochána also have a number of dogs
available to them. The acquisition of additional technical
and other equipment is considered by the Revenue
Commissioners on an ongoing basis. As part of this
review process a Customs cutter has been purchased.
Additionally, Revenue has invited tenders for the
acquisition of x-ray scanning technology for screening
containerised freight.
A review group established under the Department 
of Health and Children with Garda representation to
progress this action. This group will also be influenced
by Arrest Referral Scheme research.
A pilot Drug Court programme has been in existence 
in Dublin’s North Inner City since January 2001. The
Northern Area Health Board has provided resources 
for the operation of the Drug Court programme. The
evaluation report of the project, published in February
2003 by the Minister for JELR, was generally positive.
The recommendations of the report included the
extension of the current pilot area to further test and
refine the emerging model and to address difficulties
which have been identified. This is to take place with 
the concurrent development of a Drug Court Planning
Programme which will focus on research and
development activity necessary to roll out the Drug 
Court more widely. Since mid 2003, the pilot Drug Court
area of operation has been extended to the Dublin 7
catchment area. Another evaluation will be carried out 
by the Courts Service in 2005.
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21
22
23
24
Prison
Services
Prison
Service
Prison
Service
Prison
Service
To continue to implement the
recommendations of the
Steering Group on Prison-Based
Drug Treatment Services as a
priority and to implement
proposals designed to end
heroin use in prisons during the
period of the Strategy. 
To expand prison-based
programmes with the aim of
having treatment and
rehabilitation available to those
who need them including drug
treatment programmes, which
specifically deal with the
reintegration of the drug using
offender into the
family/community.
To commission and carry out an
independent evaluation of the
overall effectiveness of the
Prison Strategy by mid 2004.
The review should cover all
aspects of drug services in
prisons including research on
the levels and routes of supply
of drugs in prisons.
To expand the involvement of
the community and voluntary
sectors in prison drug policy via
the ongoing development of the
Local Prison Liaison Groups and
the formal meetings between
the sectors and the Steering
Group on Prison-Based Drug
Treatment Services.
Late 2005
Late 2008
Mid 2008
Late 2004
Considerable progress has been made. A group to
review education and training needs was established
and has completed its work. A Deputy Governor with
responsibility for staff training has been appointed. 
Eighty-four professional nurses have also been
appointed to work (though not exclusively) in the 
areas of detoxification, managing/supporting prisoners
on methadone and in the treatment of addiction related
conditions. A Co-ordinator of Pharmacy Services and 
a Co-ordinator of Nursing Services in prisons have 
been appointed. A senior Probation and Welfare Officer
and three team members have been assigned to 
drug treatment work within the Mountjoy complex.
Preparatory work is underway for the recruitment of
Addiction Counsellors and psychologists. New prison
rules are currently being drafted and will provide, 
inter alia, for mandatory drug testing.
A drug free unit opened in St. Patrick’s Institution in
November 2000 and drug free areas opened in
Wheatfield in 2002. The Training Unit in the Mountjoy
complex is designated a drug-free place of detention.
There is a separate wing in Cloverhill Prison for prisoners
who wish to remain drug free. Over 490 offenders have
completed the drug treatment/detox programme, which
has been running in the Medical Unit, Mountjoy Prison
since July 1996. This six-week course involves
detoxification where necessary, intensive counselling and
psychological support for prisoners. The Minister for
Justice, Equality and Law Reform is currently considering
a draft drugs policy for the Irish Prison Service.
The Irish Prison Service continually monitors the
effectiveness of its drug policies and already has a good
knowledge of the levels and routes of supply of drugs in
prisons. Pending the finalisation of the new drugs policy
currently being considered by the Minister for Justice,
Equality and Law Reform, it would be premature to
undertake a wide-ranging review of all aspects of drug
services in prisons. The better course would be to
undertake the review when the new policy has been 
in place for a sufficient period of time, to allow for
meaningful evaluation. It is intended that the review
should be initiated in 2007.
The Governors of the Dublin prisons hold regular
meetings with the Prisons and Community Drugs Liaison
Group. These meetings provide a forum for consultation
with this sector and issues raised are considered by 
the National Steering Group where appropriate.
Consideration is being given to establishing a formal
means of consultation between the National Steering
Group and this sector.
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25
26
27
28
29
D/ELG
D/ELG
Gardaí,
HBs and
VFI, LVA
HFI
Gardaí,
HBs and
VFI, LVA
HFI
D/E&S
To commission an external
evaluation of the impact of
enforcement activity under the
Housing Acts (evictions,
excluding orders) on
homelessness by end 2001.
To monitor and evaluate
homelessness initiatives in
relation to drugs issues in the
context of the Homeless Strategy
and particularly, in relation to the
Dublin Action Plan.
Representative bodies, including
the Vintners Federation of
Ireland (VFI), the Licensed
Vintner’s Association (LVA) and
the Irish Hotel Federation to
prepare guidelines, in association
with the Gardaí Authorities and
the Health Boards, for publicans
and night-club owners, regarding
drug dealing on, or in the vicinity
of their premises. These
guidelines should set out clearly
the actions which the owner of
the premises should take in
response to drug dealing e.g. co-
operation with the Gardaí, etc.
Gardaí to object to the renewal
of licences for publicans and
night-club owners where there
has been a history of drug
dealing on the premises.
Publish and implement a policy
statement on education
supports in LDTFs, including an
audit of the current level of
supports by end 2001.
Nominate an official to serve as
a member of each Task Force.
Set up a group in the Department
to discuss cross-cutting issues.
Early 2002 –
Guidelines
distributed 
to LA’s late
2004
Mid 2004
Early 2004
From late
2003
Early 2004
Early 2002
Early 2002
Based on an external evaluation undertaken in 2001,
Dublin City Council has published a document entitled
“Anti-Social Behaviour – Policy and Procedure” which
outlines their policy and procedure for dealing with anti-
social behaviour. In addition, the Housing Unit has
produced “Good Practice Guidelines on Preventing and
Combatting Anti-Social Behaviour” (December 2003)
which are being applied nationally.
Included in NACD research as per Action 98.
Guidelines for licensees produced as a result of the
considerations of the working group. Being published 
in late 2004. 
Monitoring these activities are part of the ongoing work
of An Garda Síochána.
The D/E&S is currently undertaking an extensive review 
of its education disadvantage provision. When the review
is complete, the policy statement relating to LDTF area
schools will be issued.
Officials from D/E&S are attending all LDTF meetings.
Regular meetings on social inclusion issues, chaired by
an Assistant Secretary General are held in the D/E&S.
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30
31
32
33
34
(A)
D/E&S
D/E&S, 
HPU &
HBs
D/E&S, 
HPU &
HBs
D/E&S, 
HPU &
HBs
D/E&S, 
HPU &
HBs
To prioritise LDTF areas during
the establishment and expansion
of the services of the National
Educational Welfare Board.
To put in place by end 2001
mechanisms which will support,
enhance and ensure the
delivery of school-based
education and prevention
programmes in all schools
nationwide over the next three
years.
To implement ‘Walk Tall’ and
‘On My Own Two Feet’
Programmes in all schools in
the LDTF areas, in the context of
the SPHE programme during
the academic year 2001/02.
To deliver the SPHE Programme
in all second-level schools by
September 2003.
To complete the evaluation of
the ‘Walk Tall’ and ‘On My Own
Two Feet’ programmes by end
2002 and to continue to
evaluate the programmes in
order to establish whether they
need to be augmented or
whether there is a need for
alternative programmes to
address key gaps.
Ongoing from
early 2003
Early 2002
Academic Yr
2001/2002
Sep 2003
Early 2004
The NEWB has appointed a Chief Executive Officer,
Directors of Corporate Services and Educational Welfare
Services and the necessary support and service delivery
staff. At this stage of its development, the aim of the
Board is to provide a service to the most disadvantaged
areas, including LDTF areas and areas designated under
the Government’s RAPID programme and most at-risk
groups. Five regional teams have now been established
in Dublin, Cork, Limerick, Galway and Waterford and an
educational welfare service is now available, for the first
time, in the cities of Limerick, Galway and Kilkenny.
Twelve towns with significant school going populations,
11 of which are designated under the Government’s
RAPID programme, also now have an Educational
Welfare Officer allocated to them. In addition, the Board
will follow up on urgent cases nationally.
Ongoing support to assist second level schools in the
implementation of the SPHE syllabus is being offered 
by the Post Primary SPHE Support Service. An additional
Regional Development Officer has been recruited to 
the Support Service to work with second level schools in
the LDTF areas. At primary level the Primary Curriculum
Support Service has been augmented by four SPHE
trainers. Two additional National Support Officers have
been recruited and are dedicated to working with
primary schools in LDTF areas.
D/E&S notified all primary and secondary LDTF schools 
of the requirement to implement ‘Walk Tall’ and ‘On My
Own Two Feet’ respectively from September 2001.
Information seminars were provided to facilitate this
delivery and ongoing support for the implementation 
of the programme is available in the LDTF areas. Since
September 2003 all schools have a timetabled SPHE
programme up to Junior Cert level, including ‘On My
Own Two Feet’ as a core element of the SPHE post-
primary programme. 
The programme has been on the curricula of all primary
and second level schools up to junior cycle since
September 2003.
Extensive evaluations of the ‘Walk Tall’ programme have
been conducted and the outcomes were positive. The
programme has a widely accepted rationale and has
been accepted by teachers. The SPHE post-primary
service is undertaking some preliminary evaluation of the
implementation of the SPHE to junior cycle, including the
‘On My Own Two Feet’ programme as a core element of
SPHE, throughout the country. A report on this research is
planned for late 2004. A more comprehensive evaluation
project is planned for 2005-06. 
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34
(B)
35
36
37
D/E&S, 
HPU &
HBs
D/E&S,
HPU &
HBs
D/E&S
D/E&S,
HPU &
HBs
Schools should encourage the
participation of parents on such
programmes where appropriate.
In particular, mechanisms for
engaging the parents of at-risk
children in programmes should
be examined with a view to
establishing models of best
practice.
To ensure that parents have
access to factual preventative
materials which encourage them
to discuss the issues of coping
with drug misuse with their
children.
To ensure that every second
level school has an active
programme to counter early
school leaving with particular
focus on areas with high levels
of drug misuse.
Recommendations 31-35 to
apply equally to the non-school
education sector.
Ongoing from
Mid 2004
Ongoing from
Mid 2004
2006
Ongoing
In April 2002, the Department invited representatives 
of the 14 LDTFs to engage with the Home School
Community Liaison Scheme. In relation to non-
LDTF/HSCL areas, an overall strategy with a view to
involving schools and parents of at risk children is being
developed with Department of Health and Children and
the Health Boards. Within the context of Substance Use
Policy Development, parents are identified as key
stakeholders and recommendations are made regarding
their involvement in policy committees. A number of the
health boards are also involved in the provision of parent
programmes with a drug prevention focus.
One of the aims of the Home School Liaison Scheme of
D/E&S is to raise awareness in parents of their capacities
to enhance their children’s educational progress and to
assist them in developing. Currently 278 primary and
191 second level schools are involved in the Scheme.
Raising the awareness of parents in schools not involved
in the HSCL Scheme will be the subject of discussions
between the Health Boards, the D/E&S and D/H&C. The
National Drugs Awareness Campaign, launched May
2003, is directed at parents and in conjunction with the
campaign website and helpline, a special parent’s
information booklet has been developed and
disseminated throughout the country. Also as part of the
campaign, roadshows aimed specifically at parents are
being undertaken in each Health Board area, to raise
awareness of the issues surrounding drug use.
The School Completion Programme (SCP) was
expanded from September 2002. 65 new projects
involving 225 primary schools and 75 second level
schools have been created by the expansion. The total
number of projects covered by the SCP is 82 involving
276 primary and 106 second level schools. The
Department is at present reviewing the SCP and is
examining the possibility of the inclusion of additional
schools in the programme. In addition, the National
Educational Welfare Board is actively working with
schools to ensure that school attendance policies are in
place to address absenteeism and early school leaving.
All Youthreach and Senior Traveller Training Centres 
have staff trained in the Substance Abuse Prevention
Programme and implement it. Drug education is
included in VTOS and other adult education programmes
as necessary. Community Training Workshops (CTWs)
are operated by FÁS and include a module on drugs and
substance abuse, prevention and awareness in their life
and social skills programme. CTWs operating in LDTF
areas have appointed a Drugs Education and Prevention
Officer.
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39
40
41
D/H&C
D/H&C
D/H&C
D/H&C
To develop and launch an
ongoing National Awareness
Campaign highlighting the
dangers of drugs. The campaign
should promote greater
awareness and understanding of
the causes and consequences
of drug misuse, not only to the
individual, but also to his/her
family and society in general.
To ensure that adequate training
for health care and other
professionals engaged in the
management of drug
dependency is available,
including, if necessary,
arrangements with third level
institutions and other bodies.
To consult all treatment and
rehabilitation providers in order
to ensure that performance
indicators, used in the
evaluation of services, accurately
and consistently reflect the
needs of specific areas i.e.
performance indicators should
reflect the reality of the drug
problem locally.
To oversee implementation of
the recommendations of the
Benzodiazepine Working Group,
which is due to complete its
work by end June 2001, as part
of the overall strategy of quality
improvement of current
services.
During 2003
During 2006
Ongoing from
early 2005
Ongoing from
early 2004
This advertising and PR campaign was launched by
Minister Micheal Martin and Minister of State Noel Ahern
with an overall message of “Drugs – there are answers”
in May 2003. This phase was followed up by more
parent focused communications. A third phase on
cocaine has since been rolled out.
The target groups that require training are to be
identified by Mid 2004. Health care and other
representatives will be consulted on the adequacy of
present training programmes. A report with
recommendations to address any gaps that are evident
will be produced.
Consultation has taken place in Health Boards in relation
to performance indicators for Health Board drug services.
These performance indicators are in place and
discussions are ongoing in relation to improvements for
2004. It is considered necessary to have adequate
performance indicators in place in Health Boards before
entering into consultation with voluntary service
providers. However, it should be noted that monitoring
of the services of those organisations who receive
Section 65 funding is part of the condition of the
provision of this funding.
The report of the Benzodiazepine Committee was
finalised and published in December 2002. Relevant
bodies and agencies will be consulted in relation to the
implementation of the recommendations before the end
of 2003. A lot of the recommendations are in place
already. The Report and Good Practice Guidelines for
clinicians has been widely circulated. Work on the
Pharmacist Guide has commenced.
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42
43
44
45
D/E&S &
D/H&C
D/E&S &
D/H&C
Health
Boards
Health
Boards
To ensure that the design and
delivery of all preventive
programmes is informed by
ongoing research into the
factors contributing to drug
misuse by particular groups. 
The programmes should also
include the development of
initiatives aimed at equipping
parents of at-risk children with
the skills to assist their children
to resist drug use or make
informed choices about their
health, personal lives and social
development.
To develop guidelines, in co-
operation with the Health Boards
to assist schools in the formation
of a drugs policy and ensure that
all schools have policies in place
by September 2002.
To have immediate access for
drug misusers to professional
assessment and counselling by
health board services, followed
by commencement of
treatment as deemed
appropriate, not later than one
month after assessment.
To increase the number of
treatment places for opiate
addiction to 6,000 by the end
of 2001 and to a minimum of
6,500 by the end of 2002.
Ongoing from
Mid 2002
Early 2004
Academic
Year
2004/05
Early 2003 – 
Late 2005 
Varies by HB 
Early 2003
There is regular contact between the two Departments
to ensure that the SPHE programmes in primary and
post primary schools are informed by ongoing research.
The Health Promotion Unit is represented on the NACD
prevention sub-committee who have commissioned
research into various aspects of drug use prevention 
and have published a document entitled “Drug-Use
Prevention: an Overview of Research”.
The Department of Health and Children continues to link
with the Review of Parenting Support currently underway
within the context of Best Health for Children. The
development of such initiatives will be the subject of
discussions involving the two Departments and the
Health Boards in 2004. Parents are a key target group
during the National Drugs Awareness Campaign. 
Guidelines have been developed and were issued to
schools in 2002. Support is being provided to schools 
to assist them in the formation of substance misuse
policies. All health and education personnel have been
provided with training to support them in their work with
schools. Many schools have developed policies and more
are still going through the development process. The
D/E&S will be monitoring the introduction of policies by
schools during the year. Local level consultation will be
required with the Health Boards. Support materials are
also being developed for schools and some discussions
have taken place around the evaluation of the process.
There has been considerable progress on this action
across the ERHA region including increased capacity,
new centres and increased involvement of pharmacies.
The number on waiting lists have been substantially
reduced though more work and development of services
is needed in some locations to achieve the provision of
treatment within one month. Services also need to be
developed in areas which still do not have a treatment
facility. Boards outside the ERHA region are working
towards increased involvement of GPs and Pharmacists
with regard to the Methadone Protocol. Direct access to
counselling and assessment in place, especially in larger
urban centres.
End July 2004 figure is 7,052
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47
48
49
Health
Boards
Health
Boards
Health
Boards
Health
Boards
To develop and put in place by
end 2002 a service-users charter
specific to treatment and
rehabilitation facilities which would
lead to a greater balance in the
relationship between the service
user and the service provider.
To base plans for treatment
services on a “continuum of
care” model and a “key worker”
approach to provide a seamless
transition between each
different phase of treatment.
To have in place, in each Health
Board area, a range of treatment
and rehabilitation options as
part of a planned programme 
of progression for each drug
misuser, by end 2002. This
approach will provide a series 
of options for the drug misuser,
appropriate to his/her needs
and circumstances and should
assist in their re-integration back
into society.
To develop a protocol, where
appropriate, for the treatment 
of under 18-year-olds
presenting with serious drug
problems especially in light of
the legal and other dilemmas
which are posed for
professionals involved in the
area. In this context, a Working
Group should be established to
develop the protocol. The Group
should also look at issues such
as the availability of appropriate
residential and day treatment
programmes, education and
training rehabilitative measures
and harm reduction responses
for the young. The Group
should report by mid 2002.
Early 2004
Late 2006
Varies by HB
During 
2005-2007
Early 2004
Most Health Boards have developed these charters.
Other Health Boards are in the final stages of developing
their charters. 
Each of the Area Health Boards have developed a
continuum of care model/approach to treatment and
rehabilitation. Where feasible existing staff such as
counsellors, nurses and rehabilitation workers have taken
on a key working role with clients.
Health Boards already provide a range of residential, 
day treatment and rehabilitation programmes both
directly and through Section 65 and mainstreamed LDTF
projects. The range of services being offered is currently
under assessment and based on additional needs
highlighted, services will be developed. 
Report has been finalised and is in the process of
publication. Report will be available early 2005.
50 Health
Boards
To develop, in consultation with
the NACD, criteria to ensure that
all State-funded treatment and
rehabilitation programmes
accord with quality standards as
set out by the Health Boards.
2005 The process of developing quality standards will be
ongoing in conjunction with the NACD during 2003 and
2004. Quality seminar hosted by the NACD and the
ERHA has been held. HBs reviewing current policies in
line with best practice. Training in Quality Standards has
been held in the Eastern Region.
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52
53
54
Health
Boards
Health
Boards
Health
Boards
Health
Boards
To have a clearly co-ordinated
and well publicised plan in
place for each Health Board
area by end 2002 for the
provision of a comprehensive
and locally accessible range of
treatments for drug misusers,
particularly for young people,
the planning of such services to
be linked to the national profile
of drug misuse amongst young
people and to the areas where
usage is most prevalent. Plans
to be implemented by 2004.
To produce and widely distribute
a well publicised, short, easily
read guide to the drug
treatment services available in
each Health Board area with
contact numbers for further
information and assistance.
To require from 2002 that all
Health Boards, in considering
the location and establishment
of treatment and rehabilitation
facilities, develop a
management plan in
consultation with local
communities. Existing examples
whereby Health Boards have
established monitoring
committees with the local
community to oversee the
operation of the treatment
services have proven successful
should be replicated where
appropriate.
To consider, as a matter of
priority, how best to integrate
child-care facilities with
treatment and rehabilitation
centres and how childcare can
best be provided in a residential
treatment setting. This should
be done in conjunction with the
Department of Justice, Equality
and Law Reform.
During
2004/05
(varies 
by HB)
Early 2004
2002
onwards
Late 2004
Health Boards in the ERHA have provider plans in place.
Work ongoing to implement plans during 2004/2005.
Other Boards are in various stages of implementation.
The U-18’s Report will influence this action in relation to
the treatment of young people.
Guide produced by all Boards.
Health Boards in the ERHA have a management plan in
place, monitoring committees or liaison groups. They are
working with the relevant sectors in relation to the
development of new services. This issue has not arisen
in most non-ERHA Boards but will be taken on board in
the context of the development of any centres in the
future.
Childcare facilities are being developed in new facilities.
All existing facilities present limited possibilities for on-
site childcare options. Discussions have been held with
the D/JELR and the NDST. A number of the Health
Boards have raised issues as regards the appropriateness
of on-site integration and are examining other options. 
It is hoped that this will be examined further in the mid-
term review of the NDS. In the non-ERHA Boards a
review of plans for childcare in drug treatment clinics 
(in Boards that have such clinics) is ongoing.
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56
57
58
59
Health
Boards
Health
Boards
Health
Boards
Health
Boards
Health
Boards
To explore immediately the
scope for introducing greater
provision of alternative medical
and non-medical treatment
types, which allow greater
flexibility and choice. This may
increase the number of drug
misusers presenting for
treatment as it is evident that a
“one size fits all” approach is not
appropriate to the characteristics
of Irish drug misuse.
To consider as a matter of
priority, how to increase the
level of GP and pharmacy
involvement in the provision of
treatment programmes.
To oversee the development of
comprehensive residential
treatment models incorporating
detoxification, intervention, pre-
treatment, counselling,
motivational work, therapeutic
treatment and high quality
rehabilitation for misusers who
wish to become drug-free.
Resources should continue to
be targeted at the most efficient
and effective of these services.
To report to the NACD on
efficacy of different forms of
treatment and detox facilities
and residential drug-free
regimes on an ongoing basis.
To secure easy access to
counselling services for young
people seeking assistance with
drug-related problems,
especially given the correlation
between suicide and drug
misuse and the growing
incidence of suicide amongst
young people. 
Mid 2004
Ongoing from
Early 2004
Ongoing from
Mid 2004
Ongoing from
Late 2003
2004
Alternative therapies are already available in a number of
Health Boards in the ERHA through Section 65 grants
and LDTF projects. Lofexidine is available within young
peoples programmes within the Eastern Region. A pilot
project in relation to Buprenorphine is taking place in
Trinity Court. The Health Boards outside the ERHA are
consulting with service providers in other Boards on a
range of effective, evaluated therapies that are available.
The availability of complimentary treatment will be
dependent on access to appropriate qualified staff and
financial resources.
Consultation with GPs and pharmacists in relation to this
action is an ongoing task in the ERHA region. Both the
participation of GPs and pharmacists within the region
has increased since the launch of the Strategy. In
addition, the review of the Methadone Protocol was
finalised in June 2004 and is in the final stages of
publication. Recommendations will be made in this
regard. Non-ERHA Boards are consulting with GPs and
pharmacists in order to increase their engagement in the
provision of services for drug users. A contract for GPs
involved in the Methadone Protocol has also been
agreed for the provision of methadone treatment.
A range of options exist nationwide. Boards are
identifying further needs through consultation and
options are being explored for additional residential
programmes on an ongoing basis.
All Health Boards continually liaise with the NACD. The
Eastern Boards are working with the NACD on the
Longitudinal Treatment Outcomes Study on the efficacy
of treatment programmes. 
Emergency assessment and immediate access are
available. A Suicide Resource Officer has been appointed
in a number of Boards. A review of counselling services
in the Eastern Region was undertaken in 2002 and the
Steering Group is progressing implementation. The
ECAHB runs eight week pre-intervention programmes for
concerned people. Outside the Eastern Region, access to
assessment is available in most Boards within a few
days. Priority is given to emergency cases. There is quick
access to counselling services in most regional Boards
but they are also under review.
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Health
Boards
Health
Boards
Health
Boards
Health
Boards
To ensure that treatment for
young people includes family
therapy and community
integration phases, in order to
encourage family involvement
which is a crucial component in
the treatment of young people. 
To consider developing drop-in
centres, respite facilities and
half-way houses, where a clear
need has been identified, as
such facilities have been found
to be useful in the prevention 
of relapse.
To review the existing network
of needle exchange facilities
with a view to ensuring access
for all injecting drug misusers to
sterile equipment.
To pursue with the relevant
agencies, as a matter of priority,
the setting up of a Pilot
Community Pharmacy Needle
and Syringe Exchange
Programme in the ERHA area,
and in the event of a successful
evaluation, the programme to
be extended where required.
Late 2004
(varies 
by HB)
Ongoing
2004
onwards
No date yet
In the SWAHB treatment is available as part of a
comprehensive Young Person’s Programme in Fortune
House and future programmes are being developed.
The SWAHB has indicated that they will be seeking to
employ a family therapist in the provision of new
services for Clondalkin and Tallaght. The ECAHB have
developed a psychological intervention programme for
young people. The assessment phase has commenced
and the programme will begin shortly. Funding for family
group work programmes through Section 65 grants and
the LDTFs is in place. The Northern Area Health Board
has developed a young persons programme in City
Clinic, Domville House and the Crinan Project. Facilities
are available for the development of a young persons
programme in the Finglas/Cabra area. The Drug
Treatment Centre Board, through the young persons
programme, provides family support counselling to
families attending this service.
Drop-in and aftercare services are provided by boards
and agencies funded under Section 65 grants. A pilot
drug free after care programme has commenced in the
NAHB. The Health Boards will assess the current level of
services and identify gaps and needs in conjunction with
homeless strategies during 2003 and the RDTFs will also
have a role to play in this.
The Eastern Regional Health Authority established a
working group made up of representatives from the
voluntary and statutory service providers to examine this
action. The Group reviewed the existing level of services
and supported the development of further initiatives.
During the lifetime of the group additional services were
developed in partnership with community services in
both the Northern and South Western Area Health
Boards. Additional Services have also developed in
partnership with homeless agencies and for women
working in prostitution.
This action has been stalled for a number of reasons.
There were unofficial IR issues with the Liaison
Pharmacist and ongoing concerns with the IPU regarding
commencing such a pilot. However, progress has been
made and the outstanding issue are being addressed. 
No. Agency Action Due date Commentary 
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66
67
68
69
Health
Boards
Health
Boards
Health
Boards
Coroner’s
Office 
and CSO
Health
Boards 
& LAs
LAs & HBs
To continue to develop good
practice outreach models,
including mechanisms to
outreach drug misusers who are
not in contact with mainstream
treatment or support agencies.
A reduction in the level of drug-
related deaths, particularly from
opiate abuse, through targeted
information, educational and
prevention campaigns must be
a key aspect of the Strategy.
All treatment providers should
co-operate in returning
information on problem drug
use to the Drug Misuse
Research Division of the Health
Research Board.
To consider the feasibility of
new suitably trained peer-
support groups in the context of
expanded provision. Peer-
support groups are a
component of the existing
strategy and are regarded as an
effective rehabilitative support.
Develop accurate mechanism
for recording the number of
drug-related deaths.
Liaise re housing with LA to
ensure access to housing for
recovering drug users.
To develop and implement
proposals for the collection and
safe disposal of injecting
equipment.
Ongoing 
work during
Strategy 
from 2004
Ongoing from
2004
During 
2004-05 –
varies by HB
During 
2004-05
2003
onwards
Mid 2004
A review of outreach services in the ERHA has been
completed and its recommendations are being
considered. The HBs are identifying gaps in outreach
services where such services currently exist and will
consider introducing outreach services, including drug
related deaths, where a need is identified.
Progress made in recruiting staff. Data is being provided
without difficulty from most Boards. In addition, a newly
agreed contract obliges GPs to make timely statistical
returns to the HRB. The HRB will work with the Health
Boards to ensure timely return of data. The Prison Service
is not yet in a position to provide returns to the NDTRS. 
The Area Health Boards and Trinity Court have been
allocated funding to enable them to support the
development of peer-support groups. Also peer advocacy
in the area of mental health is being explored to establish
whether or not some of the training modules could be
utilised. For example, in the ECAHB, a pilot peer support
model took place during 2003. The take up of this
support model was very low and it is being reviewed. 
In the SWAHB, peer support is to be expanded in the
context of addiction. The current levels of services will be
assessed during 2003/04 in areas outside the ERHA, as
part of the work of the RDTFs.
Preliminary discussions have taken place among those
involved in the recording process of drug-related deaths
to identify how the current mechanism could be
improved. Following further consultations and detailed
consideration of this matter, it is planned to have an
enhanced mechanism for recording such fatalities, on 
a pilot basis in the first instance, in place by mid 2005.
Regular contact established. HBs working with LAs on
this issue. 
This action is the responsibility of the Health Boards and
the Local Authorities. A sub-group has been established
to develop guidelines in relation to the collection and
disposal of injecting equipment and the Health Board
Outreach Workers will provide a training programme
around ‘needle stick’ injury and health and safety.
No. Agency Action Due date Commentary 
55National Drugs Strategy Progress Report 
Chapter Three
No. Agency Action Due date Commentary 
70
71
72
73
LAs & HBs
CDBs
Prof.
Bodies and
Training
Institutes
Public
Media
To consider how the design of
housing estates can contribute
to the prevention of drug
dealing in the context of
ongoing reviews of the Social
Housing Design Guidelines for
Local Authority Estates. In this
regard, the lessons learned from
the ISP may be relevant.
To consider the needs of those
areas that have high levels of
drug misuse when drawing up
city/countywide strategies for
economic, social and cultural
development.
To make available to individuals
interacting with groups most at
risk of drug misuse, such as
youth workers, teachers, student
welfare officer, GPs, pharmacists,
nurses, counsellors, child-care
workers, law enforcement
agents, members of the
judiciary etc. specialist drug
prevention training as part of
their initial vocational training.
The relevant professional body
or employer should ensure that
training, or up-skilling is available
on an on-going basis to ensure
that the approach taken reflects
changing attitudes and patterns
of drug misuse.
To encourage the media to play
a larger role in creating a greater
understanding of drug misuse
throughout society. Informed
coverage and analysis and
debate of drugs issues on an
ongoing basis within the public
sphere will contribute to the
successful implementation of
the Strategy. In this regard, the
role of the D/CRGA, as the co-
ordinator of the National Drugs
Strategy, as a possible central
source of information should be
considered.
Ongoing
Ongoing
Mid 2006
Ongoing
The D/ELG and LAs continue to promote the need to
eliminate anti-social behaviour in the design of new
social housing. Attention is being given to ensuring that
design criteria reflect these needs. In addition, the
Housing Unit’s “Good Practice Guidelines on Preventing
and Combatting Anti-Social Behaviour” (December
2003) provide advice and guidance to Local Authorities
on security and anti-crime design features in the design
of housing and accommodation units.
The CDB strategies are published. The CDBs, in their
work, will take account of the needs of those areas that
have high levels of drug misuse.
D/CRGA is writing to the bodies in question asking 
them to report on the availability of such training and 
to consider its inclusion. The Department will then
prepare a report on current levels of provision with
recommendations to address gaps. Where gaps exist 
and agreement is forthcoming to put in place such
courses, these will need to be developed.
D/CRGA has responsibility for co-ordinating the
implementation of the Strategy. Media queries are
referred to the most appropriate source when it is not
possible to deal with in-house. In addition, the NACD
holds media briefings in relation to research publications.
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75
76
77
78
79
FÁS
FÁS
FÁS
Oireachtas
Committee
on Drugs
IDG
IDG
To increase the number of
training and employment
opportunities for drug misusers
by 30% by end 2004, in line
with the commitment to provide
such opportunities in the PPF
and taking on board best
practice from the special FÁS
Community Employment
Programme and the Pilot
Labour Inclusion Programme.
To examine the potential to
involve recovering drug misusers
in Social Economy projects, and
in other forms of vocational
training. The ring-fencing of
places within the FÁS
Community Employment
Programme has been an
important element of the
existing approach to
rehabilitation.
To monitor the participation of
recovering drug misusers on
such programmes and to review
their overall effectiveness. In this
context, alternative models
should be developed where
appropriate.
To establish a dedicated drugs
sub-committee of the existing
departmental joint committee
which would meet at least three
times a year.
To be chaired by the Minister of
State at the D/CRGA. This will
ensure greater co-ordination
between the IDG constituents in
the future and will help to
maintain high-level
representation and more
effective communication
between the IDG and the
Cabinet Sub-Committee.
Membership of IDG to be at
Assistant Secretary level. Regular
joint meetings between the IDG
and the NDST to be held.
Late 2004
Ongoing from
mid 2003
Early 2005
Late 2004
Ongoing
Ongoing
There are 54 drugs related Community Employment
Projects up and running with a total of approximately
1,120 contracted places available of which just over 900
are filled according to the latest figures. In addition, a
drugs awareness training programme for CE supervisors
has been developed with Merchants Quay. This
programme is currently being piloted and providing
evaluation is successful, will be available to all CE
supervisors during 2004.
FÁS has approved one Social Economy project based in
the Tullow Farm, Co. Carlow. This project has already
recruited a manager and is in the process of recruiting
four project workers. The complex is under the
management of the Merchants Quay drug project in
Dublin and provides support for drug misusers drawn
mainly from LDTF areas in Dublin.
Contract specifications prepared by FÁS, with a view to
commissioning professional research on the overall
effectiveness of CE. This is part of the overall review of
CE and in conjunction with a special drugs related
working group representing the NDST, FÁS and the
Community Sector.
The new Committee formed after the election, covers
two departments (D/CRGA and Tourism and Sport) and
has a very wide brief but does not include the role
envisaged in the Strategy. There are ongoing discussions
with the Chair of the Committee in this regard, however,
the Minister of State met the full Committee to discuss
the Strategy in early 2004.
The Minister of State has chaired the IDG since 
October 2001.
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82
83
84
85
86
87
88
IDG, NDST
& D/H&C
IDG
IDG
IDG 
(in
conjunction
- with the
NDST)
IDG &
NDST
NDST
NDST
NDST
NDST
Develop formal links with
National Alcohol Policy.
Seek reports from key service
providers and to attend
meetings, also reps from
voluntary, community and
professional sectors to attend
meetings, as appropriate.
Terms of reference – advise
Cabinet Committee on critical
matters relating to the NDS,
ensuring input of
Depts./Agencies into operational
difficulties, approving plans and
initiatives of LDTFs and RDTFs,
monitoring and evaluating their
operation.
Review membership of the
Team immediately, and every
two years subsequently. To
review the workload of the
NDST, in particular the need for
a director to oversee the
management of the office and
additional technical support
workers.
Depts. and Agencies on the IDG
and NDST to commit in writing
to the process and the level and
extent of representation should
be specified.
Implementation the Terms of
Reference of NDST.
Meet regularly with Co-ordinator
of National Alcohol Policy and
represented on the body Co-
ordinating National Alcohol
Policy.
Ensure representation on YPFSF
bodies, nationally and locally.
NDST to be updated on
developments by Agencies.
NDST work to be core part of
NDST members workload.
Ongoing
Ongoing
Ongoing
Early 2004
Late 2002
Ongoing
Ongoing
Ongoing
Ongoing
The NDST and D/CRGA were represented on the
Strategic Task Force on Alcohol. The NDST also meets
with the National Alcohol Policy Co-ordinator. At RDTF
level, there are close links and cross-membership with
Health Board alcohol policy structures.
The Prison Service, the Customs and Excise and the
NACD have all given presentations to date and others
will be invited as appropriate.
Review completed in December 2001. Staff delayed due
to the change of Department and the requirement for a
Memorandum for Government. The Memo was agreed
in November 2002. All staff have since been appointed.
This was included in the Memorandum for Government
in November 2002 on staffing for the NDST which was
agreed by Government.
See Action 80.
No. Agency Action Due date Commentary 
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89
90
91
92
93
94
95
96/
97
98
99
NDST
NDST
NDST
NDST
RDTFs
RDTFs/
NDST
LDTFs/
RDTFs
LDTFs/
RDTFs
NACD
NACD
To consider funding pilot training
initiatives for RDTF/LDTF
community representatives.
Examine feasibility of standards
and accreditation framework for
Drug Workers.
Disseminate models of best
practice from work of LDTF/RDTF.
Establish RDTFs.
Representation on RDTF to be
at senior level.
Membership of RDTFs.
Community-based initiatives to
raise awareness.
LDTFs/RDTFs to raise 
awareness of drug misuse
including involving user groups.
To carry out studies on drug
misuse amongst the at-risk
groups identified e.g. Travellers,
prostitutes, the homeless, early
school leavers etc. including de-
segregation of data on these
groups. It is essential that the
individuals and groups most
affected by drug misuse and
those involved in working to
reduce, treat and prevent drug
misuse have immediate access
to relevant statistical information.
To commission further outcome
studies, within the Irish setting
to establish the current impact
of methadone treatment on
both individual health and on
offending behaviour. Such
studies should be an important
tool in determining the long
term value of this treatment.
Early 2004
Late 2004
Ongoing
Late 2003
Early 2003
Early 2003
Ongoing
Ongoing
Mid 2004
Late 2005
A review of the work of the LDTFs has been completed
and this addressed training needs for LDTF reps. Initial
training of community reps. on RDTFs was undertaken in
October 2003 in conjunction with Citywide and will be
kept under review by the NDST.
Preliminary work has been undertaken to progress this
action. 
Seminars and information sessions convened as required.
In addition, the LDTF co-ordinators network facilitates
dissemination of best practice and the RDTF interim 
co-ordinators network will do likewise going forward.
The ten Regional Health Boards have agreed to the
appointment of Interim Co-ordinators to the RDTFs.
Representatives from the other sectors involved have
also been appointed. Work is ongoing on mapping
services in the regions and identifying gaps in those
services and the first RDTF plans are due to be
submitted to the NDST in early 2005.
Membership finalised and is kept under review by the
NDST. 
Membership finalised and is kept under review by the
NDST. 
Carried out on a regular basis by Task Forces.
Carried out on a regular basis by Task Forces.
Research commissioned on drug use amongst the
Homeless and amongst Travellers. All reports due by 
Mid 2005.
A three year longitudinal study commissioned November
2002, is being carried out by NUI Maynooth. A report on
year 1 is due in late 2004.
No. Agency Action Due date Commentary 
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100 NACD To conduct research into the
effectiveness of new
mechanisms to minimise the
sharing of equipment e.g. non-
reusable syringes, mobile
syringe exchange facilities, etc. 
to establish the potential
application of new options
within particular cohorts of the
drug using population i.e.
amongst younger drug misusers,
within prisons, etc.
Early 2004 A study has been completed by DCU and the report was
published in May 2004. It is available on the NACD
website www.nacd.ie.
No. Agency Action Due date Commentary 
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Progress in Other Initiatives
This chapter looks at progress being made through
the Local Drugs Task Forces (LDTFs), the Young
People’s Facilities and Services Fund (YPFSF), the
Regional Drugs Task Forces (RDTFs) and the Premises
Initiative for Community Drugs Projects which are part
of the overall work being done under the National
Drugs Strategy.
4.1 Local Drugs Task Forces
4.1.1 As outlined in Chapter 1, Local Drugs Task
Forces represent a partnership between the
statutory, voluntary and community sectors,
which seek to link in with, and add value to,
community-based initiatives targeting drug
misuse at a local level. Thirteen of the
fourteen LDTFs were established in 1997 in
the areas experiencing the highest levels of
opiate misuse. These are: Ballyfermot,
Ballymun, Blanchardstown, the Canal
Communities, Clondalkin, Dublin North Inner
City, Dublin South Inner City, Dublin 12, Dun
Laoghaire/Rathdown, Finglas-Cabra, Cork City
North East Dublin and Tallaght. Bray was
designated as an LDTF area in 2000.
4.1.2 In 1998, the LDTFs drew up their first action
plans, following an intensive consultative
process in each area involving the community,
voluntary and statutory sectors. Each plan
represented a consensus on the priority 
issues to be addressed in tackling drug misuse
in their communities and included a range of
measures in relation to treatment, rehabilitation,
education, prevention and curbing local supply.
The over-riding aim of these plans was:
• To provide a strategic, co-ordinated
response to the drug problem in the Task
Force area; and
• To develop community-based initiatives
that added value to the programmes and
services already being delivered or planned
by the statutory agencies in the LDTF areas.
4.1.3 In June 1998, an independent evaluation 
of the Task Force initiative by PA Consulting
concluded that the LDTFs had achieved a
considerable degree of success in the short
time since they were established, not least 
in reducing the feelings of frustration and
isolation previously felt by many communities
in the affected areas.
4.1.4 In July 2000, the Cabinet Committee on Social
Inclusion approved further funding to enable
the LDTFs to expand the range of programmes
within their action plans.The types of projects
and activities receiving support as part of the
two rounds of plans include:
• Local information, advice and support
centres for drug users and their families;
• Community Drug Teams, including services
such as treatment, outreach, crisis
intervention, etc.;
• Special projects aimed at children involved
in drugs or at risk of drug misuse;
• Production of drug awareness materials;
• Drug training programmes for community
groups, teachers, youth workers and other
professionals;
• Rehabilitation programmes; and
• Initiatives to allow local communities to
work with the State Agencies in addressing
the issues of supply control in their areas.
4.1.5 Table 4.1 below gives a project breakdown by
LDTF area at July 2004. As the table shows,
122 projects from the first round of LDTF
plans were mainstreamed in January 2001
following their successful evaluation. As a
result, over €11m was transferred to the
relevant Departments and Agencies which are
now responsible for the continued funding of
these projects. Of the overall total, 61 projects
(50%) went to the three area Health Boards
in the ERHA area. A further 36 projects were
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Table 4.1 – Breakdown of Projects by LDTF Area
LDTF Round 1 Round 1 Round 2 Total
Mainstreamed Interim (Total)
Ballyfermot 11 4 11 26
Ballymun 11 2 18 31
Blanchardstown 11 1 18 30
Bray 0 0 18 18
Canal Communities 8 2 28 38
Clondalkin 8 0 33 41
Dublin N.E. 8 0 16 24
Cork 10 4 20 34
Dublin 12 5 0 17 22
DL/Rathdown 14 0 18 32
Finglas/Cabra 7 2 20 29
North Inner City 5 10 24 39
South Inner City 10 10 20 40
Tallaght 14 1 22 37
Total 122 36 283* 441
Table 4.2 – Details of LDTF projects broken down by agency – July 2004
Agency Round 1 Round 1 Round 2 Total
Mainstreamed Interim –
10 to be 
evaluated
SWAHB 27 9 94 128
NAHB 27 9 58 93
ECAHB 7 0 18 25
SHB 4 4 9 17
D/E&S 36 5 51 89
D/JE&LR 9 0 18 27
FÁS 7 4 23 35
D/ELG 5 5 12 22
Total 122 36 284* 441
*Note: Difference between total amounts of round II projects in the tables above is due to Bray Community Drugs Team being funded via two
channels of funding i.e. total of projects equals 283, but total of funding agencies equals 284.
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mainstreamed to the Department of
Education and Science with the remaining
transferring to the Departments of Justice,
Equality & Law Reform, Environment, Heritage
& Local Government, the Southern Health
Board and FÁS. In addition, 36 projects from
the first round of action plans remain on
interim funding pending their final evaluation.
In total, 283 projects are being supported
under the second round of LDTF plans,
bringing the overall total to 441 projects
between the two rounds of plans. Table 4.2
gives a breakdown of the projects by funding
agency channel.
4.1.6 By June 2004, approximately €80 million
cumulatively has been allocated or spent by
the LDTFs to implement their two rounds of
local actions plans. The financial support that
the LDTFs have provided to local initiatives
has, since 1997, allowed a variety of projects
to flourish. The following are some examples
of projects supported by the Task Forces that
help to show the diversity and innovative
approaches that have been adopted by
communities in response to drug misuse.
Star Project
4.1.7 The Star Project was established in Ballymun
on Dublin’s northside in February 1998 to
provide training, education and support for
women who have stabilised their drug use.
The project works to facilitate learning through
a group process, with the aim of developing
each participant’s individual potential and 
self-determination. It enables the participants
to examine their drug use and their lives
generally. During their time at the project,
many of the issues which directly affect them
are explored and examined so that they can
become empowered to make constructive
choices for themselves.
4.1.8 Star also maintains close links with other local
community groups, educational, medical 
and addiction services in order to assist the
women’s development in a holistic manner.
Among the challenges for the project is to 
find ways of engaging with the participants to
help them to adjust to the discipline of the
programme, and to make more effective life
choices and to have a more positive image 
of themselves and manage their lives more
effectively.
4.1.9 For a number of the women accessing Star,
this is the first time they have engaged in
employment/education since finishing school,
which for some was a negative experience and
for some participants, it can take a couple of
months to settle in. The programme offers a
wide variety of topics including modules on
personal development, health, parenting,
addiction support group, computer studies, 
first aid, arts and crafts and career development.
Since 1998, the project has developed from 
a 14 week voluntary course to a 2 year
Community Employment programme for 
15 women, with each woman participating
through that period in a structured and
supportive day programme. The project has an
annual budget of approximately €333,000.
Donnycarney Drug Project
4.1.10 Donnycarney Drug Project, a strand of the
Donnycarney Youth Project, was one of the
first projects to receive funding from the
Dublin North East Drugs Task Force in 1997.
The guiding principles of the project are to
encourage people to take control of their lives,
to develop their potential fully and to promote
community empowerment. This involves
people coming together to identify their
collective needs and to develop programmes
to address those needs. The project was
mainstreamed through the Department of
Education and Science in 2001.
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4.1.11 The project was originally designed to meet
the needs of some 30 drug misusers with a
broader group of “at risk” and experimenting
young people requiring education and
awareness training. Through a needs
assessment of the target group, a drop-in
centre, treatment clinic, counselling, crisis
intervention, education and prevention and
referral to residential treatment were
identified, as their principal needs.
4.1.12 The rehabilitation and treatment services
provided by Donnycarney Drug project
include:
• Northern Area Health Board (NAHB)
Satellite Treatment Centre, Scripting Doctor,
Methadone Maintenance (dispensed in
community pharmacies), twice weekly
supervised urines, nurse service once a
week for blood testing, etc.;
• Crisis intervention;
• Outreach service;
• Drop in (structured and unstructured);
• Family and sibling support;
• Prison visits and aftercare;
• Relapse prevention and recovery type
interventions;
• Referrals to treatment (inside and outside
catchment area) and rehabilitation;
• Counselling and Care Planning;
• Key working and referral to other agencies
as appropriate;
• Support with housing issues, childcare,
court appearances, and with accessing
outside education, training and
employment opportunities;
• Personal development training; and
• Recreational activities.
4.1.13 The project also runs an Integration Programme,
a dedicated Community Employment
Programme for people in recovery from problem
drug use in partnership with FÁS Community
Services. The day programme caters for 15
participants and is fully subscribed at present. An
NAHB funded Education and Prevention Youth
Worker is also employed by the Donnycarney
Youth Project. This worker has a specific brief to
promote positive lifestyle choices and the
development of affirming and supportive peer
groups among targeted groups of young people
who access the service, through sport and leisure
activities and through group work. Education and
prevention programmes delivered in the project
during 2003-2004 include:
• Teenage Health Programme;
• Alcohol Awareness;
• Sibling Group;
• Football Group;
• Table Tennis Club;
• Drop In Groups; and
• Jobs Club.
4.1.14 As of April 2000 when the satellite treatment
centre was opened, 37 people have attended
the Donnycarney Youth Project Drug
Programme for treatment and methadone
maintenance since 2000, of these:
• 23 clients are currently in treatment –
there is no waiting list;
• 5 clients have detoxed and remain drug free;
• 5 clients have been referred to other
clinics; and
• 4 clients remain drug free having
successfully completed residential
programmes.
In addition, the Drop In drug project sees
approximately 100 clients a week.
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4.1.15 The Donnycarney Drugs Project also delivers
an extensive education and prevention
programme to the local community. In
December 2003, it moved to new premises
in Le Chéile – the Donnycarney Community &
Youth Centre which was funded through the
Young People’s Facilities and Services Fund.
The project has an annual budget of
€285,000.
The Cumas Project
4.1.16 Established in October 1998, the Cumas
Project works with families in the Clondalkin
area of Dublin, whose children are at risk of,
or involved in drug misuse. It aims to help
them cope effectively with the impact of drug
misuse and provides a range of supports,
which include group work, one-to-one
support, home visitations and aural
acupuncture/acupressure.
4.1.17 The project was mainstreamed through the
South Western Area Health Board (SWAHB) in
January 2001. In the first 6 years, 130 families
have accessed this service, which has as its
four central aims:
• To identify needs and provide individual
support to families;
• To provide group work support as
considered appropriate to the needs
presented;
• To provide information to allow people to
make informed decisions about drug
misuse and related issues; and
• To work in partnership with statutory and
voluntary agencies to provide a co-
ordinated response to the needs of
families affected by drug misuse.
4.1.18 A Family Worker has a central role to play in
this process and acts as someone who will
listen to family’s fears in relation to drug
misuse. The Family Worker also makes a
significant contribution to the assessment,
planning and reviewing process by focusing
on the strengths of the family as well as
dealing with the reason for their contact with
the project. In the first 6 years, 203 young
people participated in group-work, which
consisted of 6 sibling groups, 2 older teenager
groups, 1 group for young drug users, groups
for young girls needing support to remain in
school and 2 peer education groups. Such
work has helped to develop self-confidence,
whilst providing young people with a space
where they can talk to other young people
who may be in similar situations.
4.1.19 Summer projects and residential trips have
also been used to give young people a break
away from the home environment and
provided them with interesting and
constructive activities. Cumas has co-facilitated
4 parent drugs education sessions, in which
approximately 35 people have participated.
Literature appropriate to both adults and
young people on drug and health-related
issues is available and is used by the project
with people – both for those who drop in and
with more long-term work.
4.1.20 The Parent/Grandparent Support Group
provides support to parents and grandparents
in a group context for those dealing with drug
misuse in the family. There have been 39
Parent/Grandparent group participants since
2002. The project is also keen to foster a
close inter-agency liaison and sharing of skills
by establishing links through networking and
communication with relevant agencies and
interagency committees. As a result, the
Cumas staff members are represented on 
12 agency committees in the community.
4.1.21 The project has 4 staff trained to provide aural
acupuncture and acupressure services. The
service is offered on a drop-in basis as well 
as through scheduled appointments and is a
form of relaxation and stress relief that also
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supports detoxification. A total of 136
individuals have accessed the service since
2002. The annual budget allocated to the
Cumas Project from the South Western Area
Health Board for 2004 is €257,032.
4.2 Young People’s Facilities and 
Services Fund
4.2.1 The Young People’s Facilities and Services
Fund (YPFSF) was established by the
Government in 1998 to assist in the
development of youth facilities, including sport
and recreational facilities, and services in
disadvantaged areas where a significant drug
problem exists or has the potential to develop.
The main aim of the Fund is to attract “at risk”
young people in disadvantaged areas into
these facilities and activities and divert them
away from the dangers of substance misuse.
The target group of the programme is young
people in the age range of 10 to 21 years
who are defined as “at risk” due to factors
such as family circumstances, educational
disadvantage, or involvement in crime or
substance misuse.
4.2.2 The main focus of the YPFSF has been on the
Local Drugs Task Force areas where integrated
plans were prepared on the basis of detailed
guidelines agreed by the Cabinet Committee
on Social Inclusion. However, in addition to
these areas in Dublin, Bray and Cork City,
funding was also allocated to four other urban
areas – Galway, Limerick, Waterford and
Carlow. Funding was also allocated to a
number of voluntary organisations with a
national or regional remit with the capacity to
deliver targeted education and prevention
initiatives. As part of the first round of
allocations, seven voluntary organisations were
also approved funding to deliver drug
prevention/education programmes, including
peer education programmes, on a national
basis. These included – the National Youth
Federation, Foróige, the Irish Society for the
Prevention of Cruelty to Children (ISPCC) and
the Irish Girl Guides.
4.2.3 In broad terms, approximately 450 facility and
services projects are being supported under
the Fund. These initiatives fall under seven
broad headings:
1. The building, renovating or fitting out of
community centres, youth facilities and
sports clubs so as to provide suitable
accommodation for programmes and
services geared for the most “at risk” young
people in an area. Access for the target
group is an essential condition of funding
for capital projects;
2. A number of purpose-built youth centres
are being funded which will provide a 
focal point for youth activities in an area,
particularly in areas such as Tallaght,
Ballymun, Clondalkin, Blanchardstown in
Dublin and Mahon in Cork, where there
has been a dearth of dedicated youth
facilities;
3. 173 youth and outreach workers1
have been appointed to work on the
ground with the target group offering
developmental activities and educational
programmes for young people who have
traditionally found themselves outside the
scope of mainstream youth work due to
family background, involvement with crime
or drugs or through lack of education;
4. 14 sports development officers are 
being funded, one in each LDTF area.
These officers use sport as a tool to
engage young people in disadvantaged
areas into active recreation and leisure
pursuits and facilities at the level to suit
their needs. Six of these appointments
were approved in August 2004;
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5. A wide variety of community-based
prevention/education programmes,
including Early School Leaving
Programmes, Sports and Recreational
Activities, Family Support Programmes, 
Art, Drama and Music Programmes,
Counselling and Transport Services are
being supported;
6. A number of targeted interventions 
for particular groups such as youth work
projects for young travellers have been 
put in place; and
7. A number of national drugs education
and training officers for youth
organisations catering for the target group
who will deliver programmes throughout
the country have also been employed.
4.2.4 As part of the first round of allocations of the
YPFSF (1998-2003), over €68 million was
allocated to almost 300 facility and services
projects. The vast majority of this funding was
allocated to support projects in Local Drugs
Task Force areas. A further €13.9m was
allocated to approx 100 projects under the
second round of the Fund in March and
August 2004 bringing the total allocation
under the Fund to almost €80m.
Round I capital projects
4.2.5 Through the funding allocated under the first
round of the fund, a number of large-scale
community/youth centres were built and have
become operational during 2004. A number
of these are set out in Table 4.3.
As outlined above, as part of the round II
allocations announced in March 2004,
substantial funding is also being made
available towards the staffing (including a
centre manager and 2 additional youth
workers) and the operational costs of these
centres.
Evaluation of the YPFSF
4.2.6 An evaluation of the YPFSF was carried out 
by WRC Consultants in December 2002. 
This evaluation examined the planning,
implementation, progress, performance and
impact of the services element of the Young
Peoples Facilities and Services Fund (YPFSF).
The executive summary and main findings of
the evaluation are attached as Appendix 11.
Mainstreaming of round I services projects
4.2.7 Eighty-five services projects funded under 
the first round of the Fund were positively
evaluated in 2002 and have been
mainstreamed with effect from 1st January
2004. As a result, an amount of €6.705m
was transferred to the Departments of
Education & Science and Justice, Equality &
Law Reform who are now responsible for the
continued funding of the projects in question.
A list of the projects in question is attached as
Appendix 9.
Round II allocations
4.2.8 Through the funding allocated under round II,
a number of new dedicated youth and
community centres will be built in areas such
as Darndale in North Dublin, Ballyfermot in
West Dublin, Knockmitten in Clondalkin,
Brookfield in Tallaght, Ballywaltrim in Bray and
Knocknaheeny in Cork city. In addition, grants
for a wide and diverse variety of youth work
projects across the 14 Drugs Task Force areas
were approved. In addition, as outlined above:
• Substantial funding was allocated towards
the staffing and operational costs of a
number of the large scale
youth/community centres built under
round I; and
• Funding was allocated for six additional
sports development officers to work with
young people at risk through the medium
of sport/recreation.
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Table 4.3 – Major Capital Projects funded under Round 1 of the YPFSF
Centre Capital Round II Officially Main facilities 
allocation allocation opened/ provided in the centre
Under towards opening
Round I staffing/
operational 
costs
St. Catherine’s Centre, €4.22m €251,000 p.a. March 2004 • Sports hall
Marrowbone Lane, • Conference and meeting rooms
Dublin 8 • Studio
Donnycarney Youth & €3.16m €237,000 p.a. February 2004 • Computer Room
Community Centre, • Sports hall
Dublin 5 • Dark room
• Arts and Crafts
Finglas Youth Centre, €1.96m €374,000 April 2004 • Gym
Dublin 11 • Meeting rooms
• Purpose-built sports hall
• Training rooms
St. Teresa’s Hall, €1.84m €232,000 p.a. Early 2005 • Multi-purpose hall
Donore Ave, • Stage
Dublin 8 • Therapy Room
• Counselling rooms
• Youth services
• Activity Rooms
• Offices
• Roof Garden
Cabra Parkside €4.84m €500,000 p.a. April 2004 • All-weather pitch
Community & • Gym/weights room
Sports Complex • Indoor basketball hall
in Dublin • Dance studio
• Full contact sports room
• Multi-purpose studio
• Multimedia room
• Office space
• Meeting rooms 
• Childcare facilities
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A breakdown of the total allocations made to
each of the LDTF areas under round II of the
Fund is attached as Appendix 10.
In addition to the capital projects outlined in
Table 4.3, a wide variety of services projects
are being supported under the Fund and the
following gives some examples of those
activities.
Cherry Orchard Integrated Youth Service
4.2.9 The Cherry Orchard Integrated Youth Service
(COYS) Outreach Service, Ballyfermot was
established in January 2003 and shows how
successful an outreach programme can be in
terms of addressing local concerns regarding the
level of anti-social behaviour and drug and
alcohol misuse by local young people. The
Ballyfermot area as a whole, and Cherry Orchard
in particular, is characterised by high levels of
social and economic disadvantage with a very
high proportion of young people in the local
population (52% are less than 25 years of age).
Project staff identified the following as some of
the most significant local issues:
• The absence of local facilities accessible to
young people;
• The prevalence of drug and alcohol use in
the youth culture of the area;
• A high proportion of young people involved
in crime and joy-riding;
• Early parenthood among young women; and
• The exposure of young people to violence
in the home.
4.2.10 The funding from the YPFSF supported the
development and implementation of an
outreach/ street work service within the
Cherry Orchard Youth Service. Two outreach
workers (one full-time and one part-time) are
employed to provide the outreach service
three nights a week with two shifts operating
each night. The workers found multiple and
serious at risk behaviours among the target
group. An estimated three-quarters of the
young people targeted were involved in drug
and alcohol misuse, theft, petty crime, joy
riding, or experienced violence in the home.
4.2.11 Working on the streets, at night, provided a
means of engaging with young people in small
groups and centre-based activity. This
demonstrated how an outreach programme
can successfully make contact and build
relationships with young people on the streets.
Bohermore Teenage Development Project
4.2.12 Bohermore Teenage Development Project in
Galway City has been funded under the
YPFSF for 4 years and aims to:
• Improve the quality of life for young people
in Bohermore;
• Facilitate the social and recreational
education of young people; and
• Provide an atmosphere where ethnic
diversity and cultures are honoured and
respected.
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Minister of State, Noel Ahern T.D. at Cabra Parkside Community and
Sports Complex, announcing an allocation of almost €400,000 under
the YPFSF, to put in place seven new Sports Development Officers
operating in a number of areas across Dublin.
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4.2.13 The project has provided excellent
developmental opportunities for the target
group, including a Youth Advocate Programme,
which provides support and diversionary
activities as part of the programme. Overall,
Bohermore provides a programme of
recreational, educational and developmental
activities that present new opportunities,
increase self-confidence and self-esteem and
build relationships with parents by encouraging
parental participation and co-operation through
formal and informal consultation.
4.2.14 The project raises drug awareness and
facilitates discussion around its use and harmful
effects. It promotes health awareness, builds
confidence and develops communication skills
and encourages group building and group
identity. Among the activities provided are –
music, computers, dance, summer sailing and
soccer programmes and other outdoor
activities. The project receives annual funding of
€50,000 from the YPFSF.
Ballymun Regional Youth Resource
4.2.15 Ballymun Regional Youth Resource (BRYR)
was established on the basis of a Youth
Development Plan commissioned in 1998.
The Project aims to enable young people to
engage, and contribute to the development of
the best possible environment in Ballymun so
that they can make a positive and enjoyable
transition to adulthood.
4.2.16 The outreach team implements a range of
organised group activities and development
programmes with almost 20 targeted groups.
They advise, directly assist and refer young
people in need of support. BRYR plays an
active role in the community; working with
young people, with youth leaders and with
other community players. It also:
• Provides different levels of support to
different youth focused organisations in 
the community;
• Assists and advises organisations with their
programmes and organisational structures
in relation to young people;
• Provides practical support such as
administration, clerical and fund raising
supports;
• Provides organisations with information
about youth work training and programme
resources available; and
• Provides specialist arts support and assists
with youth activity grants and funding.
4.2.17 There are a number of staff funded under 
the first round of YPFSF funding – namely, a
project manager, a full time administrator, an
outreach worker, a trainer and an arts worker.
The Project also received funding of €50,000
under the second round of YPFSF allocations
to employ a second arts worker to increase 
its work with the target community.
4.3 Regional Drugs Task Forces
4.3.1 The National Drugs Strategy 2001-2008
provides for the establishment of 10 Regional
Drugs Task Forces (RDTFs) throughout the
country. By the end of 2003, all of the RDTFs 
had been established. The RDTFs are currently
mapping out the patterns of drug misuse in
their areas – as well as the current levels of
services in place to address drugs misuse using
a standard template developed by the NDST.
4.3.2 It is anticipated that most of this work will 
be completed by the end of 2004 and will
then feed into the drafting of regional action
plans which will be assessed by the NDST.
Recommendations on funding will then be
made to the Inter-Departmental Group on
Drugs (IDG) and the Cabinet Committee on
Social Inclusion (CCSI) and it is hoped that
the RDTFs will be in a position to begin
implementation of their plans by mid to 
late 2005.
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A list of the RDTFs and contact details for 
their Chairpersons and interim co-ordinators 
is attached as Appendix 12.
4.4 Premises Initiative for Community
Drugs Projects
4.4.1 In 2000, the Government committed €12.7m
over 3 years to assist community-based
projects in Local Drugs Task Force areas to
address their accommodation needs. In
addition, a number of projects outside LDTF
areas which cater for clients from LDTF areas
were also allocated funding. At the end of
June 2004, all of the available funding had
been allocated to approx 50 projects across
the various Task Force areas. In some cases,
the funding was allocated to purchase
premises and for major renovations/
refurbishments while in others, it was
provided for:
• General refurbishment and upgrading;
• Fitting out and furnishings;
• Essential repairs (e.g. re-wiring); and
• Small extensions and internal renovations.
4.4.2 Funding for the projects is channelled through
the relevant State Agency (mainly the Health
Boards and Local Authorities) under the
normal conditions governing their capital grant
schemes.
Details of the projects for which funding has
been approved are set out in Appendix 13.
Chapter Four
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Future Developments in Drugs Policy
This chapter looks at on-going and future
developments at both national and EU levels in terms
of drugs policy.
5.1 Mid-Term Review of the Strategy
5.1.1 The National Drugs Strategy 2001-2008 calls
for an independent evaluation of its overall
effectiveness to be carried out by the end of
2004, the mid-point of the Strategy. The
objective of the mid-term review is to examine
the progress being made to date in achieving
the goals and actions set out in the Strategy. It
will also enable priorities for future action to be
identified and a re-focusing of the Strategy, if
necessary, for the remaining period up to 2008.
5.1.2 A Steering Group, chaired by the Department
of Community, Rural and Gaeltacht Affairs, 
is overseeing the review. The Group is 
made up of representatives of the relevant
Government Departments and Agencies
involved in implementing the Strategy and 
the Community & Voluntary sectors. The Group
is being assisted in its work by independent
consultants (PA Consulting Group) who were
appointed in August 2004 following a
competitive tender process. A full list of
members of the Steering Group is attached 
at Appendix 14. The terms of reference for 
the review are attached at Appendix 15.
5.1.3 The mid-term review is being informed by 
a widespread consultation process. Notices
were placed in the national, provincial and
local press in early June 2004 inviting
individuals and organisations to submit their
views in writing on the Strategy and how it
might be re-focused in the remaining period
up to 2008. The Steering Group also wrote 
to various Departments, Agencies and bodies
inviting written submissions from them. This
included not only those directly involved in
implementing the Strategy but also groups
such as County Development Boards, family
support groups, sporting organisations, youth
organisations, trade unions, employer
organisations, community development
groups, etc. Approximately 125 submissions
have been received to date.
5.1.4 The consultation process also involved over
25 oral presentations by relevant Departments
and Agencies in September-October 2004
and a series of open public meetings
throughout the country in October 2004 to
ensure that as broad a perspective as possible
was captured. It is expected that the review
will be completed by early 2005.
5.2 Expenditure Review of Local Drugs
Task Forces
5.2.1 The Expenditure Review Initiative (ERI) 
is a process of evaluation carried out by
Government Departments as part of their
annual business planning. The objectives of
the ERI are to analyse, in a systematic manner,
what is being achieved by Government
spending and to provide a basis on which
more informed decisions can be made on
priorities – both within and between
programmes.
5.2.2 The LDTF Programme was selected for review
during 2004. The Expenditure Review is being
carried out by Goodbody Consultants and is
due to be completed by early 2005. It is
intended that its findings will feed into the
mid-term review process outlined above.
5.2.3 The Expenditure Review is examining the
objectives of the LDTFs and the effectiveness
of expenditure to date on the Programme.
The review’s main concentration is on the
projects contained in the first round of LDTF
action plans as these are the longest
established and the most suitable in terms of
measuring outputs and outcomes. The full
terms of reference for the Expenditure Review
are contained in Appendix 16.
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5.3 Work of the National Drugs Strategy
Team (NDST)
5.3.1 As outlined in Chapter 1, the NDST is made
up of representatives from six Government
Departments, three Agencies, the community
and voluntary sectors, a medical adviser and
an independent chairperson. The Team will
continue its collaborative inter-agency
approach to tackling the issue of drug misuse,
focussing particularly on the specific actions
assigned to it in the Drugs Strategy. This work
will be supported by the Team’s 4.5 staff, and
will be informed by the “on the ground”
activities of the 14 Local and 10 Regional
Drugs Task Forces.
5.3.2 The priorities of the Team for the coming
period include:
• Inputting into the mid-term review process;
• Reviewing and consolidating the work of
14 LDTFs on an on-going basis;
• Overseeing the evaluation and
mainstreaming of the first and second 
LDTF local action plan projects, including
dissemination of best practice emerging;
• Overseeing and facilitating the
development of the RDTFs;
• Continuing to provide advice to the
Minister of State and the Department of
Community, Rural and Gaeltacht Affairs
regarding emerging issues at local and
regional levels; and
• Maintaining links with the NACD, Strategic
Task Force on Alcohol, the Homeless
Consultative Forum, the National
Assessment Committee for the YPFSF 
and other relevant fora.
5.4 Future Programme of the National
Advisory Committee on Drugs
5.4.1 An independent evaluation of the NACD 
was commissioned in early 2004. Talbot
Consultants carried out the review and looked
at the operation and work of the Committee
to date and made various recommendations
as to its future. The review made a positive
evaluation of the NACD’s work and, in the
view of the consultants, the Committee
“provides excellent value for money”. Their
primary recommendation was that the NACD
should be continued in its current role and
that its position in the Irish drug information
and policy environment context should be
maintained. In this regard, they recommended
that the new mandate for the Committee
should coincide with the National Drugs
Strategy and should, therefore, run up to the
end of 2008. These recommendations were
agreed by Government in July 2004.
5.4.2 It was also agreed that certain areas of the
current NACD work programme will need
continued funding, e.g. in prevalence
estimation (population survey, capture
recapture estimate of heroin use, etc.); in the
area of the consequences of drug misuse for
families and individuals; and in determining
treatment effectiveness.
5.4.3 The Government also agreed the focus of 
the NACD’s work programme for the coming
period. This included the establishment of an
early warning/emerging trends mechanism,
developing information on effective
rehabilitation and integration of treated drug
users in Ireland and the relationship between
drugs and crime.
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5.5 Final Evaluation of the EU Drug
Strategy and Action Plan 2000-2004
5.5.1 In December 1999, the European Council
adopted the European Union Strategy on
Drugs (2000-2004), which lays down 
the overall guidelines and objectives for the
European effort in the drugs sphere. The EU
Action Plan on Drugs was adopted by the
European Council in June 2000.
5.5.2 The final evaluation of the current EU Drugs
Strategy and Action Plan 2000-2004 is being
completed at the time of writing. The aim 
of this evaluation is to assess the level of
progress in the Action Plan and the extent to
which the achievements meet the objectives
of the Drugs Strategy. It also aims to assess
the impact of both the Drugs Strategy and 
the Action Plan on the drug situation in the
European Union. The final evaluation will 
be an important element for preparing the
new EU Strategy and Action Plan(s) in this
field from 2005 onwards. The European
Commission will prepare a Communication 
on this final evaluation which, it is planned,
will be presented to the Council and the
European Parliament in late 2004.
5.6 New EU Drugs Strategy and 
Action Plan
5.6.1 As the current European Strategy on Drugs will
expire by the end of the year, the European
Council has to adopt a new European Drugs
Strategy by December 2004. In order to
prepare for the new Strategy, the Department
of Justice, Equality and Law Reform, as part 
of the Irish Presidency of the EU and in
partnership with the forthcoming Presidencies
of the Netherlands, Luxembourg and the
United Kingdom, organised an EU Drugs
Conference. The conference, entitled 
“EU Strategy on Drugs – The Way Forward”,
took place on 10 and 11 May, in Dublin. It
was co-financed by the European Commission
under the AGIS Programme. The conference
was designed to provide a first opportunity for
Member States to exchange views on the
future EU Drugs Strategy for 2005 onwards
and to consider some of the priority issues.
5.6.2 At the conference, it was generally agreed that
the Strategy should be based on:
• A balanced and multidisciplinary approach;
• Scientific evidence;
• Respect for the principles of subsidiarity
and proportionality; and
• Providing added value in relation to
activities that are undertaken at national
level.
5.6.3 Furthermore, the future action plans resulting
from the new Strategy should contain more
measurable targets and specific time bound
actions that can be monitored and evaluated.
The Presidency prepared a report to the
Council in this regard which was discussed 
by the Horizontal Drugs Group (HDG) in May
and at Council on 8 June. At that meeting, the
Council decided that a new integrated and
balanced Drugs Strategy for the post-2004
period should be put into place.
5.6.4 The Netherlands Presidency will further
develop the new Strategy during its presidency
which, it is planned, will be brought to the
European Council in December 2004. The
adoption of the first action plan to give effect
to the Strategy is scheduled to take place
during the Luxembourg presidency in the first
half of 2005.
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5.7 British-Irish Council
5.7.1 At the first British-Irish Council (BIC) Summit
in December 1999, it was agreed that Ireland
would take the lead in the work of the Council
on the Misuse of Drugs. The second summit
meeting, held in Dublin in November 2001,
focussed on drugs and a framework for future
co-operation in the sector was agreed. This
framework is focussed on two key areas –
Demand Reduction and Supply Reduction.
Since then Drugs Ministers have met three
times. In this regard, the latest BIC Ministerial
meeting on drug use is planned to take place
in Edinburgh on 8 November 2004. The aim
of the meeting is to maintain and develop the
links that have been made across the BIC.
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Members of the Inter-Departmental Group on Drugs
Mr. Noel Ahern T.D. Minister of State (Chairperson)
Ms. Deirdre Carroll Department of Community, Rural and Gaeltacht Affairs
Ms. Kathleen Stack Department of Community, Rural and Gaeltacht Affairs
Mr. John Kelly Department of Community, Rural and Gaeltacht Affairs
Ms. Una Ní Fhaircheallaigh Department of Community, Rural and Gaeltacht Affairs
Mr. Evan Breen Department of Community, Rural and Gaeltacht Affairs
Mr. Tony Carberry Department of Finance
Mr. Tom Mooney Department of Health and Children
Mr. Michael Colgan Customs and Excise
Mr. Des Dowling Department of the Environment, Heritage and Local Government
Ms. Catherine Byrne Department of Justice, Equality and Law Reform
Mr. Paddy McDonagh Department of Education and Science
Ms. Elaine Kelly Department of An Taoiseach
Mr. Tony Hickey Garda National Drugs Unit
Asst. Commissioner
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National Drug Strategy Unit 
Department of Community, Rural and Gaeltacht Affairs
Kathleen Stack Principal Officer
John Kelly Assistant Principal
Úna Ní Fhaircheallaigh Assistant Principal
Pádraig De Stanlaigh Assistant Principal
Pat O’Grady Higher Executive Officer
Jeanette Young Higher Executive Officer
Sinéad Copeland Administrative Officer
Evan Breen Administrative Officer
Orla McGovern Executive Officer
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Membership of the National Drugs Strategy Team 
Appendix Three
Mr Pádraig White Chairman
Ms Eileen Hughes
Mr Niall Cullen
Dr Derval Howley 
Mr John Harkin
Mr Andrew Diggins
Mr Fergus Mc Cabe
Fr Seán Cassin
Dr Joe Barry
Mr Barry O’Brien
Ms Louise Kenny
Mr Pádraig Stanley
Ms Patricia O’Connor
Ms Aoife Davey
Ms Lisa Wafer
Ms Grainne Hynes
Mr Peter Walker
Department of the Environment and Local Government
Department of Justice, Equality and Law Reform
Eastern Regional Health Authority
FÁS
Department of Education and Science
Community Sector
Voluntary Sector
Medical Advisor
Garda Síochána
Department of Health and Children
Department of Community, Rural and Gaeltacht Affairs
Director
Development Worker
Finance and Research Officer
NDST Support Staff
NDST Support Staff
Name Dept./Agency
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Appendix Four
Co-ordinators of Local Drugs Task Forces
Ballyfermot Mr Frank Gilligan Tel. 01 6206488
Addiction Services Fax 01 6206401
Bridge House e-mail: frank.gilligan@erha.ie
Cherry Orchard Hospital e-mail: advance@eircom.net
Ballyfermot (support: Elfrieda: 6238001)
Dublin 10
Ballymun Mr Hugh Greaves Tel. 01 8832142
Axis Centre Fax 01 8832144
Main Street e-mail: hugh.greaves@axis-ballymun.ie
Ballymun
Dublin 9
Blanchardstown Mr Joe Doyle Tel. 01 8604845
22(a) Main Street Fax 01 8604848
Blanchardstown e-mail: joseph.doyle@nahb.ie
Dublin 15
Bray Ms Niamh Mc Alinden Tel. 01 2762975
Bray LDTF Fax 01 2762941
Unit 2, First Floor e-mail: niamhmcalinden@eircom.net
24 Florence Road
Bray
Co. Wicklow
Canal Communities Ms Mary Ryder Tel. 01 6206413
Addiction Services Fax 01 6206401
Bridge House e-mail: mary.ryder@swahb.ie
Cherry Orchard Hospital
Ballyfermot 
Dublin 10
Clondalkin Mr Enda Barron Tel. 01 4579445
Unit 5 Fax 01 4579422
Oakfield e-mail: cdtf1@indigo.ie
Clondalkin
Dublin 22
Dublin N.E. Ms Sinead Wiley Tel. 01 8465074
Le Chéile Fax 01 8465071
Collins Avenue East, e-mail: dnedtaskforce@eircom.net
Donnycarney
Dublin 5
Cork Mr David Lane Tel. 021 4923132
Community Care Offices Fax 021 4923137
St. Finbarr’s Hospital e-mail: laned@shb.ie
Douglas Road
Cork
Dublin 12 Ms Aoife Fitzgerald Tel. 01 6206422 (office)
Addiction Services Fax 01 6206401
Bridge House e-mail: aoife.fitzgerald@swahb.ie
Cherry Orchard Hospital
Ballyfermot
Dublin 10
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Dun Laoghaire/Rathdown Coordinator position vacant Tel. 01 2803335
Centenary House Fax 01 2300690
35 York Road e-mail: g.fitzpatrick@ecahb.ie 
Dun Laoghaire (until coord in position; 
Co. Dublin Task Force admin support)
Finglas/Cabra Mr John Bennett Tel. 01 8307440
Finglas/Cabra LDTF Fax 01 8820330
Tolka Clinic e-mail: finglascabradtf@eircom.net
121 Broombridge Close
Ballyboggan Road
Dublin 11
North Inner City Mr Mel MacGiobuin (Acting) Tel 01 8366592
22 Lower Buckingham St. Fax 01 8366286
Dublin 1 e-mail: nicdtf@iol.ie
(support: Caroline Gardner: 
carolinenicdtf@hotmail.com) 
South Inner City Mr Colm Browne Tel 01 6206438
Addiction Services Fax 01 6206401
Bridge House e-mail: colm.browne@swahb.ie
Cherry Orchard Hospital
Ballyfermot
Dublin 10
Tallaght Ms Lisa Baggott Tel. 01 6206414
Addiction Services Fax 01 6206401
Bridge House e-mail: lisa.baggott@swahb.ie
Cherry Orchard Hospital
Ballyfermot 
Dublin 10
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Appendix Four
Chairs of Local Drugs Task Forces
Ballyfermot Mr David Connolly Tel 01 8721321
Dublin Inner City Partnership Fax 01 8721330
Equity House e-mail: office@dicp.ie
16 Upper Ormond Quay
Dublin 7
Ballymun* Mr Mick Cowman e-mail: mickcowman@ireland.com
(To be confirmed)
Blanchardstown Mr Phillip Keegan Tel 01 8365090
(Vice Chair, acting interim) e-mail: phillip@citywide.ie
14 Dromheath Gardens
Mulhuddart
Dublin 15
Bray Mr Brendan Maloney Tel 01 2865700
Kilbride Cottages e-mail: 
Killarney Road, brendanmaloney@brendanmaloney.ie
Bray
Co. Wicklow
Canal Communities Mr Tony Mac Carthaigh Tel 01 4540021
Rialto Community Drugs Team Fax 01 4541148
St. Andrew’s Community Centre e-mail: 
468 South Circular Road rialtocommunitydrugteam@eircom.net
Dublin 8
Clondalkin Mr Aileen O’Donoghue Tel 01 4576433
Clondalkin Partnership Fax 01 4577145
Camac House, Unit 4 e-mail: 
Oakfield Industrial Estate aodonoghue@clondalkinpartnership.ie
Clondalkin
Dublin 22
Dublin N.E.* Mr George Ryan e-mail: gryan@iol.ie
110 Griffith Court
Fairview 
Dublin 3
Cork* Cllr James Corr Fax 021 4294496
“Kakuri”
Hettyfield Estate 
Douglas Road
Cork
Dun Laoghaire/Rathdown Ms Grainne Burke Tel 01 2842323
Barnardos Fax 01 2806271
14 Tivoli Terrace South e-mail: 
Dun Laoghaire grainne.burke@dunlaoghaire.barnardos.ie
Co. Dublin
Dublin 12 Mr Brian Nugent Tel 01 4059300
KWCD Partnership Ltd. Fax 01 4059359
Unit 9 e-mail: bnugent@kwcd.ie
Ashleaf Centre
Crumlin Cross
Dublin 12
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Finglas/Cabra* Mr Joey Furlong e-mail: joey@indigo.ie
134 Ratoath Estate
Cabra
Dublin 7
North Inner City* Ms Maureen O’Sullivan
39 Fairfield Avenue
East Wall 
Dublin 3
South Inner City* Mr Tom Brunkard e-mail: tbrunkard@eircom.net
5 Kilmainham Lane
Kilmainham
Dublin 8
Tallaght Mr Mick Duff Tel 4610239
26 St. Aengus Crescent Fax 4628179
Tymon North e-mail: mickduff@ntlworld.ie
Tallaght
Dublin 24
*Chairperson can be contacted through the relevant LDTF co-ordinator
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Appendix Five
Membership of National Advisory Committee
Chairperson
Dr Des Corrigan School of Pharmacy, Trinity College
Vice Chairperson
Dr Mary-Ellen McCann Voluntary Drug Treatment Network
Mr David Moloney Department of Health and Children
Dr Joe Barry Eastern Regional Health Authority
Dr Eamon Keenan Consultant Psychiatrist, Eastern Regional Health Authority
Mr Willie Collins Southern Health Board
Dr Hamish Sinclair Health Research Board
Ms Catherine Byrne Department of Justice, Equality and Law Reform
Superintendent Barry O’Brien Garda National Drugs Unit
Ms Mairín O’Sullivan Department of Education and Science
Dr Derval Howley National Drugs Strategy Team
Mr Liam O’Brien Community Sector Representative
Ms Anna Quigley Community Sector Representative
Mr Brian Melaugh Ana Liffey Drug Project
Ms Mairead Kavanage Ballymun Youth Action Project
Ms Kathleen Stack Department of Community, Rural and Gaeltacht Affairs
Ms Patricia O’Connor Director, National Drugs Strategy Team
Mr Tony Geoghegan Irish Association of Alcohol and Addiction Counsellors
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National Assessment Committee – Contact Details
Ms Kathleen Stack
Chairperson
Dept. of Community, Rural &Gaeltacht Affairs 
43-49 Mespil Road
Dublin 4
Ms Jeanette Young
Secretary
Mr Dave Spratt
Mr Fergus McCabe
Mr John Dolan
Mr David Treacy
Ms Bernie McGowan
Ms Mary Cunningham
Mr Niall Cullen 
Ms Mary Forrest
Ms Evelyn Downes
Mr Karl Mitchell
Mr Tony Carberry
Dept. of Community, Rural & Gaeltacht Affairs 
43-49 Mespil Road
Dublin 4
Dept. of Arts, Sport & Tourism,
Frederick Buildings,
Sth Frederick Street,
Dublin 2
National Drugs Strategy Team,
4-5 Harcourt Road,
Dublin 2
Dept. of Education & Science,
Social Inclusion Unit
Block 2 Floor 2
Marlboro St,
Dublin 1
City of Dublin YSB,
70 Morehampton Road,
Donnybrook,
Dublin 4
Voluntary & Community Services,
Dept. of Community, Rural & Gaeltacht Affairs,
6-7 Hanover Street, 
Dublin 2.
National Youth Council of Ireland,
3 Montague St,
Dublin 2.
Dept. of Justice, Equality & Law Reform,
94 St. Stephen’s Green,
Dublin 2.
Mater Dei Counselling Centre,
Clonliffe Road,
Dublin 3.
Dept. of Environment & Local Government
Customs House,
Dublin 1
Dublin City Council,
Civic Offices, Wood Quay,
Dublin 8
Department of Finance
Mount Street
Dublin 2
Name Address
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Appendix Seven
Irish Drug Court
The pilot Drug Court Programme was launched in 
the Dublin District Court in January 2001 in response
to the high number of drug related offenders
presenting in the Irish justice system in the mid
1990s and was influenced by the strong evidence
from other jurisdictions in support of the approach.
The programme marked a major policy initiative in
the criminal justice system and was designed as an
alternative measure for dealing with less serious and
non-violent drug offenders. It involves a court
supervised holistic programme combining medical
treatment (including counselling), intensive Probation
and Welfare supervision and education and job-
training. The Programme’s essential features are: 
• Frequent supervision contacts and drug testing;
• Direct access to full information on the drug
offender’s progress and conduct;
• Immediate responses to programme failures; and 
• Frequent progress report hearings before the same
Drug Court Judge and permanent staff.
The Drug Court Team is a multi-disciplinary grouping
and, as well as representatives from the treatment
and justice systems, the inclusion of an Education 
Co-ordinator and a Community Welfare Officer has
meant that the Team has been able to adopt an
holistic approach to participants needs. The Drug
Court Team comprises the following:
• A Co-ordinator – Senior Court Clerk;
• Drug Court Nurse;
• Two Probation and Welfare Officers;
• Education and occupational training official;
• Welfare Officer to deal with housing and welfare
issues; and 
• Four Community Garda Officers. 
The Judge chairs the pre-court meeting to review
cases with the Drug Court Team and if the meeting
fails to reach consensus, the Judge has the final
decision and is ultimately responsible for decisions
about case processing. The participant appears
continuously before the same Judge and a personal
relationship between the participant and Judge is
developed. He oversees the participants’ compliance
with the programme and issues sanctions and
incentives to encourage this compliance.
Drug Court Procedures
The following sets out the procedures on referral from
the trial court: 
Week 1: Probation and Garda Assessment:
• Eligibility, suitability and motivation
• Previous convictions, outstanding charges and
warrants
Week 2: Health Assessment – including urine test:
• Nature and extent of drug abuse
• History of treatment contacts in past
• Any other health/mental health issues
If these assessments are satisfactory, the participant is
formally admitted to the Drug Court and a treatment
plan is prepared. The participant is immediately
assessed for educational/job training needs.
Treatment Phases
Treatment encompasses three phases:
• Phase 1: Stabilisation (court attendance
weekly/urine testing weekly). The goals involved 
in this phase include stabilising physical health,
ceasing criminal activity and associations and
demonstrating a commitment by attending
education/job training. 
• Phase 2: Consolidation and early integration (court
attendance every two weeks/urine testing twice
weekly). The goals in this phase are to maintain
good physical health; generally, eliminate drug use
and remain free of illicit drugs; and continue
education, vocational training or employment.
• Phase 3: Rehabilitation and reintegration (monthly
court attendance/urine testing weekly). The goals
of this phase include remaining consistently free of
illicit drugs; maintaining stable home environment;
anticipating graduation in a minimum of 12 months
from commencement and on graduation,
remaining in contact with the Drug Court through
Rehabilitation Officers for 12 months. 
In October 2002, the final evaluation of the Pilot Drug
Court was completed. Early indications on the overall
effectiveness of the Drug Court are that particularly
towards the end of the pilot period, the Drug Court
had started to impact on the drug use and offending
behaviours of participants. The rate of re-offending
had declined substantially and, at the same time, the
number of urines that were “clean” had increased
significantly. There was also a high rate of participation
in educational activities. 
The evaluation recommended that the pilot be
extended and the catchment area be widened to
include the Dublin 7 area. This would allow it to focus
on the research and development activity necessary
to roll out the Drug Court more widely, while
continuing and expanding the current pilot to further
test and refine the emerging model and to address
difficulties which had been identified. The evaluation
can be found in full at www.justice.ie/departments/
default.asp
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Appendix Eight
Membership of the National Steering Group on Prison-Based Drug Treatment 
Director of Regimes, IPS (Chair – currently Mr. John Brosnan)
A/G Gerry Baxter, Dóchas Centre, IPS
Gov. Willie Connolly, Operations Directorate, IPS
D/G Catherine Comerford, Cloverhill Prison
Dr. Des Crowley, NAHB
Mr. Niall Cullen, Crime 2 Division, D/JELR
Dr. Enda Dooley, Director of Healthcare, IPS
Gov. Liam Dowling, Regimes Directorate, IPS
Ms. Vivienne Fay, Area Operations Manager, Drugs/Aids Service, ECAHB
Mr. David Gilbride, Regimes Directorate, IPS
A/G Aileen Greally,  Training Unit, IPS
D/G Kevin Laide, Assistant Training Officer (Drug Treatment), IPS
Gov. Seán Lennon, St. Patrick’s Institution, IPS
Ms. Catherine Linehan, Operations Directorate, IPS
A/G Tom Lynch, Wheatfield Prison, IPS
Ms. Philomena Mallon, Regimes Directorate, IPS
D/G Declan Murphy, Mountjoy Prison, IPS
Mr. Gerry McNally, Assistant Principal, Probation & Welfare Service
A/G Vincent Melvin, Castlerea Prison, IPS
D/G Liam Metcalfe, Cork Prison, IPS
Ms. Frances Nangle Connor, Co-ordinator of Prison Nursing Services, IPS
Mr. Colm O’Herlihy, Supervising Teacher, Cork Prison, IPS
Ms. Deirdre O’Reilly, Co-ordinator of Pharmacy Services, IPS
Mr. Julian Pugh, Co-ordinator Drug Treatment Services (Prisons), ERHA
Gov. Seán Quigley, Cork Prison, IPS
Ms. Sheila Reaper Reynolds, SWAHB
Mr. Colm Regan, Senior Psychologist, IPS
Mr. Martin Rogan, Director of Mental Health and Addiction Services, SWAHB
Dr. Siobhan Rooney, Consultant General Psychiatrist in Addictions,  NAHB
Ms. Ruth Ryan, Directorate Manager of Planning & Commissioning, ERHA
Mr. John Shelly, Human Resources Directorate, IPS
Ms. Gerri Skehan, Senior Probation & Welfare Officer, PWS
Dr. Brion Sweeney, Clinical Director/Consultant Psychiatrist, NAHB Drugs/Aids Services
Mr. David Wyse, Senior Counsellor, NAHB
Dun Laoghaire Rathdown
Sallynoggin Youth Worker
Sandyford Youth Project
Loughlinstown and Ballybrack Youth Project
Rosemount/St. Columbanus/Windy Arbour Youth Project
Prevention Through Education Project
Hillview/Mountainview Youth Work Project
Southside Travellers Youth Service/ Exchange House
Cuala Sports & Social Integration Project
Ballymun
BRYR 
Young Women’s Programme
Family Support Worker
BACA
Columban Youth Project
Young Travellers Youth Project
Ballyfermot
Ballyfermot Youth Service (Gurteen)
Ballyfermot Youth Service (Information Officer)
CANDLE Community Trust Ltd.
Mary Queen of Angels After School
Labre Park (After School)
Cherry Orchard Integrated Youth Service 
Cherry Orchard After Schools Project
Canal Communities
Bluebell Youth Worker
Rialto Youth Worker
St. Michael’s Youth Worker
CC Regional Youth Service 
Common Ground (Prog. Costs)
Bluebell Young Women’s Education Project
Dublin 12
Dublin 12 Regional Youth Service
St. John Bosco – New Options New Choices
St. John Bosco – Youth Project
Dublin North East
CDP – Priorswood Youth Worker
Kilmore West Youth Project
St. Monica’s Youth Project
Kilbarrack Youth Project
Trinity Youth Project
Northside Travellers
Dublin North Inner City
Market Areas Youth Service
Stoneybatter Youth Service
Eastwall/Northport Youth Project
North Wall
Aosóg (After Schools)
St. Agatha’s – Youth Worker
Ballybough Youth Service – Youth Worker
Wexford Centre – Caretaker
Cavan Centre – Youth Worker
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Young People’s Facilities & Services Fund
Projects mainstreamed through Department of Education and Science
under Round 1
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South Inner City
Ringsend/Dodder Youth Service
SWICNYS
Whitefriar St. Youth Service
St. Andrew’s Youth Service
Donore Avenue Network (DEN)
Westland Row CBS
Finglas/Cabra
Cabra Youth Service
Parent Support Project – Fingal Centre
Blanchardstown
*The BOND Project 
(This project was mainstreamed through Department
of Justice, Equality and Law Reform)
Potential Early School Leavers (P.E.S.L.)
Mulhuddart Community Youth Project (MCYP)
Baldoyle Youth Forum (Dublin North East)
Clondalkin
CASP
Teen Counselling
Catholic Youth Care (CYC) Workers
CYC – Quarryvale
CYC – Deansrath/Sruleen
Youth Support and Training Unit 
Clondalkin Partnership
Collinstown Park Sports Complex 
Youth Support Worker 
Tallaght
Travellers Youth Service
Tallaght Youth Service – Springfield
Tallaght Youth Service – Brookfield
CARP
Cork
U4EA Arts Programme
Togher Link Up
Glen Young Adults Project
Togher Family Centre Ltd. – After School Activities
Ballyphehane Action for Youth
Bishopstown Outreach Project
Blarney Street & Surrounding Areas Community
Association – The Rock Youth Group
St. Joseph’s Mayfield Youth Affairs Project
Badoireacht – Meitheall Mara
Churchfield Youth Community Trust (CYCT)
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Round II allocations of the YPFSF in LDTF areas
Dublin North East €1,019,500 €725,000 €294,500*
South Inner City €1,202,000 €409,000 €793,000*
Dublin 12 €1,110,000 €673,000 €437,000*
Ballymun €839,500 €385,000 €454,500
Finglas/Cabra €909,500 €160,000 €749,500
North Inner City €905,000 €533,000 €372,000
Ballyfermot €827,500 €710,000 €117,500
Canal Communities €685,100 €60,000 €625,100*
Blanchardstown €857,000 €327,000 €530,000*
Clondalkin €850,000 €450,000 €400,000*
Tallaght €950,000 €540,000 €410,000*
Dun Laoghaire €957,000 €449,000 €508,000*
Bray €2,002,000 €1,850,000 €222,000
Cork €1,207,000 €881,000 €326,000
Sub total €14,391,300 €8,152,000 €6,239,100
Sub total €14,391,300
Technical assistance to VECs and Local Authorities €384,200
Overall total – Round II €14,775,000 
* includes funding of €55,000 p.a. for sports development officer post
LDTF Area Total Capital Services 
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Evaluation of the Young Peoples
Facilities and Services Fund 
Executive Summary
1. This evaluation examines the planning,
implementation, progress, performance and
impact of the services element of the Young
People’s Facilities and Services Fund (YPFSF). The
evaluation situates the introduction of the YPFSF
in the context of the recommendations made in
the Second Report of the Ministerial Task Force 
on Measures to Reduce the Demand for Drugs
(1997) and the establishment of structures and
initiatives to develop a strategic response to drugs
misuse during the late 1990s.
2. The YPFSF is currently located in the prevention
pillar of the National Drugs Strategy (2002-2008)
and aims, through the provision of services and
facilities funded by the programme, to divert “at
risk” young people in disadvantaged areas from
the dangers of substance misuse. Funding of just
under €150 million is provided in the National
Development Plan (2000-2006) for the YPFSF.
Under round one of the YPFSF, spanning 1998 –
the year in which it was introduced – to the 
end of 2002, a total of €68 million has been
allocated to the programme. Of this funding, 
just under €18 million is currently allocated to
approximately 200 service projects that provide 
a wide range of activities, programmes, and
services. The YPFSF is being implemented in 18
locations, 14 of which are areas in which a Local
Drugs Task Force (LDTF) has been established.
The other four are the urban areas of Carlow,
Galway, Limerick and Waterford. The majority 
of the funding is allocated to the 14 areas in
which a LDTF has been established.
Structures
3. The structures established to implement the
YPFSF include a National Assessment Committee
(NAC) operating under the auspices of the Inter-
Departmental Group on the National Drugs
Strategy. The initial role of the NAC included
drawing up a set of guidelines for the
implementation of the YPFSF. These guidelines
required the establishment of Development
Groups (DGs) in each of the 18 areas identified
for implementation of the YPFSF. In areas in
which a LDTF existed, the DG comprised
representatives of the relevant local VEC, the Local
Authority, and the LDTF, with the latter being
responsible for initiating the work of the DG. In
locations outside of LDTF areas the development
of local plans was the responsibility of the VEC.
The DGs/VECs were charged with developing
integrated local plans based on local consultations
and securing project applications from projects in
their areas, and supporting, monitoring, and
reporting on the implementation of local plans
and projects approved by the Cabinet Committee
on Social Inclusion on the recommendation of the
National Assessment Committee. Within the DG
structure, the VEC is responsible for the services
element of the YPFSF with the Local Authority
being responsible for the facilities element.
Findings
4. Given the manner in which the programme was
designed (i.e. encompassing national, local and
project levels and including service and facilities
projects) it was concluded in Chapter 2 that the
structures established to support its
implementation were appropriate for their
functions. However, underestimation of the
resources required to effectively manage and
implement such a large scale programme –
particularly at national level – together with the
practical difficulties experienced in actually getting
projects off the ground has resulted in a
considerable time delay in the implementation of
round one of the YPFSF. Taking actual expenditure
as a crude indicator of progress, it is estimated that
at the end of 2001, expenditure on the service
element of the programme was approximately €9
million, representing 50% of the actual allocation
to this element of the programme. A similar
situation was found to exist in relation to progress
on the facilities element of the programme.
5. The findings concerning the planning of the
programme presented in Chapter 3 show that
there was considerable divergence in the
approach taken by DGs/VECs to undertaking 
the local consultation process and in the manner
and coverage of relevant issues in the local plans
that were prepared. The variation in the planning
documentation can be seen as in part reflecting
local circumstances and a desire on the part of
the DGs/VECs to respond to this. However,
particular weaknesses were identified in the
manner in which local services were profiled 
and, associated with this, in the identification of
strategies and the setting of operational targets 
at the level of local plans.
6. As indicated above, the implementation of the
services element of the programme has
experienced delays and this is reflected in the high
proportion of projects (i.e., 69%) that reported
experiencing a major difficulty in relation to project
implementation. The main factor contributing to
delayed and interrupted implementation at project
level is the difficulty that projects experienced in
recruiting and retaining suitably qualified and
experienced personnel to run projects. Despite 
a degree of variation in the manner in which 
VECs supported projects, projects were satisfied
with the support they received in relation to
addressing problems arising during project
implementation and with the nature and level 
of advice and support they received from VEC
personnel on an on-going basis.
7. The findings concerning the monitoring and
reporting system in place in the YPFSF pointed 
to a number of weaknesses and inconsistencies
in the procedures and practices used by VECs.
Among the weaknesses documented were the
general absence of data on the numbers and
profile of young people actually benefiting from
the Fund and the focus of reporting procedures
on progress at the level of individual projects with
little consideration being given to reporting on the
implementation of local plans and their strategic
impact at local level. A number of factors were
identified as contributing to the weakness of the
monitoring and reporting system including the
absence of detailed consideration being given to
this issue at planning stage, the lack of detail in
the actual templates provided by the NAC, and
the varying expertise available at VEC and project
levels. Recommendations to address these
weaknesses are presented in Chapter 7.
8. The findings of the survey of projects undertaken
during this evaluation found that there was
considerable diversity in the nature of the projects
being funded and in the target groups being
reached by them. The detailed findings of this
survey are presented in Chapter 4 and they show
that the predominant types of actions being
implemented by projects include providing activity
and club based programmes followed by a range
of specialist type services including street work,
family support and counselling services.
Combined, these two categories account for over
half of all the specific actions being implemented
by projects. It was also found that just over two
fifths (i.e., 44%) of project actions were being
implemented in the context of objectives that
specifically referenced issues such as preventing
substance misuse or diverting young people from
drug usage. The survey findings also showed that
the majority of young people participating in the
YPFSF are at the younger end of the target age
range of the YPFSF (e.g., 52% are 13 years old 
or under and 73% are 15 years old or under).
This profile can be interpreted as reflecting an
emphasis in local plans on preventing substance
misuse and diverting young people from
substance misuse. However, the data also point 
to difficulties in engaging with older adolescents
and young people experiencing multiple
difficulties including engaging in behaviours
placing themselves and others at risk. The nature
of the work required to engage with this group 
of young people is highlighted in a number of the
case studies of projects presented in Chapter 6.
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9. Despite the range of difficulties experienced
during project implementation and the experience
of a level of under-resourcing on the part of
approximately two-thirds of projects, the vast
majority of projects indicated that they were
being successful in achieving their objectives and
in contributing to achieving the main aim of the
YPFSF. More generally, with regard to the impact
of projects funded under the YPFSF, the findings
of the survey of projects concerning self-assessed
impact, the comments of support personnel in
the VECs concerning the operation and impact of
projects, and the accounts of projects actions and
effectiveness presented in the case studies all
point to the general conclusion that the projects
are having an impact in terms of the main
objective of YPFSF.
Overall conclusions
10. In drawing overall conclusions from the evaluation
it was noted that the YPFSF is currently operating in
the context of a number of other programmes
targeting disadvantaged young people as well as 
a range of initiatives addressing substance misuse
among young people. This situation is reflected in
the pattern of funding to promoting organisations
and projects in the YPFSF where it was found that
over half (55%) of projects were in receipt of
funds from at least one additional source. While
this finding indicates that the YPFSF is being
effective in relation to achieving its operational
objectives of enhancing existing services for young
people in its target group as well as developing
additional youth services for its target group, it
raises issues regarding the effectiveness of
providing funding from multiple sources to support
the operations of individual projects. Consistent
with the conclusions and recommendations of
other reports (e.g., the National Youth Work
Advisory Committee’s report on Proposals for the
National Youth Work Development Plan, 2003-
2007) it is recommended that:
• a strategic review of all programmes and
funding targeted toward disadvantaged and 
“at risk” youth be undertaken and that allied
to this there is need to devise and introduce 
a common framework for monitoring and
assessing the performance and impact of
programmes and projects working in this area.
11. A number of specific conclusions and
recommendations are made with reference to 
the roll out of round two of the YPFSF, including
the need: 
• to revisit and systematically update local plans,
particularly in relation to documenting levels
of provision and identifying the pattern of
service usage by young people; 
• to adopt a consistent and systematic approach
to the areas of project development and
support, monitoring and reporting and,
provide resources and support for projects 
to develop capacities in the areas of self-
evaluation and documenting project progress;
and 
• to develop a clear focus on the local plan 
as providing a framework for local action to
address drugs misuse by the target group and
that projects approved for funding in round
two should be facilitated to meet collectively
to that end. 
12. To strengthen the national dimension of the
YPFSF and to ensure the identification of policy
lessons and effective exchange with other
programmes, it is recommended that:
• a National Co-ordinator be appointed; 
• an annual report on the implementation of
the programme be prepared; and 
• a national forum or network for VEC personnel
involved in supporting and reporting on the
implementation of the YPFSF be established. 
13. In line with the targets set for the prevention pillar
of the National Drugs Strategy, it is recommended
that: 
• the selection of projects for mainstreaming as
well as new projects should be firmly based
on the identification of their capacity to
contribute to the reduction of drugs misuse
among young people in school. To this end, 
a number of lines of action showing potential
on the basis of the findings of this evaluation
are presented. In presenting these lines of
action emphasis is placed on the need for a
co-ordinated approach to the provision and
development of services if gaps in services 
are to be avoided.
14. The overall recommendations made by the
evaluator – and set out in Chapter 7 of the
Report – are summarised below. 
Young People’s Facilities & Services
Fund – Overall recommendations
Chapter 7 of the evaluators report contains a series
of recommendations in relation to various aspects of
the Fund. These are summarised below. 
Issue: Context in which YPFSF is operating
• A strategic review of the objectives, operations
and funding of all initiatives and programmes
targeted toward disadvantaged youth should be
undertaken as a matter of urgency;
• A common framework together with an
associated set of templates and procedures for
the monitoring and reporting of actions and
projects targeted toward disadvantage youth
should be established and used by the relevant
funding authorities. A starting point for this would
be the adoption/modification of the framework
used for monitoring and reporting on the actions
and beneficiaries of ESF assisted actions;
• All funding authorities should make a specific
allocation of resources to enable the development
of capacity at the level of projects to effectively
document project performance and engage in
effective self-evaluation at project level;
Issue: Implementation of the services element 
of the YPFSF
• Each Development Group (D/G) should be
required to review its original plan and to provide
an assessment of the current situation particularly
taking into account the profile of services for
disadvantaged young people in its area. This audit
of local services should be done in a consistent
and comprehensive manner in all areas. In the
light of the experience of the first round of the
YPFSF, funding authorities and statutory agencies
should be required to provide D/Gs with
information on the nature and extent of the
services they are providing in each area and on
the profile of young people using their services;
• A set of templates should be put in place to 
be used in the area of planning, monitoring 
and reporting on performance and impact at 
local plan and projects levels 
• A set of specifications for the deployment of
technical assistance by VECs involved in
implementing the YPFSF is required. This should
take the form of a common contract for all VECs.
This contract should specify a core set of
responsibilities to be discharged by the technical
assistance function;
• A forum or network for D/G and VEC personnel
involved in supporting, monitoring and reporting
on the YPFSF should be established. This forum
or network should be developed and resourced
as a means of linking the work of the YPFSF 
in each of the local areas in which it is being
implemented, identifying common lessons for
practice and policy, and acting as a clearing house
to identify and address any difficulties arising in
the implementation of the programme in a timely
and consistent manner;
• As part of the implementation of round two of 
the YPFSF, projects funded in each local area
should be facilitated to meet on a regular basis.
The purpose of such meetings should include
reviewing the collective performance and impact
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of projects in the context of targets and objectives
set in local plans and identifying lessons for policy
and practice at the local level. Such meetings
should also be seen as providing a basis to
improve co-ordination at the local level;
• The work of the NAC requires the preparation of
integrated reports on the progress and lessons of
the YPFSF at a national level at a minimum on an
annual basis. The implementation of a common
framework in relation to monitoring and reporting
should be seen as providing the basis for this. In
this regard, the appointment of a National Co-
ordinator with responsibility for supporting
programme implementation and reporting on the
YPFSF at a national level should be considered. The
National Co-ordinator would report to the NAC.
Issue: Performance & impact at the level of individual
projects 
• All projects should be required to identify and
document the precise manner in which their
activities, services and programmes are contributing
to the achievement of the central aim of the YPFSF.
More attention also needs to be paid to the
specification of quantitative targets at project level
in such a manner that these targets provide a
realistic basis for reviewing performance; and,
• All projects should be facilitated and resourced to
develop the capacity to adequately document and
review their performance and impact.
Issue: Identifying round II priorities for YPFSF
• The decision-making process in relation to setting
priorities and criteria for the inclusion of service
projects in the second round of the YPFSF and
mainstreaming should be firmly placed in the
context of the results of the planning operations
of the D/Gs as recommended in Chapter 7. Allied
to this, the process of project selection should be
based firmly on identifying the specific role and
contribution of each project in relation to
achieving the performance indicators set for the
prevention pillar of the National Drugs Strategy,
particularly those in relation to the reduction of
drug misuse among young people in school.
A number of project types and actions have been
identified that show potential in this regard,
including: 
• The provision of street work services
encompassing the capacity for effective one-to-
one work with young people that are
behaviourally at risk and backed up by effective
systems of referral;
• Developing and providing access to recreational
opportunities in areas lacking such provision and
at times when the need for such alternatives is
greatest, that is, in the evenings and week-ends;
• The provision of specialist services addressing the
presence of at risk factors deriving from poor
parent-adolescent relationships;
• The development of an effective interface
between the work of Home School Community
Co-ordinators and out-of-school supports for
young people who are actually identified as a risk
of early school leaving;
• The provision of systematic supports to engage
young people in a sustained way in sports and
health supporting recreational activities and life-
styles; and,
• An increased focus on working with the parents 
of young people who are identified as being
behaviourally at risk.
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1. Midland Mr Jack Taffe 
Rath Colman
Mullingar
Co. Westmeath
Tel: 044 40061
Mr Bill Ebbitt
Midland Health Board
Health Promotion Service 
The Old Maltings
Coote St
Portlaoise
Co Laois
Work: 0502 64566
Email: bill.ebbitt@mhb.ie
2. Mid-Western
3. North-Eastern
4. North-Western
5. Southern
Mr Tom Gleeson, 
Blackwater, 
Ardnacrusha, 
Co Clare
Tel: 061 341969
Mr Pat Shields
Regional Co-ordinator
D/CF&SA, NE Region
Dundalk,
Co. Louth
Address: Government Building, 
St. Alphonsus Road, Dundalk, Co Louth
Tel: 042 9392683
Fax: 042 9392696
Email: pat.shields@welfare.ie
Mr Loman Conway,
CEO,
Co. Sligo VEC,
Quay Street
Sligo
Tel: 071 9138301
Fax: 071 9144121
Email: ceo@sligovec.ie
Mr Kevin Davis
Senior Development Officer
FÁS Community Services
FÁS Training Centre
Rossa Ave
Bishopstown 
Cork 
Tel: 021 4856405
Fax: 021 4544297
Email: kevin.davis@sw.fas.ie
Ms Maria McCully
Drugs Strategy Co-ordinator 
Mid Western Health Board 
57 O’Connell St 
Limerick
Work: 061 318633
Email: mariamccully@eircom.ie
Dr Nazih Eldin
Health Promotion Unit 
North Eastern Health Board 
Railway Street
Navan
Co Meath
Work: 046 9076400
Email: nazih.eldin@nehb.ie
Ms Patricia Garland
Addiction and Counselling Services 
North Western Health Board 
Charter House
Old Market Street
Sligo
Work: 071 9140409
Email: patricia.garland@nwhb.ie
Secretary: Belinda Taylor: 071 9135061
Mr Willie Collins 
Co-ordinator 
Drugs and Alcohol Services
Southern Health Board
St. Finbarr’s Hospital
Douglas Road 
Cork
Work: 021 4923135
Email: collinsw@shb.ie or
williecollins@eircom.net
RDTF Co-ordinator Chairperson
RDTF Contact List Interim Co-ordinators and Chairpersons
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RDTF Co-ordinator Chairperson
7. Western
8. East Coast Area (Dublin region)
9. Northern Area (Dublin region)
10. South-Western Area (Dublin region)
Mr Padraic Hughes (Retired) 
Tullycommons
Castlebar
Co Mayo 
Tel: 094 9026891
Email: padraighughes1@eircom.net
Mr John O’Brien (Retired FÁS)
Hillcrest,
Timmore,
Newcastle,
Co. Wicklow.
Tel: 01 2819054
Eleanor McEvoy 
Managing Director 
Phonecard Warehouse Ltd.
Unit E, Site 1
Swords Business Park
Dublin
Tel: 01 8903475
Fax: 01 8903476
Email: eleanor@phonecardwarehouse.ie
To be selected
Ms Fiona Walsh
Regional Drugs Co-ordinator
Western Health Board 
Drugs Services
64 Dominic Street
Galway
Work: 091 561198
Fax: 091 561499
Email: f.walsh@whb.ie
Ms Siobhan Turner 
Acting Regional Drugs Co-ordinator
East Coast Area Health Board
Southern Cross House
Southern Cross Business Park
Boghall Road
Bray 
Co. Wicklow
Work: 01 2014200
Email: siobhan.turner@erha.ie
Dr Jane Renehan 
Park House
North Circular Road
Dublin 7 
Work: 01 8823482
Email: jrenehan@eircom.net
Mr Maurice Farnan 
Drug and Addiction Services 
Bridge House 
Cherry Orchard Hospital 
Ballyfermot
Dublin 10
Work: 01 6206400
Fax: 01 6206401
Email: Maurice.farnan@erha.ie
6. South-Eastern Mr Cyril Darcy
11 Seaview Park
Tramore
Co. Waterford
Tel: 051 381122
Mr Tony Barden 
Drugs Co-ordinator
South Eastern Health Board 
St. Patrick’s Hospital
John’s Hill
Waterford
Work: 051 846720
Email: bardent@sehb.ie
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Projects allocated funding under the LDTF Premises Initiative 
Ballymun Community Addiction Centre Ballymun €1,115,790 Construction to begin early 2005
Mountview/Blakestown Community Blanchardstown €89,672 Complete 
Drugs Team 
Corduff Drug Counselling Service Blanchardstown €53,092 Complete 
Moatview/Fairfield Rehab & Support Group Dublin North East €76,184 Complete 
Bonnybrook/Fairfield Community Dublin North East €1,237,409 Complete
Building Project 
Anna Liffey Drug Project North Inner City €820,657 Complete 
The Cavan Centre North Inner City €79,994 Complete 
Chrysalis Community Drug Project North Inner City €22,300 Complete 
Inchicore Community Drugs Team Canal Communities €788,868 Due for completion mid 2005
Rialto Community Drug Team Canal Communities €41,000 Due for completion by end 2004
TURAS Rehabilitation Project Canal Communities €38,000 Due for completion by end 2004
LYNKS Rehabilitation Project Canal Communities €50,000 Due for completion by end 2004
Hesed House Family Support Canal Communities €240,461 Complete 
Programme
Rialto Family Centre Canal Communities €330,132 Complete
Clondalkin Addiction Support Clondalkin €1,273,737 Complete
Programme (CASP) 
YSTU Clondalkin LDTF Clondalkin €157,847 Complete 
Carline Project Clondalkin €222,415 Complete 
Addiction Response Crumlin Dublin 12 €25,395 Complete
Dublin 12 Drugs Task Force Dublin 12 €36,188 Complete
Walkinstown/Greenhills Resource Centre Dublin 12 €71,105 Complete
Sunshine Education, Dublin 12 €591,766 Complete 
Training & Rehabilitiation Centre
Bawnlea Family Support Programme Tallaght €14,100 Due for completion by end 2004
(Barnardos) 
Brookfield Community Centre Tallaght €50,000 Due for completion by end 2004
CARP Killinarden Tallaght €1,007,895 Complete
JADD Jobstown Tallaght €324,158 Complete
St. Aengus Community Action Tallaght €88,882 Complete
St. Dominic’s Tallaght €8,000 Due for completion by end 2004
Springfield Family Support Tallaght €11,500 Due for completion by end 2004
Jobstown Addiction Support Tallaght €33,000 Due for completion by end 2004
St. Francis Farm Tullow Cross-Task Force €63,487 Complete
Advance Ballyfermot €634,870 Complete
Project Name LDTF Area Amount Allocated Current Status 
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Ballyfermot STAR Ballyfermot €125,669 Complete
Liberties Recycling Rehabilitation Project Ballyfermot €99,000 Complete 
CASADH Rehabilitation Centre South Inner City €76,200 Complete 
School St. & Thomas Court South Inner City €101,600 Complete 
Family Support Centre 
ELAH Counselling Service South Inner City €44,500 Complete 
Ringsend & District Response to Drugs South Inner City €450,000 Complete 
CASADH Rehabilitation Project South Inner City €88,000 Due for completion by end 2004
Oliver Bond Community Addiction Team South Inner City €13,000 Due for completion by end 2004
High Park Drumcondra South Inner City €30,000 Due for completion by end 2004
Coolmine Therapeutic Community, Clonee South Inner City €210,000 Due for completion by end 2004
Donore Community Drug Team South Inner City €388,000 Complete  
St. James Resource Centre Cross-Task Force €203,200 Ongoing
Fountain Resource Centre South Inner City €28,100 Complete 
Dun Laoghaire/Rathdown Outreach Project Dun Laoghaire €187,933 Complete 
Bray LDTF Bray €76,184 Complete 
Bray Travellers Community Dev Group – Bray €43,000 Complete
Youth Dev Project 
Bray Community Addiction Drugs Team Bray €15,300 Due for completion by end 2004
Marist Rehabilitation Centre Cross-Task Force €457,400 Complete 
Millennium Carving Project North Inner City €110,467 Complete 
Collamber Drug Rehabilitation Finglas Cabra €350,448 Complete 
Mahon Action Youth Project Cork €126,974 Due for completion mid 2005
Cork Community Drug Team Cork €8,000 Due for completion by end 2004
Project Name LDTF Area Amount Allocated Current Status 
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Ms. Kathleen Stack Dept. Community, Rural & Gaeltacht Affairs
Mr. David Gilbride/ Irish Prison Service
Ms. Philomena Mallon
Ms. Mairead Lyons NACD
Det. Supt. Barry O’Brien Garda National Drugs Unit
Mr. Fergus McCabe/ Citywide
Ms. Anna Quigley
Ms. Alice O’Flynn/ ERHA
Dr. Derval Mowley
Mr. David Moloney Dept. Health & Children
Mr. Tony Geoghegan Voluntary Drug Treatment Network
Ms. Patricia O’Connor NDST
Mr. Andrew Diggins Dept. Education & Science
Ms. Catherine Byrne Dept. Justice, Equality & Law Reform
Ms. Úna Ní Fhaircheallaigh Dept. Community, Rural & Gaeltacht Affairs
Mr. Pat O’Grady Dept. Community, Rural & Gaeltacht Affairs
Contact List of Steering Group on the National Drugs Strategy 
Mid-term Review
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• Examine the progress and the impact of the 
NDS across the four pillars of supply reduction,
prevention, treatment and research in the context
of the objectives set for it, the 100 actions
assigned to be implemented by Departments 
and Agencies and the cost effectiveness of the
various elements; 
• Examine the relevance of the objectives and
actions in tackling the current nature and extent 
of drug misuse in Ireland, including emerging
trends, and identify any gaps presenting and 
how they might be addressed;
• Review the operational effectiveness of the
structures of the NDS, including co-ordination
mechanisms;
• Develop performance indicators and baselines 
in order to measure the effectiveness of the NDS
in the future;
• In light of the foregoing, consider how the
Strategy, including the structures involved in its
delivery, should be refocused or modified for the
remaining period of the Strategy up to 2008; and 
• Make recommendations to the Cabinet
Committee on Social Inclusion on the basis 
of the findings. 
Terms of Reference for the Mid-term 
Review of the National Drugs Strategy (NDS)
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The Terms of Reference for the proposed Expenditure
Review are as follows:
• Examine the objectives of the LDTFs and the
extent to which they have been achieved;
• Measure the outputs and, as far as possible, the
outcomes of the LDTF process and projects;
• Assess the overall effectiveness of the expenditure
with particular reference to:
- The numbers of drug users, families and
others in the community assisted;
- The quality of that assistance;
- The level and nature of services provided;
- Whether those services meet the defined
needs of the LDTF areas;
- Whether the measures accord with the aims,
objectives and targets of the National Drugs
Strategy 2001-2008;
- The extent to which the community, voluntary
and statutory sectors have become involved in
the process;
- The preventative achievements of the process;
and
- The impact on the communities as a whole.
• Define performance indicators and baselines in
order to measure the work of the LDTFs in the
future;
• Review the effectiveness of the mainstreaming
process with particular reference to the cost
implications; and
• Review the overall costs and staffing resources
associated with the process and make
recommendations in relation to improving the
efficiency and effectiveness in the context of the
resources allocated to the LDTF process.
The review should concentrate on the projects
contained in the first action plans as these are 
the longest established and the most suitable in
terms of measuring outputs and outcomes. The
majority of these projects from the first round of LDTF
action plans are now mainstreamed and are funded
through a number of other Departments and
agencies as outlined in paragraph 1 above.
Terms of Reference for the LDTF Expenditure Review

